Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type |Pathology location|Pathology Description|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-1|1|100|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-2|1|100|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-3|1|100|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-4|1|106|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWG: TGAC TO CN. LN..|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-5|1|113|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-6|1|120|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-7|1|124|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-8|1|127|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-9|1|127|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-10|1|131|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-11|1|134|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-12|1|135|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-13|1|135|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-14|1|135|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-15|1|135|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-16|1|135|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-17|1|145|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-18|1|148|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-19|1|155|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-20|1|155|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-21|1|155|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-22|1|155|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-23|1|155|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-24|1|155|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-25|1|157|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-26|1|162|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-27|1|162|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-28|1|162|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-29|1|164|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-30|1|169|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-31|1|170|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-32|1|170|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-33|1|170|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-34|1|170|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-35|1|170|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-36|1|180|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-37|1|190|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-38|1|190|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-39|1|197|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-40|1|199|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-41|1|208|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-42|1|208|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-43|1|208|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-44|1|208|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-45|1|208|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-46|1|208|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-47|1|208|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-48|1|211|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-49|1|211|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-50|1|211|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-51|1|212|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-52|1|212|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-53|1|218|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-54|1|219|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-55|1|219|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-56|1|219|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-57|1|219|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-58|1|226|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-59|1|233|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-60|1|233|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-61|1|236|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-62|1|236|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-63|1|236|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-64|1|243|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-65|1|254|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-66|1|254|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-67|1|254|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-68|1|262|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-69|1|262|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-70|1|262|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-71|1|262|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-72|1|262|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-73|1|262|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-74|1|262|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-75|1|262|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-76|1|262|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-77|1|262|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-78|1|262|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-79|1|262|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-80|1|262|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-81|1|262|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-82|1|262|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-83|1|269|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-84|1|269|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-85|1|269|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-86|1|269|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-87|1|333|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-88|1|491|Other deterministic changes|Whole body|MCDU/  |
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-89|1|492|Other deterministic changes|Whole body|MCDU/  |
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-90|1|560|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-91|1|578|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study 
|1003-22-1-92|1|609|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-93|1|609|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-94|1|640|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-95|1|641|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-96|1|652|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-97|1|673|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-98|1|688|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT. LN..|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-99|1|696|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-100|1|698|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-101|1|703|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ lumbar region. Muscle|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-102|1|704|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-103|1|757|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-104|1|757|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWG: TGAC TO CN. LN..|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-105|1|775|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-106|1|777|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ thigh. Muscle Metastases Lung tmvs of thigh to lung.|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-107|1|792|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-108|1|805|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-109|1|823|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-110|1|832|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-111|1|838|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-112|1|848|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-113|1|848|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-114|1|855|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-115|1|855|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-116|1|856|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-117|1|860|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-118|1|865|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-119|1|869|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-120|1|877|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-121|1|878|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-122|1|884|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-123|1|894|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-124|1|896|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-125|1|904|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-126|1|906|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT. LN..|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-127|1|906|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-128|1|906|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-129|1|908|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle trac to costal muscles. Metastases  Lymphoret.System trac to pt. ln..,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-130|1|911|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-131|1|923|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-132|1|927|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-133|1|929|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-134|1|935|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-135|1|937|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-136|1|939|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-137|1|940|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-138|1|946|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKVS/  ,MPATH: 551 - sarcoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-139|1|949|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-140|1|952|Inflammation and/or fibrotic diseases|Lower digestive tract,MA: 0000328 - intestine|MIIA/ colon.Enteritis acute,MPATH: 212 - inflammation|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-141|1|958|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-142|1|961|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-143|1|963|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWY: TYVS TO LUNG.|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-144|1|967|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-145|1|967|Other deterministic changes|Whole body|MCDU/  |
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-146|1|968|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-147|1|969|Neoplasia unclassified|Other local manifestations and miscellaneus|THWR: TRAC TO LIVER.|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-148|1|971|Other deterministic changes|Whole body|MCDU/  |
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-149|1|971|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|TSBC/ abdomen.,MPATH: 446 - squamous cell carcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-150|1|971|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/   Metastases  Muscle tcfs against spine to muscle along spine.,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-151|1|977|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-152|1|977|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-153|1|980|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-154|1|982|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-155|1|984|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-156|1|984|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-157|1|988|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-158|1|990|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-159|1|995|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-160|1|995|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-161|1|1011|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-162|1|1013|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ adj. to preputial gl. Metastases  Skin tcvs of conn. tiss. adjac. to preputial gl. to skin. Metastases Heart tcvs of conn. tiss. adjac. to preputial gl. to heart.|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-163|1|1017|Neoplasia malignant|Endocrine system|TGAC/   Metastases Lung Metastases  Lymphoret.System tgac to cn. ln..|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-164|1|1018|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-165|1|1019|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases Heart,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-166|1|1020|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-167|1|1021|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-168|1|1024|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-169|1|1026|Neoplasia unclassified|Other local manifestations and miscellaneus|TKWA: TACC TO KIDNEY.|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-170|1|1030|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-171|1|1030|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-172|1|1033|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-173|1|1036|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-174|1|1037|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-175|1|1041|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-176|1|1041|Other deterministic changes|Whole body|MCDU/  |
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-177|1|1043|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-178|1|1044|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-179|1|1045|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-180|1|1048|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-181|1|1048|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-182|1|1051|Neoplasia unclassified|Other local manifestations and miscellaneus|TKWA: TACC TO KIDNEY.|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-183|1|1052|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|TACC/   Metastases Kidney,MPATH: 549 - carcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-184|1|1054|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-185|1|1056|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-186|1|1057|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-187|1|1059|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-188|1|1061|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-189|1|1062|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-190|1|1062|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle trac to costal and neck muscles.,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-191|1|1065|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-192|1|1065|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-193|1|1066|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-194|1|1067|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-195|1|1075|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-196|1|1076|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-197|1|1076|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-198|1|1078|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-199|1|1081|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-200|1|1082|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases Kidney Metastases Heart,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-201|1|1083|Neoplasia malignant|Bloodvessels among cardiovascular system|TYVS/  Heart Metastases Lung|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-202|1|1086|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-203|1|1086|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-204|1|1092|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-205|1|1093|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-206|1|1094|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-207|1|1095|Other deterministic changes|Whole body|MCDU/  |
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-208|1|1097|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-209|1|1098|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-210|1|1102|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-211|1|1107|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-212|1|1107|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-213|1|1112|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-214|1|1113|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-215|1|1117|Other deterministic changes|Whole body|MCDU/  |
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-216|1|1121|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-217|1|1121|Neoplasia unclassified|Other local manifestations and miscellaneus|THWR: TRAC TO LIVER.|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-218|1|1122|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-219|1|1122|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-220|1|1123|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-221|1|1123|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac to pt. ln., br. ln.. Metastases Liver,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-222|1|1132|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|MRMP/  Murine,MPATH: 212 - inflammation|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-223|1|1135|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-224|1|1135|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-225|1|1137|Other deterministic changes|Whole body|MCDU/  |
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-226|1|1139|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-227|1|1142|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-228|1|1154|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-229|1|1156|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-230|1|1158|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-231|1|1163|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-232|1|1168|Other deterministic changes|Whole body|MCDU/  |
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-233|1|1170|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-234|1|1174|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-235|1|1176|Neoplasia unclassified|Other local manifestations and miscellaneus|TSWC: TCVS OF CONN. TISS. ADJAC. TO PREPUTIAL GL. TO SKIN.|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-236|1|1179|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-237|1|1181|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-238|1|1184|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-239|1|1185|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-240|1|1187|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-241|1|1187|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-242|1|1190|Inflammation and/or fibrotic diseases|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|MHIC/  chronic hepatitis,MPATH: 212 - inflammation|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-243|1|1194|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-244|1|1195|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-245|1|1204|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-246|1|1205|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-247|1|1205|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-248|1|1214|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-249|1|1216|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-250|1|1221|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-251|1|1222|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-252|1|1222|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-253|1|1224|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-254|1|1227|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-255|1|1240|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-256|1|1241|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-257|1|1244|Other deterministic changes|Whole body|MCDU/  |
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-258|1|1258|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-259|1|1269|Other deterministic changes|Whole body|MCDU/  |
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-260|1|1277|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-261|1|1278|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-262|1|1282|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-263|1|1287|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-264|1|1291|Inflammation and/or fibrotic diseases|Kidney among urinary system diseases,MA: 0000368 - kidney|MPNE/  acute,MPATH: 212 - inflammation|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-265|1|1310|Other deterministic changes|Whole body|MCDU/  |
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-266|1|1310|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-267|1|1312|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-268|1|1330|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-269|1|1331|Inflammation and/or fibrotic diseases|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|MHIC/  chronic hepatitis,MPATH: 212 - inflammation|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-270|1|1342|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-271|1|1345|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-272|1|1346|Other deterministic changes|Whole body|MCDU/  |
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-273|1|1355|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-274|1|1365|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-275|1|1380|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-276|1|1387|n/a|n/a|n/a|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-277|1|1387|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-278|1|1418|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-279|1|1429|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-1|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|280 (280 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|195 records survival 928 ± 15 lifespan study|1003-22-1-280|1|1442|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-1|2|135|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-2|2|135|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-3|2|135|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-4|2|135|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-5|2|135|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-6|2|135|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-7|2|135|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-8|2|135|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-9|2|135|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-10|2|135|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-11|2|135|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-12|2|135|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-13|2|135|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-14|2|135|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-15|2|135|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-16|2|135|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-17|2|135|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-18|2|135|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-19|2|135|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-20|2|135|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-21|2|385|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-22|2|429|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-23|2|478|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-24|2|478|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-25|2|478|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-26|2|478|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-27|2|478|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-28|2|478|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-29|2|478|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-30|2|478|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-31|2|478|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-32|2|478|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-33|2|478|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-34|2|478|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-35|2|478|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-36|2|478|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-37|2|478|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-38|2|478|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-39|2|478|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-40|2|478|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-41|2|478|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-42|2|478|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-43|2|491|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-44|2|520|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-45|2|520|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-46|2|520|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-47|2|520|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-48|2|520|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-49|2|527|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-50|2|527|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-51|2|527|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-52|2|527|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-53|2|527|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-54|2|527|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-55|2|527|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-56|2|527|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-57|2|527|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-58|2|527|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-59|2|534|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-60|2|534|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-61|2|534|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-62|2|534|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-63|2|534|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-64|2|596|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-65|2|620|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-66|2|624|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-67|2|625|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ dorsal-lumbar region.|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-68|2|634|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-69|2|660|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-70|2|697|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ c.t. adnexal tissue about ov. & uterus.|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-71|2|697|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWG: TGAC TO LUNG.|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-72|2|709|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-73|2|715|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-74|2|717|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-75|2|722|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-76|2|729|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-77|2|731|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-78|2|759|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-79|2|762|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases  tcfs of lumbar region to visc. pleura at base of heart.,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-80|2|764|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWC: TCFS OF LUMBAR REGION TO LUNG.|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-81|2|780|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-82|2|785|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-83|2|792|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS OF THIGH TO THIGH MUSCLE.|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-84|2|792|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS OF THIGH TO THIGH MUSCLE.|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-85|2|808|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-86|2|813|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS OF PELVIC REGION INVAS. OF SKEL. MUSCLE & BONE.|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-87|2|829|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-88|2|831|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-89|2|834|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-90|2|843|Other deterministic changes|Whole body|MCDU/  |
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-91|2|854|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-92|2|855|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWB: TBVS OF TIBIA TO MUSCLE OF LEG.|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-93|2|857|Other deterministic changes|Whole body|MCDU/  |
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-94|2|869|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-95|2|870|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-96|2|872|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-97|2|875|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-98|2|876|Neoplasia malignant|Bloodvessels among cardiovascular system|TPVS/  Pituitary|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-99|2|877|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-100|2|885|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-101|2|890|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-102|2|890|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-103|2|892|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-104|2|903|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-105|2|911|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-106|2|911|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-107|2|911|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-108|2|912|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-109|2|914|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-110|2|920|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-111|2|925|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-112|2|953|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-113|2|960|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-114|2|964|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-115|2|964|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-116|2|965|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-117|2|966|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-118|2|967|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWB: TBVS OF TIBIA TO MUSCLE OF LEG.|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-119|2|968|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-120|2|971|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ leg muscle. Muscle Metastases  Skin tcvs to axilla. Metastases  Muscle tcvs of axilla to axillary & forelimb muscle.|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-121|2|971|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-122|2|974|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-123|2|975|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-124|2|977|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS OF THORAX TO THOR. MUSCLE & RIB.|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-125|2|978|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-126|2|982|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ prob. on back. Metastases  Skin tcfs invas. of skin.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-127|2|984|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/   Metastases  Muscle tbvs of tibia to muscle of leg.,MPATH: 242 - hemangiosarcoma|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-128|2|993|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-129|2|995|Other deterministic changes|Whole body|MCDU/  |
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-130|2|998|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS OF THIGH TO THIGH MUSCLE.|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-131|2|1003|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS OF THIGH TO THIGH MUSCLE.|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-132|2|1006|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ thigh. Metastases  Muscle tcvs of thigh to thigh muscle. Metastases  Skin tcvs of thigh to thigh skin.|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-133|2|1017|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-134|2|1030|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-135|2|1036|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-136|2|1040|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases Kidney,MPATH: 268 - adenocarcinoma|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-137|2|1041|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-138|2|1041|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-139|2|1041|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-140|2|1044|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOVO/  ,MPATH: 242 - hemangiosarcoma|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-141|2|1045|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TXEC/ saliv. gland.,MPATH: 446 - squamous cell carcinoma|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-142|2|1050|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  Eye(s) missing,MPATH: 242 - hemangiosarcoma|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-143|2|1055|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-144|2|1060|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-145|2|1074|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-146|2|1081|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-147|2|1087|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|TNUS/ trigem. nerve.,MPATH: 551 - sarcoma|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-148|2|1093|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-149|2|1097|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS OF PERIT. TO ABDOM. MUSCLE.|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-150|2|1101|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-151|2|1103|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-152|2|1106|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOVO/  ,MPATH: 242 - hemangiosarcoma|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-153|2|1106|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-154|2|1110|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-155|2|1111|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-156|2|1111|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-157|2|1120|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-158|2|1123|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-159|2|1126|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-160|2|1129|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-161|2|1132|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-162|2|1137|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-163|2|1142|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases  trac to visc. pleura. Metastases Heart,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-164|2|1143|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-165|2|1144|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-166|2|1144|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-167|2|1145|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ pelvic region. Metastases  Muscle tcfs of pelvic region invas. of skel. muscle & bone.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-168|2|1148|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/  |
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-169|2|1149|Neoplasia unclassified|Lower digestive tract,MA: 0000328 - intestine|TIAC/ jejunum.,MPATH: 218 - neoplasm|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-170|2|1149|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-171|2|1151|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-172|2|1158|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-173|2|1158|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-174|2|1160|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-175|2|1171|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ against spine, encasing nerve fibers.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-176|2|1172|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ thorax. Metastases  Muscle tcfs of thorax to thor. muscle & rib.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-177|2|1179|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-178|2|1180|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-179|2|1187|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-180|2|1187|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/   Metastases  Muscle tcfs of perit. to abdom. muscle.,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-181|2|1188|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-182|2|1188|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-183|2|1209|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-184|2|1217|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-185|2|1217|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-186|2|1219|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-187|2|1219|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-188|2|1219|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-189|2|1226|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ thigh. Metastases  Skin tcvs of thigh to skin of thigh. Metastases  Muscle tcvs of thigh to thigh muscle.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-190|2|1241|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-191|2|1244|Neoplasia malignant|Endocrine system|TGAC/   Metastases Lung|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-192|2|1249|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-193|2|1254|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-194|2|1261|n/a|n/a|n/a|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-195|2|1261|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TXAC/ ureter with mark distortion of visc. perit., uterus, & colon.,MPATH: 268 - adenocarcinoma|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-196|2|1277|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-197|2|1332|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ lumbar region. Metastases Lung,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-198|2|1335|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-199|2|1336|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-2|n/a,KO|1| 100|shamexposed|0|grays|External exposure| code K0 24 fractions 45 m 1/w|200 (200 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|140 records survival 890 ± 16 lifespan study|1003-22-2-200|2|1394|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-1|3|107|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-2|3|131|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-3|3|131|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-4|3|131|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-5|3|131|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-6|3|134|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-7|3|134|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-8|3|135|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-9|3|152|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-10|3|152|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-11|3|152|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-12|3|155|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-13|3|155|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-14|3|155|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-15|3|155|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-16|3|155|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-17|3|155|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-18|3|159|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-19|3|162|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-20|3|162|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-21|3|162|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-22|3|171|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-23|3|171|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-24|3|173|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-25|3|173|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-26|3|173|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-27|3|183|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-28|3|190|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-29|3|199|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-30|3|199|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-31|3|205|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-32|3|205|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-33|3|205|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-34|3|205|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-35|3|205|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-36|3|206|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-37|3|206|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-38|3|208|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-39|3|208|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-40|3|208|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-41|3|208|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-42|3|208|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-43|3|218|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-44|3|218|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-45|3|233|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-46|3|233|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-47|3|233|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-48|3|233|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-49|3|233|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-50|3|233|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-51|3|236|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-52|3|243|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-53|3|247|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-54|3|247|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-55|3|247|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-56|3|254|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-57|3|254|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-58|3|254|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-59|3|254|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-60|3|254|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-61|3|261|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-62|3|261|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-63|3|261|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-64|3|261|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-65|3|261|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-66|3|261|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-67|3|261|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-68|3|262|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-69|3|262|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-70|3|262|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-71|3|262|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-72|3|262|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-73|3|262|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-74|3|262|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-75|3|269|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-76|3|269|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-77|3|269|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-78|3|270|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-79|3|300|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWG: TGAC TO SKIN OF FACE.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-80|3|337|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-81|3|420|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-82|3|470|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-83|3|476|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/   Metastases  trac to mediast. tissue.,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-84|3|479|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-85|3|487|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-86|3|502|Neoplasia unclassified|Other local manifestations and miscellaneus|TKWR: TRAC TO KIDNEY.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-87|3|521|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-88|3|531|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ subcutis on back. Metastases Liver Metastases Lung|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-89|3|540|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-90|3|542|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-91|3|548|Neoplasia malignant|Lower digestive tract,MA: 0000328 - intestine|TIEC/ stomach. Metastases  tiec of stomach to visc. peritoneal surfaces of organs.,MPATH: 549 - carcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-92|3|548|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-93|3|566|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-94|3|576|Neoplasia unclassified|Central nervous system among nervous system|TNXS/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-95|3|578|Neoplasia malignant|Endocrine system|TGAC/   Metastases Lung Metastases  Muscle tgac to muscle around eye.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-96|3|582|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-97|3|603|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  trac to visceral & parietal pleura. Metastases  Muscle trac to intercostal muscles.,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-98|3|605|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Eye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-99|3|618|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-100|3|620|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-101|3|621|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-102|3|625|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-103|3|634|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-104|3|638|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-105|3|638|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-106|3|641|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWG: TGAC TO ORBITAL TISSUES.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-107|3|649|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-108|3|652|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWG: TGAC TO ORBITAL TISSUES.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-109|3|653|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-110|3|660|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-111|3|668|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ thigh. Muscle|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-112|3|669|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-113|3|669|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWR: TRAC TO STERNAL MUSCLE.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-114|3|672|Neoplasia systemic|Haematolymphatic system|TLML/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-115|3|672|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-116|3|674|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-117|3|675|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases Liver,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-118|3|677|Neoplasia malignant|Endocrine system|TGAC/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-119|3|680|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS TO MUSCLE OF THIGH.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-120|3|684|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-121|3|688|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-122|3|689|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-123|3|691|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-124|3|692|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-125|3|694|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWS: TSEC OF ABDOMEN TO VISC. PERITONEUM, OF LIVER, SLEEN, AND DIAPHRAGM.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-126|3|695|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-127|3|697|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-128|3|697|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-129|3|698|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS TO MUSCLE OF LUMBAR SPINE.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-130|3|702|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO BRONCH. L.N.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-131|3|713|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-132|3|715|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-133|3|717|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-134|3|722|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-135|3|725|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-136|3|727|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-137|3|731|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-138|3|732|Neoplasia systemic|Haematolymphatic system|TLML/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-139|3|732|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWB: TBOS OF STERNABRA & RIB TO THOR. MUSCLE.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-140|3|733|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ thigh. Muscle|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-141|3|736|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac to pt. l.n.. Metastases  Muscle trac to thoracic muscles.,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-142|3|737|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-143|3|739|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/   Metastases  Lymphoret.System trac to pt. l.n.,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-144|3|739|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-145|3|741|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-146|3|743|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-147|3|743|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-148|3|744|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-149|3|745|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-150|3|746|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac to pt. l.n..,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-151|3|747|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-152|3|747|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-153|3|749|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-154|3|752|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-155|3|761|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-156|3|762|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWG: TGAC TO SKULL.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-157|3|763|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWI: TIVS OF OUTER WALL OF JEJUNUM INVAS. OF PANCREAS.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-158|3|764|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-159|3|764|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-160|3|765|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-161|3|766|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-162|3|768|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-163|3|768|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-164|3|771|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-165|3|771|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TXUO/ zymbal gl. of ear canal.,MPATH: 218 - neoplasm|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-166|3|772|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-167|3|772|Neoplasia unclassified|Other local manifestations and miscellaneus|THWR: TRAC TO LIVER.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-168|3|773|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-169|3|774|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-170|3|775|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-171|3|776|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO BRONCH. & PT. L.N.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-172|3|778|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-173|3|778|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO BRONCH. & PT. L.N.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-174|3|778|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO BRONCH. L.N.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-175|3|779|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-176|3|779|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-177|3|779|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT. L.N..|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-178|3|780|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-179|3|781|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWI: TIEC OF STOMACH TO LUNG.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-180|3|785|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-181|3|786|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-182|3|787|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-183|3|788|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWK: TKAC TO PT. L.N..|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-184|3|791|Neoplasia unclassified|Other local manifestations and miscellaneus|THWR: TRAC TO LIVER.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-185|3|792|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-186|3|792|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-187|3|795|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-188|3|796|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-189|3|796|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-190|3|800|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-191|3|800|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWS: TSEC OF ABDOMEN TO VISC. PERITONEUM, OF LIVER, SLEEN, AND DIAPHRAGM.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-192|3|800|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac to parathymic l.n. & spleen. Metastases Liver Metastases  Muscle trac to lumbar vert. muscle. Metastases Heart,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-193|3|800|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWG: TGAC TO LUNG.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-194|3|801|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRVS/ multiple.,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-195|3|802|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPAO/  Adenoma,MPATH: 218 - neoplasm|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-196|3|802|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-197|3|803|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-198|3|807|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-199|3|808|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-200|3|809|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-201|3|810|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-202|3|813|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-203|3|815|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-204|3|816|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-205|3|817|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-206|3|817|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO MEDIAST. L.N.'S.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-207|3|820|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-208|3|821|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-209|3|821|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-210|3|823|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-211|3|824|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-212|3|824|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-213|3|825|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ thigh. Muscle|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-214|3|827|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-215|3|828|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-216|3|828|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-217|3|829|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases Lung tiec of stomach to lung.,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-218|3|830|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWI: TIEC OF STOMACH TO VISC. PERITONEAL SURFACES OF ORGANS.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-219|3|832|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-220|3|832|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-221|3|833|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-222|3|834|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-223|3|835|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  trac to tissue adj. to but separate from kidney and adrenal.,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-224|3|836|Neoplasia malignant|Bloodvessels among cardiovascular system|TTVS/ metas. visc. & pariet. perit. & diaphragm.Testis|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-225|3|836|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-226|3|837|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-227|3|837|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-228|3|837|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-229|3|838|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-230|3|841|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-231|3|841|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-232|3|842|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-233|3|842|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-234|3|842|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-235|3|844|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-236|3|844|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-237|3|844|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-238|3|845|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-239|3|845|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-240|3|846|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-241|3|847|Inflammation and/or fibrotic diseases|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|MHCN/  Coagulative focal hepatitis,MPATH: 212 - inflammation|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-242|3|848|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-243|3|849|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-244|3|849|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-245|3|849|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-246|3|851|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-247|3|852|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-248|3|852|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-249|3|854|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-250|3|856|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-251|3|857|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWI: TIEC OF STOMACH TO VISC. PERITONEAL SURFACES OF ORGANS.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-252|3|858|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-253|3|858|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-254|3|858|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-255|3|859|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-256|3|859|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ rectal area. Muscle|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-257|3|859|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-258|3|859|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-259|3|860|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-260|3|862|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-261|3|865|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-262|3|865|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-263|3|866|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-264|3|866|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-265|3|867|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-266|3|868|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-267|3|868|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-268|3|868|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-269|3|869|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-270|3|869|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-271|3|869|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-272|3|870|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-273|3|870|Inflammation and/or fibrotic diseases|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|MHIC/  chronic hepatitis,MPATH: 212 - inflammation|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-274|3|871|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-275|3|871|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ dorsal pelvic reg. with lysis of bone. Metastases  Muscle tcvs invas. skel. muscle.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-276|3|871|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO BRONCH. L.N.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-277|3|876|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-278|3|877|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-279|3|877|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT. L.N..|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-280|3|877|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-281|3|878|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases Lung,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-282|3|878|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-283|3|878|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-284|3|879|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-285|3|879|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-286|3|882|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-287|3|883|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-288|3|884|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-289|3|885|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-290|3|886|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-291|3|887|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-292|3|887|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-293|3|887|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases  Lymphoret.System trac to bronch. l.n.,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-294|3|891|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-295|3|892|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-296|3|892|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-297|3|894|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-298|3|894|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT. L.N..|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-299|3|894|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-300|3|896|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-301|3|897|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-302|3|898|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-303|3|899|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-304|3|899|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-305|3|899|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-306|3|900|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWC: TCFS OF UNDETERMINED SITE TO LUNG.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-307|3|900|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWI: TIVS OF OUTER WALL OF JEJUNUM INVAS. OF PANCREAS.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-308|3|901|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-309|3|901|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-310|3|904|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-311|3|905|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-312|3|906|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases Kidney,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-313|3|906|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS TO MUSCLE OF FOOT.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-314|3|908|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWI: TIVS OF OUTER WALL OF JEJUNUM INVAS. OF PANCREAS.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-315|3|910|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-316|3|910|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-317|3|911|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-318|3|911|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-319|3|911|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-320|3|913|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-321|3|913|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-322|3|917|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-323|3|917|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-324|3|917|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-325|3|918|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-326|3|918|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-327|3|920|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases Lung,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-328|3|921|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-329|3|922|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-330|3|922|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-331|3|922|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-332|3|922|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWG: TGAC TO SKIN OF FACE.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-333|3|925|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWI: TIEC OF STOMACH TO LUNG.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-334|3|925|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-335|3|927|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-336|3|927|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-337|3|927|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-338|3|929|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-339|3|930|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ thigh. Metastases  Muscle tcvs of thigh to muscle of thigh.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-340|3|932|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWB: TBOS OF STERNABRA & RIB TO THOR. MUSCLE.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-341|3|932|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-342|3|932|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-343|3|932|Changes due to an abnormal circulation|Bloodvessels among cardiovascular system|MTHR/  auricular|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-344|3|932|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-345|3|932|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac to parathymic l.n.,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-346|3|933|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-347|3|936|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-348|3|937|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-349|3|937|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-350|3|939|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-351|3|939|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-352|3|940|Neoplasia malignant|Bloodvessels among cardiovascular system|TYVS/  Heart Metastases Lung tmvs of rectal area to lung.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-353|3|940|Changes due to an abnormal circulation|Bloodvessels among cardiovascular system|MTHR/  auricular|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-354|3|941|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-355|3|943|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-356|3|943|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-357|3|946|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-358|3|947|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-359|3|947|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-360|3|947|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-361|3|947|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/   Metastases  Lymphoret.System tkac to pt. l.n.. Metastases  Muscle tkac to intercostal muscles. Metastases Lung,MPATH: 549 - carcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-362|3|947|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-363|3|949|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-364|3|949|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-365|3|950|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ thoracic spine.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-366|3|950|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-367|3|952|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-368|3|953|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-369|3|955|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-370|3|957|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-371|3|957|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-372|3|958|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-373|3|959|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-374|3|959|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-375|3|961|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-376|3|961|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-377|3|961|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TXAC/ saliv. gl.,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-378|3|962|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ sternal muscle. Muscle|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-379|3|963|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases  Lymphoret.System trac to bronch. l.n.,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-380|3|963|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO MEDIAST. L.N.'S.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-381|3|963|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-382|3|964|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-383|3|965|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-384|3|966|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ perineal c.t. adj. to scrotum.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-385|3|968|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac to bronch. & pt. l.n.,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-386|3|968|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-387|3|968|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  trac to mediast. tissue between lung & esoph. & trachea.,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-388|3|968|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-389|3|970|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-390|3|971|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-391|3|971|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-392|3|972|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-393|3|972|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-394|3|973|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-395|3|974|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWR: TRAC TO INTERCOSTALS.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-396|3|974|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-397|3|974|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-398|3|975|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-399|3|976|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-400|3|976|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-401|3|977|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases Liver,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-402|3|978|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ thigh with invas. on femur.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-403|3|978|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-404|3|978|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-405|3|979|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-406|3|982|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-407|3|984|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWR: TRAC TO STERNAL MUSCLE.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-408|3|984|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-409|3|987|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-410|3|988|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-411|3|989|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-412|3|989|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle trac to sternal muscle.,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-413|3|989|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-414|3|989|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-415|3|989|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-416|3|992|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/   Metastases  Muscle trac to rib cage,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-417|3|992|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-418|3|995|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-419|3|996|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-420|3|998|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-421|3|998|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-422|3|998|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ sternabra & rib. Metastases  Muscle tbos of sternabra & rib to thor. muscle.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-423|3|1002|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-424|3|1002|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-425|3|1002|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  trac to mediast. above ht, about esoph. & trach. serosa. Metastases  Lymphoret.System trac to mediast. l.n.'s. Metastases  Muscle trac to diaphragm.,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-426|3|1002|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-427|3|1002|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-428|3|1002|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS OF INGUINAL REGION TO MUSCLE OF INGUINAL REGION.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-429|3|1002|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-430|3|1003|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-431|3|1003|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle trac to intercostals.,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-432|3|1005|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-433|3|1005|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-434|3|1006|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ abdomen. Metastases  Skin tcvs of abdomen to abd. skin. Metastases  tcvs of abdomen to ureter.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-435|3|1009|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-436|3|1009|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO BRONCH. L.N. & PARATHYMIC L.N.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-437|3|1009|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-438|3|1010|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-439|3|1010|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-440|3|1011|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-441|3|1012|Neoplasia malignant|Bloodvessels among cardiovascular system|TYVS/  Heart|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-442|3|1012|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-443|3|1012|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-444|3|1016|Neoplasia malignant|Lower digestive tract,MA: 0000328 - intestine|TIFS/ caecum.,MPATH: 551 - sarcoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-445|3|1017|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-446|3|1018|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-447|3|1018|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-448|3|1019|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWK: TKAC TO LUNG.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-449|3|1020|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-450|3|1023|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-451|3|1023|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-452|3|1023|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  trac to pariet. & visc. pleura - thorax. Metastases  Muscle trac to intercostal muscle. Metastases  Lymphoret.System trac to bronch. l.n. & parathymic l.n.,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-453|3|1024|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-454|3|1025|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-455|3|1028|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/ tissues autol.,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-456|3|1029|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO BRONCH. L.N.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-457|3|1029|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-458|3|1030|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-459|3|1030|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS TO MUSCLE OF LUMBAR SPINE.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-460|3|1030|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-461|3|1031|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-462|3|1031|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-463|3|1031|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-464|3|1031|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-465|3|1032|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-466|3|1033|Neoplasia malignant|Bloodvessels among cardiovascular system|TYVS/  Heart|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-467|3|1034|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-468|3|1037|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-469|3|1038|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-470|3|1040|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-471|3|1044|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-472|3|1044|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-473|3|1044|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ adj. to pelvis. Metastases  Muscle tcvs to skel. muscle of pelvis.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-474|3|1044|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-475|3|1045|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-476|3|1045|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-477|3|1047|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-478|3|1048|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-479|3|1048|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ leg. Muscle|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-480|3|1049|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-481|3|1051|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-482|3|1051|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-483|3|1054|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-484|3|1055|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-485|3|1055|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-486|3|1057|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-487|3|1058|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-488|3|1060|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-489|3|1060|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-490|3|1062|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-491|3|1062|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-492|3|1064|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-493|3|1064|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-494|3|1065|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-495|3|1065|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-496|3|1066|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-497|3|1066|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-498|3|1066|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-499|3|1068|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-500|3|1069|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-501|3|1072|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-502|3|1072|Neoplasia malignant|Endocrine system|TGAC/   Metastases  tgac to skin of face.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-503|3|1072|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-504|3|1072|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-505|3|1072|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-506|3|1072|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-507|3|1076|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-508|3|1079|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ inguinal region. Metastases  Muscle tcvs of inguinal region to muscle of inguinal region.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-509|3|1079|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/   Metastases Lung,MPATH: 549 - carcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-510|3|1079|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-511|3|1079|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-512|3|1079|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-513|3|1079|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-514|3|1081|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWG: TGAC TO SKULL.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-515|3|1081|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-516|3|1082|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-517|3|1082|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-518|3|1083|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-519|3|1084|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-520|3|1084|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-521|3|1086|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-522|3|1086|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac to pt. l.n..,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-523|3|1087|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-524|3|1087|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-525|3|1088|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO BRONCH. L.N. & PARATHYMIC L.N.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-526|3|1090|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-527|3|1091|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-528|3|1091|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-529|3|1093|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-530|3|1093|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-531|3|1093|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-532|3|1094|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-533|3|1095|Neoplasia malignant|Endocrine system|TGAC/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-534|3|1097|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-535|3|1097|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-536|3|1100|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-537|3|1100|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-538|3|1102|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-539|3|1103|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS TO MUSCLE OF LUMBAR SPINE.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-540|3|1104|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-541|3|1104|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-542|3|1104|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-543|3|1109|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-544|3|1109|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-545|3|1111|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-546|3|1111|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-547|3|1114|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-548|3|1116|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-549|3|1118|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-550|3|1118|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-551|3|1119|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT. L.N..|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-552|3|1121|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWR: TRAC TO STERNAL MUSCLE.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-553|3|1121|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-554|3|1121|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-555|3|1122|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ prim. site undetermined. Metastases Lung Metastases Heart tcfs of undetermined site to heart. Metastases Lung,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-556|3|1122|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-557|3|1122|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-558|3|1124|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-559|3|1124|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-560|3|1124|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/ jejunal wall.,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-561|3|1128|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-562|3|1128|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-563|3|1129|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-564|3|1130|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-565|3|1130|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-566|3|1131|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-567|3|1132|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-568|3|1133|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-569|3|1135|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-570|3|1135|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-571|3|1136|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-572|3|1137|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-573|3|1138|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-574|3|1138|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ lumbar spine with invas. & lysis of bone.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-575|3|1138|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS INVAS. SKEL. MUSCLE.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-576|3|1139|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-577|3|1139|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ thigh. Muscle|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-578|3|1142|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWR: TRAC TO INTERCOSTAL MUSCLES.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-579|3|1143|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-580|3|1144|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-581|3|1145|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-582|3|1145|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-583|3|1145|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-584|3|1148|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-585|3|1149|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-586|3|1149|Neoplasia unclassified|Lower digestive tract,MA: 0000328 - intestine|TIAC/ ileum.,MPATH: 218 - neoplasm|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-587|3|1150|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-588|3|1150|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-589|3|1151|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-590|3|1152|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-591|3|1153|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-592|3|1157|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWH: THAC TO LUNG.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-593|3|1164|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-594|3|1165|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-595|3|1166|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-596|3|1166|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-597|3|1169|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases  tgac to orbital tissues.,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-598|3|1170|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ thigh. Metastases  Muscle tcvs to muscle of thigh.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-599|3|1172|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PARATHYMIC L.N.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-600|3|1174|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-601|3|1178|Neoplasia malignant|Bloodvessels among cardiovascular system|TYVS/  Heart|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-602|3|1179|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ foreleg. invas. of bone. Metastases  Muscle tcvs of foreleg to muscle of foreleg. Metastases  Skin tcvs of foreleg to skin of foreleg.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-603|3|1179|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-604|3|1184|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-605|3|1187|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ inguinal region.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-606|3|1191|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-607|3|1194|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-608|3|1195|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-609|3|1196|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/   Metastases Heart,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-610|3|1198|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-611|3|1199|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-612|3|1200|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-613|3|1200|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-614|3|1206|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-615|3|1206|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-616|3|1209|Neoplasia malignant|Bloodvessels among cardiovascular system|TLVS/ mesenteric lymph node. Lymphoret.tissue|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-617|3|1209|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-618|3|1211|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/   Metastases  Muscle tcvs to muscle of foot.,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-619|3|1219|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|MCRD/  ,MPATH: 1 - cell and tissue damage|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-620|3|1219|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-621|3|1220|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-622|3|1223|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-623|3|1223|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-624|3|1227|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-625|3|1227|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-626|3|1228|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-627|3|1229|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-628|3|1230|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-629|3|1238|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-630|3|1239|Neoplasia malignant|Bloodvessels among cardiovascular system|TIVS/ outer wall of jejunum. Metastases  tivs of outer wall of jejunum invas. of pancreas.|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-631|3|1240|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System tcvs to prob. abd. l.n.,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-632|3|1240|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases Heart , mediastinal tiss. , Kidney,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-633|3|1247|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-634|3|1247|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-635|3|1249|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-636|3|1249|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-637|3|1249|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-638|3|1258|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|MCLC/ prolapse.Colitis|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-639|3|1259|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-640|3|1260|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-641|3|1260|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-642|3|1263|Neoplasia unclassified|Integumentary system,MA: 0000151 - skin|TSEC/ abdomen. Metastases  tsec of abdomen to visc. peritoneum, of liver, sleen, and diaphragm.,MPATH: 218 - neoplasm|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-643|3|1263|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-644|3|1268|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-645|3|1269|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-646|3|1269|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-647|3|1272|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-648|3|1272|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-649|3|1276|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-650|3|1277|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-651|3|1278|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle tcvs to muscle of lumbar spine.,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-652|3|1281|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-653|3|1282|Inflammation and/or fibrotic diseases|Cardiovascular system,MA: 0000164 - myocardium|MMCA/ MMCA/ MMCA/ MMCA/  acute,MPATH: 212 - inflammation|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-654|3|1283|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-655|3|1285|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-656|3|1288|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-657|3|1289|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|MCRD/   Metastases Lung Metastases  Muscle tgac to skull.,MPATH: 1 - cell and tissue damage|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-658|3|1297|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-659|3|1305|Changes due to an abnormal circulation|Bloodvessels among cardiovascular system|MTHR/  auricular|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-660|3|1307|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-661|3|1310|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-662|3|1314|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-663|3|1321|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-664|3|1324|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-665|3|1326|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-666|3|1339|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-667|3|1347|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-668|3|1349|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-669|3|1354|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-670|3|1366|Other deterministic changes|Whole body|MCDU/  |
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-671|3|1375|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-672|3|1380|n/a|n/a|n/a|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-673|3|1386|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-674|3|1394|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-3|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|598 records survival 854 ± 8 lifespan study|1003-22-3-675|3|1443|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-1|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-2|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-3|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-4|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-5|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-6|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-7|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-8|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-9|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-10|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-11|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-12|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-13|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-14|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-15|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-16|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-17|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-18|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-19|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-20|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-21|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-22|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-23|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-24|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-25|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-26|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-27|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-28|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-29|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-30|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-31|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-32|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-33|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-34|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-35|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-36|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-37|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-38|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-39|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-40|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-41|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-42|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-43|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-44|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-45|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-46|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-47|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-48|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-49|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-50|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-51|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-52|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-53|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-54|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-55|4|430|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-56|4|466|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-57|4|471|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-58|4|472|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-59|4|472|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-60|4|472|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-61|4|472|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-62|4|472|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-63|4|472|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-64|4|472|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-65|4|472|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-66|4|472|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-67|4|472|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-68|4|472|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-69|4|472|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-70|4|472|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-71|4|472|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-72|4|472|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-73|4|472|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-74|4|472|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-75|4|472|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-76|4|479|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-77|4|479|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-78|4|479|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-79|4|479|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-80|4|479|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-81|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-82|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-83|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-84|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-85|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-86|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-87|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-88|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-89|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-90|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-91|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-92|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-93|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-94|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-95|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-96|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-97|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-98|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-99|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-100|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-101|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-102|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-103|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-104|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-105|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-106|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-107|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-108|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-109|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-110|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-111|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-112|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-113|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-114|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-115|4|486|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-116|4|762|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-117|4|782|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-118|4|1009|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-119|4|1037|n/a|n/a|n/a|
1003-22-4|n/a,K1|1| 100|gamma-rays Co-60|2.06|grays|External exposure| code K1 24 fractions 45 m 1/w|120 (120 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|7 records females reassigned|1003-22-4-120|4|1150|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-1|5|124|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-2|5|124|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-3|5|124|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-4|5|124|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-5|5|134|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-6|5|134|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-7|5|145|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-8|5|145|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-9|5|145|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-10|5|152|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-11|5|155|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-12|5|155|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-13|5|157|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-14|5|162|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-15|5|162|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-16|5|169|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-17|5|169|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-18|5|169|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-19|5|169|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-20|5|171|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-21|5|173|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-22|5|187|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-23|5|190|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-24|5|190|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-25|5|191|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-26|5|191|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-27|5|191|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-28|5|205|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-29|5|205|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-30|5|208|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-31|5|208|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-32|5|208|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-33|5|208|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-34|5|208|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-35|5|218|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-36|5|218|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-37|5|233|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-38|5|243|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-39|5|243|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-40|5|247|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-41|5|247|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-42|5|254|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-43|5|254|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-44|5|254|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-45|5|254|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-46|5|262|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-47|5|262|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-48|5|262|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-49|5|262|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-50|5|262|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-51|5|264|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-52|5|269|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-53|5|269|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-54|5|269|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-55|5|269|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-56|5|269|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-57|5|377|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-58|5|430|Neoplasia malignant|Bloodvessels among cardiovascular system|TTVS/ testis.Testis|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-59|5|441|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-60|5|479|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ perianal region.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-61|5|483|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-62|5|512|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-63|5|527|Neoplasia unclassified|Other local manifestations and miscellaneus|TKWM: TMFS RIGHT SIDE AND LEG TO KIDNEY.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-64|5|531|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWR: TRAC TO INTERCOSTAL MUSCLES.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-65|5|533|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-66|5|537|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-67|5|564|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-68|5|587|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-69|5|592|Neoplasia malignant|Bone among musculo-skeletal system diseases,MA: 0000018 - skeletal system|TBFS/ periosteum of femur. Metastases  Muscle tbfs to muscle of femur and pelvis.,MPATH: 551 - sarcoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-70|5|596|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT. L.N..|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-71|5|596|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-72|5|597|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-73|5|614|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-74|5|617|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-75|5|619|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-76|5|622|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-77|5|624|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TMFS/ area of cowper's gl.muscle,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-78|5|634|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-79|5|636|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-80|5|638|Other deterministic changes|Whole body|MCDU/  |
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-81|5|638|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWH: THAC TO LUNG.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-82|5|639|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-83|5|639|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-84|5|640|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TMFS/ right side & leg.muscle Metastases  Kidney tmfs right side and leg to kidney.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-85|5|640|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-86|5|654|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-87|5|655|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS INV. OF MUSCLE.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-88|5|655|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-89|5|657|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-90|5|662|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-91|5|666|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-92|5|666|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT. L.N..|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-93|5|667|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-94|5|667|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-95|5|668|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/   Metastases  tmfs to cowper's gl.,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-96|5|669|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-97|5|673|Neoplasia unclassified|Other local manifestations and miscellaneus|TKWM: TMFS RIGHT SIDE AND LEG TO KIDNEY.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-98|5|676|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-99|5|676|Other deterministic changes|Whole body|MCDU/  |
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-100|5|677|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-101|5|680|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-102|5|680|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-103|5|681|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-104|5|682|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-105|5|687|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ thigh. Muscle|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-106|5|690|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle trac to intercostal muscles.,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-107|5|691|Acute infections|Lower digestive tract,MA: 0000054 - peritoneal cavity|MXWI/ adhes. fibr. with obstr. of gut.,MPATH: 212 - inflammation|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-108|5|691|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-109|5|694|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-110|5|694|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-111|5|698|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-112|5|703|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-113|5|705|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT. L.N..|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-114|5|708|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-115|5|709|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-116|5|713|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-117|5|715|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-118|5|716|Other deterministic changes|Whole body|MCDU/  |
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-119|5|722|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-120|5|722|Other deterministic changes|Whole body|MCDU/  |
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-121|5|723|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-122|5|724|Neoplasia unclassified|Other local manifestations and miscellaneus|TNWR: TRAC TO TRIGEMINAL NERVE.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-123|5|726|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ lt. hip with inv. of bone & bone marrow. Metastases  Muscle tcvs inv. of muscle.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-124|5|729|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-125|5|729|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWC: TCVS INVAS. OF CN. L.N.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-126|5|729|Neoplasia unclassified|Central nervous system among nervous system|TNXS/ cerebrum, dorsum, mid-pt..|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-127|5|729|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-128|5|730|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-129|5|731|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-130|5|731|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-131|5|732|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWB: TBOS TO MUSCLE OF NOSE.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-132|5|735|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWM: TMFS TO COWPER'S GL.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-133|5|736|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-134|5|738|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-135|5|739|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-136|5|740|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-137|5|743|Neoplasia malignant|Other local manifestations and miscellaneus|TCSS/ TCSS/ TCSS/ TCSS/ thigh, bilateral with ext. from one to other thigh. Metastases Heart tcss of thigh origin to heart. Metastases  Muscle tcss to diaphragm from thigh via blood.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-138|5|744|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-139|5|746|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-140|5|750|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-141|5|753|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-142|5|754|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-143|5|754|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-144|5|756|Neoplasia malignant|Bloodvessels among cardiovascular system|TYVS/  Heart|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-145|5|758|Neoplasia unclassified|Other local manifestations and miscellaneus|THWR: TRAC TO LIVER.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-146|5|759|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-147|5|764|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-148|5|768|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT. L.N..|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-149|5|769|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-150|5|770|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-151|5|771|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-152|5|772|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-153|5|773|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-154|5|773|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle trac to sternal/rib muscles. Metastases  Lymphoret.System trac to pt. l.n.. Metastases Heart,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-155|5|776|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-156|5|779|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-157|5|780|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-158|5|781|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-159|5|783|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-160|5|785|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/   Metastases Lung|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-161|5|785|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-162|5|785|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-163|5|790|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS TO SKEL. MUSCLE.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-164|5|793|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-165|5|793|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWG: TGAC TO ORBITAL MUSCLE.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-166|5|794|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-167|5|794|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle tgac to muscle & skin of skull.,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-168|5|794|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-169|5|795|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ angiosarc of visc. & pariet. perit. of guts, visc. organs.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-170|5|796|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-171|5|799|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-172|5|801|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-173|5|802|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases Liver,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-174|5|805|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-175|5|806|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWG: TGAC TO MUSCLE & SKIN OF SKULL.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-176|5|806|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-177|5|809|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TXAC/ seminal vesicle.,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-178|5|810|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-179|5|813|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRVS/  Eye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-180|5|815|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-181|5|816|Neoplasia malignant|Bloodvessels among cardiovascular system|TBVS/ spine, lumbar.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-182|5|817|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-183|5|817|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-184|5|817|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-185|5|817|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-186|5|820|Other deterministic changes|Whole body|MCDU/  |
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-187|5|820|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-188|5|821|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-189|5|822|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle trac to dorsum of spine. Metastases Liver Metastases Heart Metastases Kidney,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-190|5|824|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-191|5|824|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-192|5|827|Neoplasia unclassified|Other local manifestations and miscellaneus|THWR: TRAC TO LIVER.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-193|5|830|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-194|5|831|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-195|5|831|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-196|5|833|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-197|5|838|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-198|5|842|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac to pt. l.n..,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-199|5|844|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-200|5|844|Other deterministic changes|Whole body|MCDU/  |
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-201|5|845|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-202|5|845|Neoplasia malignant|Bloodvessels among cardiovascular system|TTVS/  Testis|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-203|5|848|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-204|5|848|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-205|5|848|Other deterministic changes|Whole body|MCDU/  |
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-206|5|848|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-207|5|849|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-208|5|850|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-209|5|850|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/   Metastases Lung,MPATH: 549 - carcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-210|5|851|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-211|5|852|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-212|5|852|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-213|5|853|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-214|5|853|Other deterministic changes|Whole body|MCDU/  |
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-215|5|855|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-216|5|856|Neoplasia malignant|Bloodvessels among cardiovascular system|TSVS/ hind leg.Skin|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-217|5|856|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-218|5|862|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-219|5|866|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS INV. OF MUSCLE.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-220|5|869|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases Heart Metastases  Lymphoret.System trac to pt. ln.,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-221|5|870|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-222|5|871|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-223|5|872|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ abdomen.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-224|5|872|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-225|5|872|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-226|5|874|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ nose (nasal bone) Metastases  Muscle tbos to muscle of nose.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-227|5|875|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-228|5|876|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-229|5|876|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-230|5|877|Other deterministic changes|Whole body|MCDU/  |
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-231|5|878|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-232|5|878|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle trac to rib & sternal muscles (continuous) Metastases Heart,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-233|5|879|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-234|5|880|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-235|5|880|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-236|5|883|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-237|5|885|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-238|5|885|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-239|5|885|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-240|5|891|Neoplasia malignant|Bloodvessels among cardiovascular system|TYVS/  Heart|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-241|5|891|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-242|5|892|Neoplasia unclassified|Other local manifestations and miscellaneus|THWR: TRAC TO LIVER.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-243|5|892|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-244|5|894|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-245|5|895|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ thigh. Muscle|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-246|5|896|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-247|5|896|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-248|5|897|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-249|5|898|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-250|5|898|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKVS/  ,MPATH: 551 - sarcoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-251|5|898|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-252|5|899|Neoplasia malignant|Bloodvessels among cardiovascular system|TLVS/ mn. ln. Lymphoret.tissue|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-253|5|899|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-254|5|903|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-255|5|903|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-256|5|904|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-257|5|905|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-258|5|905|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-259|5|907|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-260|5|907|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac to pt. l.n..,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-261|5|908|Other deterministic changes|Whole body|MCDU/  |
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-262|5|911|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-263|5|911|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  Head/neck missing Eye(s) missing,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-264|5|911|Other deterministic changes|Whole body|MCDU/  |
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-265|5|911|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-266|5|911|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-267|5|913|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-268|5|913|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-269|5|914|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-270|5|914|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-271|5|915|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle trac to sternal muscles. Metastases Heart Metastases LiverEye(s) missing Head/neck missing,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-272|5|915|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-273|5|918|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases  Lymphoret.System trac to pt. l.n..,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-274|5|920|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-275|5|922|Other deterministic changes|Whole body|MCDU/  |
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-276|5|922|Other deterministic changes|Whole body|MCDU/  |
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-277|5|927|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT. L.N..|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-278|5|928|Neoplasia unclassified|Lower digestive tract,MA: 0000328 - intestine|TIAC/ ileum.,MPATH: 218 - neoplasm|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-279|5|931|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-280|5|931|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-281|5|932|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-282|5|932|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-283|5|932|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-284|5|932|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWK: TKAC TO LUNG.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-285|5|935|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-286|5|937|Other deterministic changes|Whole body|MCDU/  |
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-287|5|939|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-288|5|942|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-289|5|944|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-290|5|946|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/   Metastases  Muscle trac to intercostal muscles.,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-291|5|946|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ subcut. abdom. wall.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-292|5|946|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-293|5|948|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-294|5|950|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-295|5|953|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-296|5|953|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-297|5|954|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-298|5|955|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT. LN.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-299|5|955|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-300|5|956|Inflammation and/or fibrotic diseases|Cardiovascular system,MA: 0000164 - myocardium|MMCC/ MMCC/ MMCC/ MMCC/  chronic,MPATH: 212 - inflammation|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-301|5|956|Other deterministic changes|Whole body|MCDU/  |
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-302|5|957|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-303|5|958|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-304|5|958|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-305|5|958|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac to pt. l.n..,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-306|5|960|Other deterministic changes|Whole body|MCDU/  |
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-307|5|962|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-308|5|963|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-309|5|963|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-310|5|967|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-311|5|967|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-312|5|969|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-313|5|969|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-314|5|969|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS TO SKEL. MUSCLE.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-315|5|970|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-316|5|971|Neoplasia unclassified|Other local manifestations and miscellaneus|THWR: TRAC TO LIVER.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-317|5|974|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-318|5|974|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-319|5|974|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-320|5|975|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-321|5|976|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-322|5|978|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-323|5|979|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-324|5|981|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-325|5|981|Other deterministic changes|Whole body|MCDU/  |
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-326|5|981|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-327|5|982|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-328|5|983|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-329|5|988|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-330|5|989|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-331|5|990|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-332|5|990|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-333|5|993|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-334|5|994|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-335|5|996|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-336|5|996|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-337|5|997|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-338|5|997|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-339|5|999|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWH: THAC TO LUNG.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-340|5|1004|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-341|5|1004|Other deterministic changes|Whole body|MCDU/  |
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-342|5|1007|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT. L.N..|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-343|5|1009|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-344|5|1010|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-345|5|1012|Other deterministic changes|Whole body|MCDU/  |
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-346|5|1014|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-347|5|1015|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-348|5|1016|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-349|5|1018|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases Liver,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-350|5|1020|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-351|5|1021|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-352|5|1023|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-353|5|1024|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-354|5|1025|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-355|5|1027|Other deterministic changes|Whole body|MCDU/  |
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-356|5|1029|Other deterministic changes|Whole body|MCDU/  |
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-357|5|1030|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-358|5|1031|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-359|5|1032|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-360|5|1034|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-361|5|1038|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-362|5|1039|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-363|5|1042|Neoplasia unclassified|Integumentary system,MA: 0000151 - skin|TSEC/ rt. hip. Metastases Lung Metastases  Muscle tsec to muscle of rt. hip.,MPATH: 218 - neoplasm|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-364|5|1044|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-365|5|1044|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-366|5|1045|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-367|5|1045|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-368|5|1047|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-369|5|1050|Other deterministic changes|Whole body|MCDU/  |
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-370|5|1053|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-371|5|1057|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-372|5|1061|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-373|5|1069|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-374|5|1070|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-375|5|1071|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  Thorax missing Head/neck missing Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-376|5|1076|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-377|5|1079|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-378|5|1079|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-379|5|1079|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-380|5|1081|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ along pelvic spine with lysis of vert. Metastases  Muscle tcvs to skel. muscle.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-381|5|1085|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWB: TBOS TO MUSCLE OF NOSE.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-382|5|1086|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-383|5|1087|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-384|5|1093|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-385|5|1094|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-386|5|1095|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle tgac to orbital muscle.,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-387|5|1097|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-388|5|1102|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac to pt. ln.,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-389|5|1103|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWB: TBFS TO MUSCLE OF FEMUR AND PELVIS.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-390|5|1104|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-391|5|1107|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-392|5|1114|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-393|5|1115|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCSS TO DIAPHRAGM FROM THIGH VIA BLOOD.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-394|5|1115|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-395|5|1116|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-396|5|1117|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-397|5|1118|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-398|5|1119|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-399|5|1120|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-400|5|1121|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-401|5|1122|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-402|5|1124|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-403|5|1130|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-404|5|1132|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-405|5|1135|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-406|5|1142|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-407|5|1143|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-408|5|1143|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-409|5|1144|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-410|5|1146|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-411|5|1149|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-412|5|1149|Other deterministic changes|Whole body|MCDU/   Metastases Liver|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-413|5|1150|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-414|5|1150|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-415|5|1151|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-416|5|1172|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases  Lymphoret.System tsec of rt. hip to axillary l.n..,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-417|5|1172|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases  Lymphoret.System trac to pt. l.n..,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-418|5|1173|Neoplasia unclassified|Other local manifestations and miscellaneus|THWR: TRAC TO LIVER.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-419|5|1181|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-420|5|1184|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-421|5|1187|Other deterministic changes|Whole body|MCDU/  |
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-422|5|1188|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ adjacent to sal. gl. & cn. l.n. Metastases  Lymphoret.System tcvs invas. of cn. l.n. Metastases Lung Metastases  tcvs invas. of sal. gl.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-423|5|1198|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-424|5|1198|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ thigh & abdomen. Muscle|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-425|5|1199|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-426|5|1205|Other deterministic changes|Whole body|MCDU/  |
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-427|5|1205|Neoplasia unclassified|Other local manifestations and miscellaneus|THWR: TRAC TO LIVER.|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-428|5|1205|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-429|5|1207|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-430|5|1210|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle trac to intercostal muscle.,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-431|5|1212|n/a|n/a|n/a|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-432|5|1214|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-433|5|1215|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-434|5|1216|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-435|5|1219|Other deterministic changes|Whole body|MCDU/  |
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-436|5|1220|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-437|5|1233|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-438|5|1233|Other deterministic changes|Whole body|MCDU/  |
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-439|5|1237|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-440|5|1240|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-441|5|1251|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-442|5|1255|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-443|5|1270|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-444|5|1274|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-445|5|1303|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-446|5|1310|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-447|5|1311|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-448|5|1313|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-449|5|1316|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-450|5|1324|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-451|5|1331|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-452|5|1334|Other deterministic changes|Whole body|MCDU/  |
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-453|5|1335|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-454|5|1360|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-5|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|455 (455 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 802 ± 9 lifespan study|1003-22-5-455|5|1366|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-1|6|149|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-2|6|156|Neoplasia unclassified|Other local manifestations and miscellaneus|THWO: TOGC TO LIVER.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-3|6|226|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-4|6|226|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-5|6|226|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-6|6|226|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-7|6|226|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-8|6|386|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/   Metastases Lung|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-9|6|430|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-10|6|443|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TMAB/  Predominantly ductal Metastases  tmab to visc. perit. of spleen and surface of pancreas - not invasive.,MPATH: 218 - neoplasm|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-11|6|446|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-12|6|460|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ lumbar with lysis of bone. Metastases  Muscle tcvs of lumbar spine to skeletal muscle.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-13|6|485|Neoplasia unclassified|Integumentary system,MA: 0000151 - skin|TSEC/ near rt. ear. Metastases Lung,MPATH: 218 - neoplasm|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-14|6|509|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-15|6|512|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-16|6|528|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-17|6|529|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXL/  Mixed histiocyt.leukemia,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-18|6|534|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-19|6|541|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-20|6|543|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-21|6|552|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-22|6|559|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ pelvic region & leg.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-23|6|568|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-24|6|578|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWC: TCFS OF LEFT AXIL. REG. TO LUNG.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-25|6|586|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-26|6|595|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-27|6|598|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-28|6|599|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ lumbar spine & vert. Metastases  Muscle tcvs of lumbar spine & vert. to skel. muscle.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-29|6|607|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-30|6|609|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-31|6|610|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-32|6|614|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-33|6|618|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-34|6|624|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-35|6|631|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWH: THVS INVAS. ABDOM. MUSCLE.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-36|6|634|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-37|6|638|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-38|6|638|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ spine near urin. bla..|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-39|6|639|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-40|6|643|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-41|6|652|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-42|6|652|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-43|6|653|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-44|6|655|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-45|6|655|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ base of skull.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-46|6|656|Neoplasia unclassified|Other local manifestations and miscellaneus|THWO: TOGC TO LIVER.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-47|6|657|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-48|6|665|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS OF LUMBAR SPINE & VERT. TO SKEL. MUSCLE.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-49|6|671|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-50|6|680|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO BRONCH. L.N..|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-51|6|680|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS OF LUMBAR SPINE TO SKELETAL MUSCLE.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-52|6|683|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-53|6|687|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-54|6|689|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases Lung,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-55|6|690|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle trac to muscle adj. to bone in pelvis.,MPATH: 268 - adenocarcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-56|6|691|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-57|6|691|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-58|6|695|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-59|6|697|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac to bronch. l.n.. Metastases Ovary,MPATH: 268 - adenocarcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-60|6|701|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-61|6|704|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TMAB/ Predominantly ductal Metastases  Lymphoret.System tmab to ax. pt. renal nodes. also Kidney tmab to kidney also Lung tmab to lung also Heart also GI tract tmab to tongue musculature also Liver also Muscle tmab to rib cage muscle,MPATH: 218 - neoplasm|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-62|6|712|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-63|6|713|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS OF LUMBAR SPINE TO SKELETAL MUSCLE.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-64|6|714|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-65|6|715|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-66|6|718|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ inside pelvis.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-67|6|722|Neoplasia unclassified|Other local manifestations and miscellaneus|THWM: TMRS OF SKEL MUSC. OF PELVIS TO LIVER.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-68|6|722|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-69|6|725|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-70|6|726|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-71|6|729|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-72|6|730|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ forearm. Muscle Metastases  tmvs of forearm to visc. pleura. Metastases Lung tmvs of forearm to lung.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-73|6|732|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-74|6|732|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/   Metastases  tmab to ureter.,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-75|6|733|Neoplasia unclassified|Central nervous system among nervous system|TNAS/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-76|6|741|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/   Metastases Lung,MPATH: 549 - carcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-77|6|742|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWM: TMVS OF FOREARM TO LUNG.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-78|6|742|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-79|6|744|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-80|6|746|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/   Metastases  Muscle thvs invas. abdom. muscle.,MPATH: 242 - hemangiosarcoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-81|6|746|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-82|6|749|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT. L.N.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-83|6|752|Neoplasia unclassified|Other local manifestations and miscellaneus|THWM: TMAB TO LIVER.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-84|6|754|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-85|6|754|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-86|6|754|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-87|6|758|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-88|6|758|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-89|6|762|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-90|6|764|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWZ: TZAC TO LUNG.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-91|6|765|Other deterministic changes|Whole body|MCDU/   Metastases  Lymphoret.System trac to bronch. l.n..|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-92|6|765|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-93|6|769|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ pelvis with lysis of bone. Metastases  Muscle tcvs of pelvis to skeletal muscle.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-94|6|770|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS OF SCAPULA INVAS. SCAPULAR & THOR. MUSCLE.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-95|6|774|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/   Metastases  Muscle tbvs of lumbar spine spread into adj. muscle.,MPATH: 242 - hemangiosarcoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-96|6|774|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-97|6|775|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  Eye(s) missing Head/neck missing,MPATH: 242 - hemangiosarcoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-98|6|777|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-99|6|778|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-100|6|783|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases Lung,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-101|6|787|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-102|6|789|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-103|6|791|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-104|6|792|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-105|6|792|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-106|6|792|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-107|6|793|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-108|6|794|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-109|6|796|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-110|6|796|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-111|6|799|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-112|6|800|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-113|6|803|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-114|6|803|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-115|6|808|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-116|6|809|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  Eye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-117|6|810|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/   Metastases Lung|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-118|6|810|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-119|6|811|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-120|6|812|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-121|6|813|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-122|6|813|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-123|6|813|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-124|6|814|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-125|6|818|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS OF HIND LEG TO MUSCLE & BONE WITH LYSIS OF BONE.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-126|6|820|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-127|6|820|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ left axil. reg.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-128|6|821|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-129|6|822|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-130|6|822|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-131|6|822|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases  Muscle tcvs of fatty tissue about tibia to skel. muscle.,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-132|6|824|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-133|6|825|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-134|6|827|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-135|6|827|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-136|6|828|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-137|6|831|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-138|6|834|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-139|6|835|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-140|6|835|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-141|6|836|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-142|6|836|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-143|6|837|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/   Metastases  Muscle tcfs of lower abdom. invas. of muscle of lower abdom. and cecal wall.,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-144|6|838|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-145|6|840|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-146|6|840|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-147|6|841|Inflammation and/or fibrotic diseases|Cardiovascular system,MA: 0000164 - myocardium|MMCC/ MMCC/ MMCC/ MMCC/  chronic Metastases  Muscle tmab infilt. muscle.,MPATH: 212 - inflammation|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-148|6|841|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-149|6|842|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWB: TBVS OF LUMBAR SPINE SPREAD INTO ADJ. MUSCLE.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-150|6|843|Inflammation and/or fibrotic diseases|Cardiovascular system,MA: 0000164 - myocardium|MMCA/ MMCA/ MMCA/ MMCA/  acute,MPATH: 212 - inflammation|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-151|6|843|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-152|6|844|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle tcfs of pelvic region to muscle of pelvis, outer wall of vagina and colon.,MPATH: 268 - adenocarcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-153|6|847|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-154|6|847|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-155|6|848|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-156|6|849|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-157|6|850|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-158|6|852|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS OF LUMBAR SPINE TO SKELETAL MUSCLE.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-159|6|854|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-160|6|855|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-161|6|855|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS OF PELVIS TO SKELETAL MUSCLE.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-162|6|856|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ hip. Metastases  Muscle tcvs of hip invading muscle and lysing bone.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-163|6|857|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ hind leg. Metastases  Muscle tcvs of hind leg to muscle & bone with lysis of bone.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-164|6|859|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-165|6|859|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-166|6|862|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-167|6|862|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-168|6|862|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-169|6|863|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|TMRS/ skel.muscle pelvic reg.Metastases Lymphoret.System tmrs of skel musc.of pelvis to mn.l.n.also tmrs of skel musc.of pelvis to visc.perit.of gut kid.adr. and spl.also Liver also Lung tmrs of skel musc. of pelvs to lungs with invas.of pleura,MPATH: 428 - rhabdomyosarcoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-170|6|865|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  Head/neck missing Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-171|6|865|Changes due to an abnormal circulation|Bloodvessels among cardiovascular system|MTHR/ abdom. aorta.auricular|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-172|6|867|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS OF LUMBAR SPINE TO VERTEBRAL MUSCLE.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-173|6|867|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-174|6|868|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-175|6|870|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-176|6|870|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases  Muscle tcvs of thigh to thigh muscle.,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-177|6|870|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-178|6|871|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-179|6|872|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS OF PERINEAL REGION INVASION OF MUSCLE OF TAIL BASE.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-180|6|872|Neoplasia unclassified|Other local manifestations and miscellaneus|THWO: TOGC TO LIVER.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-181|6|873|Inflammation and/or fibrotic diseases|Heart among cardiovascular system,MA: 0000076 - heart endocardium|MECC/  Chronic valvular endocarditis,MPATH: 214 - chronic inflammation|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-182|6|873|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-183|6|873|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-184|6|873|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ thigh with lysis of bone. Muscle|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-185|6|876|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS OF SCAPULA INVAS. SCAPULAR & THOR. MUSCLE.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-186|6|876|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-187|6|877|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-188|6|878|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-189|6|879|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-190|6|881|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-191|6|881|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-192|6|881|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-193|6|882|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-194|6|883|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-195|6|883|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-196|6|883|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-197|6|883|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPAO/  Adenoma,MPATH: 218 - neoplasm|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-198|6|884|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-199|6|886|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-200|6|887|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-201|6|893|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-202|6|893|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWK: TKAC TO PROB. BR. L.N.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-203|6|894|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/   Metastases Kidney|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-204|6|895|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-205|6|898|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ thigh. Metastases  Muscle tcvs of thigh invas. of thigh muscle. Metastases Lung Metastases  Skin tcvs of thigh to skin of thigh.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-206|6|898|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-207|6|900|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|TACC/  ,MPATH: 549 - carcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-208|6|901|Inflammation and/or fibrotic diseases|Lower digestive tract,MA: 0000328 - intestine|MIIA/ jejunum - div.Enteritis acute,MPATH: 212 - inflammation|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-209|6|904|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS OF LUMBAR SPINE TO VERTEBRAL MUSCLE.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-210|6|904|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS OF THIGH INVAS. OF THIGH MUSCLE.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-211|6|905|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-212|6|906|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS OF PERINEAL REGION INVASION OF MUSCLE OF TAIL BASE.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-213|6|911|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-214|6|911|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-215|6|911|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-216|6|911|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-217|6|911|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-218|6|912|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-219|6|912|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-220|6|914|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-221|6|915|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-222|6|915|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-223|6|915|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-224|6|917|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC PT. L.N.'S.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-225|6|917|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-226|6|917|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-227|6|918|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWC: TCFS OF LEFT AXIL. REG. TO LUNG.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-228|6|918|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-229|6|918|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-230|6|920|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ subcutis of left shoulder. Metastases Lung Metastases  tcfs of left shoulder metas. to pancr. visc. periton (kid) parietal periton. (abdom. wall) visc. pleura (lung). Metastases Liver,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-231|6|920|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-232|6|922|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/ extends through pelvis into opposite kidney. Metastases Lung,MPATH: 549 - carcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-233|6|923|Other deterministic changes|Whole body|MCDU/   Metastases  Muscle tcvs of pelvis to skel. muscle of pelvis.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-234|6|926|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-235|6|927|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ lower abdom. Metastases  tcfs of lower abdom. to  mediast. (visc.pleura of ht.). Metastases Lung Metastases Liver Metastases  Lymphoret.System tcfs of lower abdom. to brach. l.n. & mesen. l.n.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-236|6|928|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-237|6|928|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  Thorax missing Eye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-238|6|930|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-239|6|935|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-240|6|936|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-241|6|938|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-242|6|938|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-243|6|939|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-244|6|939|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-245|6|939|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-246|6|939|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-247|6|941|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TMAB/  Predominantly ductal Metastases Lung tmab metas. to lung.,MPATH: 218 - neoplasm|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-248|6|942|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-249|6|945|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS OF LUMBAR SPINE TO VERTEBRAL MUSCLE.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-250|6|946|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-251|6|946|Neoplasia unclassified|Other local manifestations and miscellaneus|THWO: TOGC TO LIVER.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-252|6|946|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-253|6|949|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-254|6|949|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ left hind leg. Metastases  tcfs of left hind leg to visc. perit., visc. pleura & pancreas. Metastases  Muscle tcfs of left hind leg to skel. muscle femur, stom. muscle. Metastases Lung,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-255|6|949|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-256|6|950|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-257|6|953|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-258|6|955|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ left thoracic reg. Metastases  Muscle tcfs of left thoracic region to muscle of thoracic reg.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-259|6|957|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  trac to visc. pleura, pariet. pleura. Metastases  Lymphoret.System trac to pt. l.n. Metastases  Muscle trac to costal muscle. Metastases Heart,MPATH: 268 - adenocarcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-260|6|957|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-261|6|958|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-262|6|959|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-263|6|960|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ between shoulders. Metastases  Muscle tbos of sacral vert. to muscle of sacral vert.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-264|6|961|Other deterministic changes|Whole body|MCDU/   Metastases Lung|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-265|6|961|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-266|6|961|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-267|6|962|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-268|6|962|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ lumbar spine with bone lysis. Metastases  Muscle tcvs of lumbar spine to vertebral muscle.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-269|6|963|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-270|6|963|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-271|6|963|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/   Metastases  Skin tcfs of subcutis to epidermis.,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-272|6|964|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-273|6|965|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-274|6|969|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases  Muscle tcfs of perineal region invasion of muscle of tail base.,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-275|6|971|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ pelvic area. Metastases  Muscle tcfs of pelvic area infiltr. muscle of pelvis. Metastases  Skin tcfs of pelvic area infiltr. skin of pelvis.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-276|6|971|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-277|6|974|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-278|6|975|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ hind leg Metastases  Muscle tcvs of hind leg foreskel. muscle & fat.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-279|6|977|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-280|6|978|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-281|6|981|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-282|6|981|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-283|6|983|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-284|6|984|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-285|6|986|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-286|6|988|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-287|6|988|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-288|6|988|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-289|6|988|Neoplasia malignant|Bloodvessels among cardiovascular system|TIVS/ jejunum.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-290|6|988|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-291|6|988|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-292|6|990|Neoplasia malignant|Bloodvessels among cardiovascular system|TIVS/ ileum.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-293|6|993|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ left pelvis & hip, infiltr. skin. Muscle|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-294|6|994|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-295|6|995|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ across shoulder.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-296|6|996|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ thigh. Metastases  Muscle tcfs of thigh to thigh muscle.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-297|6|997|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ lumbar spine. Muscle|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-298|6|997|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-299|6|997|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-300|6|998|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-301|6|998|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-302|6|999|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|TZAC/   Metastases Lung,MPATH: 278 - follicular adenocarcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-303|6|999|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-304|6|1000|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-305|6|1000|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-306|6|1000|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-307|6|1002|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-308|6|1005|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-309|6|1006|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-310|6|1007|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-311|6|1009|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-312|6|1009|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS OF HIP INVADING MUSCLE AND LYSING BONE.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-313|6|1009|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-314|6|1011|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-315|6|1016|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|MCRD/  ,MPATH: 1 - cell and tissue damage|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-316|6|1017|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-317|6|1020|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-318|6|1020|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|TACC/   Metastases Liver,MPATH: 549 - carcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-319|6|1022|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-320|6|1023|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-321|6|1023|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-322|6|1024|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-323|6|1025|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-324|6|1027|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-325|6|1027|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-326|6|1027|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-327|6|1029|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-328|6|1030|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-329|6|1034|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-330|6|1034|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  Head/neck missing Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-331|6|1038|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-332|6|1040|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ scapula with lysis of bone. Metastases  Muscle tcfs of scapula invas. scapular & thor. muscle.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-333|6|1040|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/   Metastases Lung,MPATH: 549 - carcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-334|6|1041|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-335|6|1042|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/   Metastases Liver|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-336|6|1044|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-337|6|1046|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/   Metastases  Lymphoret.System tkac to prob. br. l.n.,MPATH: 549 - carcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-338|6|1053|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-339|6|1055|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-340|6|1056|Neoplasia malignant|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOVS/ bilateral. Metastases  Muscle tbvs of spiine to skel. muscle lumbar reg.,MPATH: 242 - hemangiosarcoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-341|6|1058|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-342|6|1064|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-343|6|1065|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-344|6|1065|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-345|6|1067|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-346|6|1067|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MCIG/  ,MPATH: 213 - acute inflammation|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-347|6|1081|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|MCRD/  ,MPATH: 1 - cell and tissue damage|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-348|6|1081|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/   Metastases  tpac to thalamus.,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-349|6|1083|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases  tpac to thalamus.,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-350|6|1085|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases Lung,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-351|6|1086|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-352|6|1090|Inflammation and/or fibrotic diseases|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|MHIA/  acute,MPATH: 212 - inflammation|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-353|6|1093|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-354|6|1096|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-355|6|1102|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-356|6|1103|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-357|6|1104|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-358|6|1105|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-359|6|1105|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|TNMS/  ,MPATH: 551 - sarcoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-360|6|1107|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-361|6|1107|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-362|6|1111|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-363|6|1114|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ rt. hind leg.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-364|6|1114|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-365|6|1115|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-366|6|1117|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-367|6|1121|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWB: TBVS OF SPIINE TO SKEL. MUSCLE LUMBAR REG.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-368|6|1124|Neoplasia malignant|Bloodvessels among cardiovascular system|TXVS/ on serosa and/or adnexal tissue of uterus.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-369|6|1128|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-370|6|1130|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-371|6|1132|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases Liver,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-372|6|1138|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-373|6|1146|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ rt. side dorsal abd. & pelvis. Metastases  Skin tcfs of rt side to adnexal. Metastases  Lymphoret.System tcfs of rt side to mn. l.n. Metastases  tcfs of rt side to pancreas. Metastases  Muscle tcfs of rt side to skel. muscle.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-374|6|1149|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-375|6|1150|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-376|6|1151|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-377|6|1152|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-378|6|1153|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-379|6|1167|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-380|6|1167|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-381|6|1174|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPAO/  Adenoma,MPATH: 218 - neoplasm|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-382|6|1174|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac pt. l.n.'s. Metastases  Muscle trac costal muscle. Metastases  trac pariet. pleura of thorax.,MPATH: 268 - adenocarcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-383|6|1181|Inflammation and/or fibrotic diseases|Lower digestive tract,MA: 0000328 - intestine|MIIC/ prolapse.Enteritis chronic,MPATH: 212 - inflammation|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-384|6|1194|Neoplasia systemic|Haematolymphatic system|TLML/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-385|6|1195|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-386|6|1205|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-387|6|1205|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-388|6|1210|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLSS/  undifferentiated lymphoma,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-389|6|1213|Neoplasia malignant|Bloodvessels among cardiovascular system|TXVS/ pancreas. Metastases  Kidney txvs of pancreas to visc. perit. of kidney. Metastases  Lymphoret.System txvs of pancreas to mn. l.n.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-390|6|1213|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-391|6|1223|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-392|6|1228|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TMFS/ dorsal - pelvic reg.muscle,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-393|6|1254|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-394|6|1261|n/a|n/a|n/a|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-395|6|1270|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-396|6|1279|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-397|6|1319|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-398|6|1350|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/ rt. with mult. blood cysts.|
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-399|6|1377|Other deterministic changes|Whole body|MCDU/  |
1003-22-6|n/a,K2|1| 100|gamma-rays Co-60|4.17|grays|External exposure| code K2 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|394 records survival 783 ± 9 lifespan study|1003-22-6-400|6|1380|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-1|7|117|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-2|7|120|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-3|7|120|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-4|7|120|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-5|7|120|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-6|7|120|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-7|7|120|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-8|7|124|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-9|7|124|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-10|7|124|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-11|7|134|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-12|7|134|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-13|7|134|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-14|7|134|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-15|7|141|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-16|7|141|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-17|7|141|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-18|7|141|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-19|7|145|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-20|7|145|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-21|7|155|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-22|7|155|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-23|7|155|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-24|7|155|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-25|7|155|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-26|7|155|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-27|7|155|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-28|7|155|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-29|7|155|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-30|7|157|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-31|7|157|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-32|7|166|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-33|7|166|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-34|7|183|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-35|7|183|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-36|7|191|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-37|7|191|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-38|7|191|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-39|7|191|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-40|7|191|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-41|7|194|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-42|7|194|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-43|7|204|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-44|7|204|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-45|7|204|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-46|7|208|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-47|7|208|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-48|7|208|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-49|7|208|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-50|7|208|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-51|7|211|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-52|7|212|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-53|7|212|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-54|7|212|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-55|7|212|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-56|7|233|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-57|7|233|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-58|7|233|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-59|7|239|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-60|7|239|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-61|7|247|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-62|7|247|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-63|7|247|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-64|7|262|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-65|7|262|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-66|7|262|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-67|7|262|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-68|7|262|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-69|7|269|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-70|7|269|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-71|7|269|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-72|7|269|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-73|7|269|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-74|7|275|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-75|7|275|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-76|7|317|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-77|7|317|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-78|7|317|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-79|7|317|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-80|7|317|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-81|7|330|Other deterministic changes|Whole body|MCDU/  |
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-82|7|347|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-83|7|397|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-84|7|411|Degenerative changes|Haematolymphatic system,MA: 0000134 - bone marrow|MBMZ/  ,MPATH: 127 - atrophy|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-85|7|415|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-86|7|464|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ back of neck - fat.|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-87|7|465|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-88|7|497|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-89|7|505|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-90|7|519|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-91|7|526|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-92|7|529|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-93|7|536|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-94|7|565|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-95|7|577|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWK: TKAC TO PANCREAS.|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-96|7|598|Changes due to an abnormal circulation|Bloodvessels among cardiovascular system|MTHR/  auricular|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-97|7|605|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-98|7|610|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-99|7|619|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-100|7|624|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-101|7|625|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-102|7|626|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-103|7|627|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT LN.|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-104|7|627|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TMFS/ base of tail.muscle Metastases Lung tmfs to lung.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-105|7|628|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INVAS OF SKEL MUSC.|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-106|7|634|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-107|7|645|Degenerative changes|Haematolymphatic system,MA: 0000134 - bone marrow|MBMZ/  ,MPATH: 127 - atrophy|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-108|7|649|Neoplasia malignant|Bloodvessels among cardiovascular system|TNVS/ frontal lobe, cerebrum.|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-109|7|651|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-110|7|651|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-111|7|657|Other deterministic changes|Whole body|MCDU/  |
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-112|7|666|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-113|7|672|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-114|7|673|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-115|7|680|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-116|7|681|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ subcutis of thigh. Metastases Liver Metastases Lung Metastases  Muscle tcvs to thigh muscle.|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-117|7|682|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-118|7|684|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-119|7|687|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-120|7|688|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-121|7|703|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-122|7|704|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-123|7|709|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-124|7|718|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-125|7|720|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-126|7|720|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-127|7|724|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-128|7|726|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-129|7|726|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-130|7|730|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-131|7|731|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-132|7|731|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-133|7|732|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-134|7|735|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-135|7|735|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-136|7|739|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-137|7|740|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-138|7|745|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-139|7|750|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ abdomen.|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-140|7|750|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-141|7|752|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-142|7|755|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ thigh musc. Muscle|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-143|7|755|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWM: TMFS TO LUNG.|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-144|7|758|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-145|7|759|Neoplasia malignant|Bloodvessels among cardiovascular system|TYVS/  Heart Metastases Lung|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-146|7|760|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-147|7|767|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-148|7|767|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-149|7|768|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-150|7|772|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-151|7|778|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-152|7|783|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-153|7|786|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-154|7|793|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-155|7|798|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INVAS OF SKEL MUSC.|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-156|7|800|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INVAS OF SKEL MUSC.|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-157|7|802|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-158|7|806|Other deterministic changes|Whole body|MCDU/  |
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-159|7|807|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INVAS OF SKEL MUSC.|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-160|7|808|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-161|7|809|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ abdomen.|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-162|7|813|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-163|7|813|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-164|7|813|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-165|7|816|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-166|7|817|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-167|7|825|Other deterministic changes|Whole body|MCDU/  |
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-168|7|825|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-169|7|827|Neoplasia malignant|Bloodvessels among cardiovascular system|TBVS/ spine.|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-170|7|830|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-171|7|831|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/   Metastases Heart Metastases  Muscle tkac to sternal & rib muscle. Metastases Lung Metastases  Lymphoret.System tkac to pt. l.n..,MPATH: 549 - carcinoma|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-172|7|832|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/   Metastases  tkac to mesentery & serosa of gut.,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-173|7|834|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ rt. inguinal region.|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-174|7|835|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-175|7|837|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac to pt. l.n.. Metastases  trac to visc. perit. (ht. base).,MPATH: 268 - adenocarcinoma|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-176|7|837|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  Head/neck missing Eye(s) missing|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-177|7|838|Neoplasia malignant|Endocrine system|TGAC/   Metastases Kidney Metastases  Muscle tgac spread to muscle about orbit.|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-178|7|838|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-179|7|841|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWK: TKAC TO PANCREAS.|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-180|7|844|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-181|7|845|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-182|7|845|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-183|7|862|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKVS/  ,MPATH: 551 - sarcoma|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-184|7|864|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-185|7|864|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-186|7|868|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-187|7|869|Neoplasia malignant|Bloodvessels among cardiovascular system|TIVS/ sm intestinal wall, diffuse.|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-188|7|870|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-189|7|871|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-190|7|871|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-191|7|871|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-192|7|872|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-193|7|872|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-194|7|877|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-195|7|877|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-196|7|879|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-197|7|880|Other deterministic changes|Whole body|MCDU/  |
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-198|7|882|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-199|7|884|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-200|7|885|Other deterministic changes|Whole body|MCDU/  |
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-201|7|885|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-202|7|891|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-203|7|891|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-204|7|892|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ tail. Muscle|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-205|7|894|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-206|7|895|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ in area of sem ves, but not involving the organ.|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-207|7|904|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-208|7|906|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-209|7|908|Other deterministic changes|Whole body|MCDU/  |
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-210|7|908|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-211|7|909|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-212|7|911|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-213|7|915|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-214|7|916|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ thigh. Metastases  Muscle tcvs to thigh muscle.|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-215|7|920|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-216|7|922|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-217|7|925|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/   Metastases  Muscle tbvs of spine to muscle.,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-218|7|925|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-219|7|926|Inflammation and/or fibrotic diseases|Lower digestive tract,MA: 0000328 - intestine|MIIA/ jejunum.Enteritis acute,MPATH: 212 - inflammation|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-220|7|927|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-221|7|928|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ thigh. Muscle|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-222|7|931|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-223|7|932|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-224|7|932|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-225|7|935|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-226|7|939|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-227|7|939|Neoplasia unclassified|Other local manifestations and miscellaneus|THWC: TCVS OF THIGH TO LIVER.|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-228|7|941|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ pelvic region. Metastases  Muscle tcfs invas of skel musc. Metastases  tcfs invas of visc perit. Metastases  Skin tcfs invas of skin.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-229|7|950|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ pelvis. Muscle|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-230|7|953|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-231|7|953|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-232|7|955|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-233|7|958|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-234|7|962|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-235|7|963|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-236|7|969|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-237|7|972|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-238|7|978|Other deterministic changes|Whole body|MCDU/  |
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-239|7|979|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-240|7|980|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-241|7|992|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-242|7|993|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-243|7|996|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ hilus of kidney.|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-244|7|997|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-245|7|998|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle trac to costal musc. Metastases  Lymphoret.System trac to pt ln.,MPATH: 268 - adenocarcinoma|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-246|7|1006|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-247|7|1006|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-248|7|1018|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-249|7|1018|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-250|7|1020|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-251|7|1025|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases  tkac to pancreas.,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-252|7|1027|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-253|7|1027|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-254|7|1030|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-255|7|1034|Neoplasia malignant|Bloodvessels among cardiovascular system|TIVS/ ileum. Metastases Lung|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-256|7|1038|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-257|7|1044|n/a|n/a|n/a|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-258|7|1046|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPAO/  Adenoma,MPATH: 218 - neoplasm|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-259|7|1046|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-260|7|1048|Other deterministic changes|Whole body|MCDU/  |
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-261|7|1051|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-262|7|1051|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-263|7|1054|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-264|7|1065|Neoplasia malignant|Bloodvessels among cardiovascular system|TTVS/ w/ extension into adnexal fat.Testis|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-265|7|1073|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-266|7|1078|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-267|7|1086|Other deterministic changes|Whole body|MCDU/  |
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-268|7|1093|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-269|7|1114|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-270|7|1126|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ groin area.|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-271|7|1128|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-272|7|1138|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS TO THIGH MUSCLE.|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-273|7|1168|Neoplasia unclassified|Other local manifestations and miscellaneus|THWC: TCVS OF THIGH TO LIVER.|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-274|7|1172|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-7|n/a,K3|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 725 ± 12 lifespan study|1003-22-7-275|7|1244|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-1|8|367|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-2|8|416|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-3|8|425|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-4|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-5|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-6|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-7|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-8|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-9|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-10|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-11|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-12|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-13|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-14|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-15|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-16|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-17|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-18|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-19|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-20|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-21|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-22|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-23|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-24|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-25|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-26|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-27|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-28|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-29|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-30|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-31|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-32|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-33|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-34|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-35|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-36|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-37|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-38|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-39|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-40|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-41|8|430|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-42|8|431|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-43|8|462|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-44|8|472|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-45|8|472|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-46|8|472|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-47|8|472|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-48|8|472|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-49|8|472|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-50|8|472|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-51|8|472|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-52|8|472|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-53|8|472|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-54|8|479|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-55|8|479|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-56|8|479|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-57|8|479|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-58|8|479|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-59|8|479|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-60|8|479|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-61|8|479|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-62|8|479|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-63|8|479|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-64|8|479|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-65|8|479|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-66|8|479|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-67|8|479|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-68|8|486|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-69|8|486|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-70|8|486|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-71|8|486|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-72|8|486|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-73|8|486|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-74|8|486|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-75|8|486|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-76|8|486|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-77|8|486|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-78|8|486|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-79|8|486|n/a|n/a|n/a|
1003-22-8|n/a,K|1| 100|gamma-rays Co-60|9.59|grays|External exposure| code K3 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|5 records females reassigned|1003-22-8-80|8|486|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-1|9|113|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-2|9|113|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-3|9|117|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-4|9|124|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-5|9|124|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-6|9|127|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-7|9|127|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-8|9|127|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-9|9|127|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-10|9|131|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-11|9|134|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-12|9|134|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-13|9|134|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-14|9|141|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-15|9|141|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-16|9|141|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-17|9|148|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-18|9|148|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-19|9|152|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-20|9|155|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-21|9|155|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-22|9|155|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-23|9|157|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-24|9|159|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-25|9|159|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-26|9|164|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-27|9|166|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-28|9|169|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-29|9|169|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-30|9|169|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-31|9|169|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-32|9|169|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-33|9|169|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-34|9|169|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-35|9|169|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-36|9|169|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-37|9|173|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-38|9|173|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-39|9|191|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-40|9|191|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-41|9|197|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-42|9|197|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-43|9|197|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-44|9|197|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-45|9|198|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-46|9|198|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-47|9|198|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-48|9|208|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-49|9|208|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-50|9|208|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-51|9|208|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-52|9|208|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-53|9|232|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-54|9|233|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-55|9|233|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-56|9|233|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-57|9|233|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-58|9|239|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-59|9|240|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-60|9|261|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-61|9|261|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-62|9|261|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-63|9|261|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-64|9|261|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-65|9|261|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-66|9|262|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-67|9|262|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-68|9|262|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-69|9|262|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-70|9|262|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-71|9|262|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-72|9|262|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-73|9|262|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-74|9|269|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-75|9|269|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-76|9|291|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-77|9|303|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-78|9|311|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-79|9|311|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-80|9|318|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWR: TRAC GROWTH INTO MUSC OF DIAP.|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-81|9|318|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-82|9|323|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-83|9|326|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-84|9|330|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-85|9|331|Degenerative changes|Haematolymphatic system,MA: 0000134 - bone marrow|MBMZ/ sternabrae - aplasia.,MPATH: 127 - atrophy|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-86|9|332|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|MCRD/  ,MPATH: 1 - cell and tissue damage|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-87|9|340|Changes due to an abnormal circulation|Bloodvessels among cardiovascular system|MTHR/  auricular|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-88|9|347|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-89|9|351|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWK: TKAC TO LUNG.|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-90|9|358|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-91|9|358|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWG: TGAC TO LUNG.|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-92|9|365|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-93|9|365|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-94|9|371|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-95|9|372|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-96|9|374|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-97|9|375|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-98|9|376|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-99|9|376|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-100|9|379|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWK: TKAC TO LUNG.|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-101|9|395|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-102|9|401|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-103|9|402|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-104|9|405|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-105|9|407|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-106|9|407|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-107|9|408|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-108|9|408|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-109|9|409|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWK: TKAC TO LUNG.|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-110|9|409|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-111|9|409|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-112|9|411|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-113|9|414|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-114|9|415|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-115|9|415|Degenerative changes|Haematolymphatic system,MA: 0000134 - bone marrow|MBMZ/ aplastic,MPATH: 127 - atrophy|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-116|9|428|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-117|9|432|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-118|9|433|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-119|9|436|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-120|9|436|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-121|9|438|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-122|9|444|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-123|9|445|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-124|9|446|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-125|9|450|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-126|9|450|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-127|9|460|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-128|9|461|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-129|9|462|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-130|9|463|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-131|9|466|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-132|9|467|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-133|9|476|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-134|9|484|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWR: TRAC GROWTH INTO MUSC OF DIAP.|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-135|9|486|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS TO MUSC OF LEG.|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-136|9|492|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-137|9|507|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-138|9|507|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-139|9|507|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-140|9|511|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-141|9|511|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-142|9|511|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ thorax.|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-143|9|512|Other deterministic changes|Whole body|MCDU/  Head/neck missing Eye(s) missing|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-144|9|513|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-145|9|523|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-146|9|525|Other deterministic changes|Whole body|MCDU/  |
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-147|9|529|Other deterministic changes|Whole body|MCDU/  |
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-148|9|529|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ thigh. Muscle|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-149|9|533|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-150|9|545|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-151|9|547|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-152|9|551|Other deterministic changes|Whole body|MCDU/  |
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-153|9|551|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-154|9|551|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-155|9|552|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-156|9|557|Neoplasia malignant|Endocrine system|TGAC/   Metastases Lung|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-157|9|560|Neoplasia malignant|Bloodvessels among cardiovascular system|TBVS/ femur.|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-158|9|561|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-159|9|567|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-160|9|567|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-161|9|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-162|9|569|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-163|9|581|Other deterministic changes|Whole body|MCDU/  |
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-164|9|583|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-165|9|584|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-166|9|585|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-167|9|585|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-168|9|589|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-169|9|590|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-170|9|599|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-171|9|603|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-172|9|603|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|TDEC/ urethral junction with urinary bladder.Squamous cell carcinoma Metastases  Muscle tdec to diaphragm.,MPATH: 549 - carcinoma|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-173|9|607|Other deterministic changes|Whole body|MCDU/  |
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-174|9|607|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-175|9|614|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-176|9|614|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-177|9|615|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-178|9|621|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ abdom.|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-179|9|626|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-180|9|626|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-181|9|632|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-182|9|632|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-183|9|634|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases Lung,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-184|9|636|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-185|9|641|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-186|9|645|Other deterministic changes|Whole body|MCDU/  |
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-187|9|649|Inflammation and/or fibrotic diseases|Kidney among urinary system diseases,MA: 0000368 - kidney|MPNP/  ,MPATH: 212 - inflammation|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-188|9|650|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-189|9|651|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-190|9|652|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-191|9|653|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-192|9|655|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  trac seeding on diap & pleura of heart base. Metastases  Muscle trac growth into musc of diap.,MPATH: 268 - adenocarcinoma|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-193|9|661|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-194|9|666|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-195|9|667|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  Head/neck missing Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-196|9|669|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-197|9|670|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-198|9|682|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-199|9|696|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-200|9|700|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-201|9|709|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases  Muscle trac to sternal muscle.,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-202|9|715|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-203|9|715|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-204|9|719|Neoplasia malignant|Bloodvessels among cardiovascular system|TYVS/  Heart|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-205|9|729|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-206|9|738|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-207|9|741|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-208|9|741|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-209|9|743|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-210|9|752|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-211|9|757|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-212|9|770|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ 2 sites; subcut l hind leg. Metastases  Muscle tcvs to musc of leg. Metastases  Skin tcvs to skin of leg.|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-213|9|780|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ spine. Muscle|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-214|9|780|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-215|9|785|Other deterministic changes|Whole body|MCDU/  |
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-216|9|802|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-217|9|818|Other deterministic changes|Whole body|MCDU/  |
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-218|9|834|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-219|9|843|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWK: TKAC TO LUNG.|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-220|9|843|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-221|9|855|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWR: TRAC TO STERNAL MUSCLE.|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-222|9|870|n/a|n/a|n/a|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-223|9|883|Other deterministic changes|Whole body|MCDU/  |
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-224|9|888|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-9|n/a,3|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 441 ± 12 lifespan study|1003-22-9-225|9|941|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/   Metastases Lung,MPATH: 549 - carcinoma|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-1|10|235|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-2|10|298|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-3|10|311|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-4|10|316|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-5|10|324|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-6|10|352|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-7|10|369|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-8|10|381|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-9|10|406|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-10|10|417|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-11|10|417|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-12|10|428|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-13|10|430|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-14|10|430|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-15|10|430|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-16|10|430|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-17|10|430|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-18|10|430|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-19|10|430|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-20|10|430|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-21|10|430|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-22|10|430|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-23|10|430|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-24|10|430|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-25|10|430|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-26|10|430|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-27|10|430|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-28|10|430|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-29|10|430|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-30|10|430|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-31|10|430|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-32|10|430|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-33|10|430|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-34|10|430|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-35|10|472|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-36|10|472|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-37|10|472|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-38|10|472|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-39|10|479|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-40|10|479|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-41|10|479|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-42|10|479|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-43|10|479|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-44|10|479|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-45|10|479|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-46|10|479|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-47|10|479|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-48|10|479|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-49|10|479|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-50|10|479|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-51|10|486|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-52|10|486|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-53|10|486|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-54|10|486|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-55|10|486|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-56|10|486|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-57|10|486|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-58|10|486|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-59|10|486|n/a|n/a|n/a|
1003-22-10|n/a,K4|1| 100|gamma-rays Co-60|19.19|grays|External exposure| code K4 24 fractions 45 m 1/w|60 (60 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|13 records females reassigned|1003-22-10-60|10|486|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-1|11|106|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-2|11|106|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-3|11|106|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-4|11|106|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-5|11|106|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-6|11|106|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-7|11|106|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-8|11|110|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-9|11|110|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-10|11|113|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-11|11|113|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-12|11|113|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-13|11|131|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-14|11|131|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-15|11|134|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-16|11|134|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-17|11|134|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-18|11|135|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-19|11|135|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-20|11|135|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-21|11|135|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-22|11|135|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-23|11|141|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-24|11|141|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-25|11|145|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-26|11|145|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-27|11|148|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-28|11|152|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-29|11|152|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-30|11|155|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-31|11|155|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-32|11|155|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-33|11|155|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-34|11|171|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-35|11|171|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-36|11|171|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-37|11|183|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-38|11|183|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-39|11|199|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-40|11|199|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-41|11|213|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-42|11|240|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-43|11|247|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-44|11|254|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-45|11|261|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-46|11|261|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-47|11|261|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-48|11|261|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-49|11|266|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-50|11|267|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-51|11|268|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-52|11|270|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-53|11|271|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-54|11|271|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-55|11|273|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-56|11|275|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-57|11|277|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-58|11|278|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-59|11|281|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-60|11|281|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-61|11|283|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-62|11|283|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-63|11|285|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-64|11|285|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-65|11|285|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-66|11|288|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-67|11|289|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-68|11|290|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-69|11|297|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-70|11|297|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-71|11|299|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-72|11|299|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-73|11|299|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-74|11|301|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-75|11|301|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-76|11|304|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-77|11|305|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-78|11|309|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-79|11|311|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWR: TRAC TO INTERCOSTAL MUSCLE.|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-80|11|311|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-81|11|313|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-82|11|316|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-83|11|319|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-84|11|323|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-85|11|324|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-86|11|325|Inflammation and/or fibrotic diseases|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|MHIA/  acute,MPATH: 212 - inflammation|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-87|11|326|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-88|11|326|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-89|11|329|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-90|11|330|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-91|11|331|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-92|11|332|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-93|11|335|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-94|11|336|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-95|11|337|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-96|11|337|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-97|11|338|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-98|11|338|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-99|11|339|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-100|11|344|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-101|11|344|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-102|11|345|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-103|11|346|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-104|11|347|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-105|11|348|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-106|11|351|Inflammation and/or fibrotic diseases|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|MHIA/  acute,MPATH: 212 - inflammation|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-107|11|351|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-108|11|351|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-109|11|351|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-110|11|353|Degenerative changes|Haematolymphatic system,MA: 0000134 - bone marrow|MBMZ/  ,MPATH: 127 - atrophy|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-111|11|354|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-112|11|359|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-113|11|359|Inflammation and/or fibrotic diseases|Cardiovascular system,MA: 0000164 - myocardium|MMCA/ MMCA/ MMCA/ MMCA/  acute,MPATH: 212 - inflammation|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-114|11|364|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-115|11|365|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-116|11|367|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-117|11|368|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-118|11|370|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-119|11|370|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-120|11|372|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-121|11|372|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-122|11|375|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-123|11|375|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-124|11|376|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-125|11|376|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-126|11|380|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-127|11|381|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-128|11|386|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-129|11|387|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-130|11|392|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-131|11|392|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-132|11|393|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ thoracic spine. Muscle|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-133|11|394|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-134|11|396|Other deterministic changes|Hepato-pancreatic system|MHCY/  Hepatic cyst|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-135|11|398|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-136|11|401|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-137|11|401|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-138|11|403|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-139|11|406|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-140|11|406|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-141|11|408|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-142|11|409|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-143|11|410|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  trac to pleura, parietal. Metastases  Muscle trac to intercostal muscle.,MPATH: 268 - adenocarcinoma|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-144|11|411|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-145|11|411|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-146|11|413|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-147|11|414|Degenerative changes|Haematolymphatic system,MA: 0000134 - bone marrow|MBMZ/  ,MPATH: 127 - atrophy|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-148|11|416|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-149|11|416|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-150|11|416|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-151|11|416|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-152|11|417|Inflammation and/or fibrotic diseases|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|MHIA/  acute,MPATH: 212 - inflammation|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-153|11|417|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-154|11|418|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-155|11|420|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-156|11|428|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-157|11|428|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-158|11|430|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-159|11|431|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-160|11|435|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-161|11|436|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-162|11|439|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-163|11|440|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-164|11|442|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-165|11|442|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-166|11|451|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-167|11|456|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-168|11|458|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-169|11|459|Inflammation and/or fibrotic diseases|Kidney among urinary system diseases,MA: 0000368 - kidney|MPNP/  ,MPATH: 212 - inflammation|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-170|11|465|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-171|11|465|Inflammation and/or fibrotic diseases|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|MHIA/  acute,MPATH: 212 - inflammation|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-172|11|473|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-173|11|477|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-174|11|480|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-175|11|484|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-176|11|491|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-177|11|494|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-178|11|498|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-179|11|501|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-180|11|502|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-181|11|505|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-182|11|506|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-183|11|513|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-184|11|534|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-185|11|554|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-186|11|562|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-187|11|563|n/a|n/a|n/a|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-188|11|568|Degenerative changes|Haematolymphatic system,MA: 0000134 - bone marrow|MBMZ/  ,MPATH: 127 - atrophy|
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-189|11|582|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-11|n/a,K4|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|147 records survival 269 ± 7 lifespan study|1003-22-11-190|11|610|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-1|12|271|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-2|12|277|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-3|12|282|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-4|12|283|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-5|12|285|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-6|12|286|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-7|12|288|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-8|12|309|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-9|12|310|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-10|12|317|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-11|12|332|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-12|12|340|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-13|12|342|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-14|12|345|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-15|12|345|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-16|12|354|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-17|12|362|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-18|12|371|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-19|12|383|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-20|12|390|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-21|12|396|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-22|12|425|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-23|12|425|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-24|12|430|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-25|12|430|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-26|12|430|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-27|12|442|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-28|12|478|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-29|12|486|n/a|n/a|n/a|
1003-22-12|n/a,K5|1| 100|gamma-rays Co-60|38.2|grays|External exposure| code K5 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|25 records survival 244 ± 12 lifespan study|1003-22-12-30|12|486|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-1|13|106|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-2|13|106|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-3|13|106|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-4|13|106|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-5|13|113|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-6|13|113|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-7|13|113|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-8|13|127|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-9|13|127|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-10|13|127|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-11|13|131|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-12|13|131|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-13|13|131|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-14|13|131|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-15|13|134|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-16|13|134|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-17|13|135|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-18|13|135|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-19|13|135|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-20|13|135|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-21|13|135|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-22|13|141|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-23|13|141|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-24|13|148|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-25|13|155|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-26|13|155|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-27|13|159|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-28|13|159|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-29|13|166|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-30|13|166|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-31|13|176|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-32|13|176|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-33|13|178|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-34|13|178|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-35|13|178|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-36|13|183|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-37|13|183|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-38|13|198|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-39|13|199|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-40|13|199|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-41|13|199|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-42|13|205|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-43|13|205|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-44|13|206|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-45|13|209|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-46|13|210|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-47|13|212|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-48|13|212|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-49|13|212|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-50|13|216|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-51|13|217|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-52|13|217|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-53|13|218|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-54|13|219|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-55|13|219|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-56|13|219|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-57|13|221|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-58|13|221|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-59|13|221|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-60|13|221|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-61|13|223|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-62|13|223|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-63|13|226|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-64|13|226|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-65|13|226|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-66|13|226|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-67|13|227|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-68|13|228|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-69|13|228|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-70|13|228|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-71|13|228|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-72|13|228|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-73|13|229|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-74|13|229|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-75|13|231|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-76|13|231|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-77|13|232|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-78|13|233|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-79|13|233|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-80|13|233|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-81|13|235|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-82|13|235|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-83|13|235|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-84|13|235|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-85|13|236|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-86|13|236|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-87|13|238|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-88|13|239|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-89|13|240|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-90|13|240|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-91|13|241|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-92|13|241|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-93|13|242|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-94|13|243|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-95|13|244|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-96|13|246|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-97|13|247|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-98|13|248|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-99|13|248|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-100|13|249|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-101|13|249|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-102|13|250|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-103|13|251|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-104|13|253|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-105|13|254|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-106|13|254|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-107|13|254|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-108|13|254|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-109|13|254|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-110|13|256|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-111|13|257|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-112|13|257|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-113|13|258|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-114|13|259|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-115|13|260|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-116|13|260|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-117|13|261|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-118|13|261|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-119|13|261|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-120|13|262|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-121|13|267|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-122|13|269|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-123|13|269|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-124|13|270|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-125|13|270|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-126|13|271|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-127|13|277|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-128|13|278|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-129|13|278|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-130|13|281|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-131|13|283|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-132|13|284|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-133|13|287|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-134|13|288|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-135|13|307|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-136|13|320|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-137|13|323|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-138|13|333|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-139|13|383|n/a|n/a|n/a|
1003-22-13|n/a,K5|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|100 records survival 143 ± 3 lifespan study|1003-22-13-140|13|389|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-1|14|193|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-2|14|193|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-3|14|198|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-4|14|205|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-5|14|205|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-6|14|206|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-7|14|207|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-8|14|209|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-9|14|209|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-10|14|209|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-11|14|212|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-12|14|214|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-13|14|214|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-14|14|214|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-15|14|214|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-16|14|216|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-17|14|216|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-18|14|217|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-19|14|219|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-20|14|219|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-21|14|219|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-22|14|220|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-23|14|221|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-24|14|221|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-25|14|221|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-26|14|222|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-27|14|222|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-28|14|223|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-29|14|224|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-30|14|226|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-31|14|228|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-32|14|228|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-33|14|229|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-34|14|230|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-35|14|232|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-36|14|236|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-37|14|239|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-38|14|241|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-39|14|251|n/a|n/a|n/a|
1003-22-14|n/a,K6|1| 100|gamma-rays Co-60|51.11|grays|External exposure| code K6 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|40 records survival 112 ± 2 lifespan study|1003-22-14-40|14|256|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-1|15|102|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-2|15|127|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-3|15|131|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-4|15|131|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-5|15|131|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-6|15|131|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-7|15|134|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-8|15|142|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-9|15|159|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-10|15|159|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-11|15|159|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-12|15|159|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-13|15|162|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-14|15|162|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-15|15|164|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-16|15|169|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-17|15|169|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-18|15|169|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-19|15|169|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-20|15|169|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-21|15|169|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-22|15|178|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-23|15|183|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-24|15|187|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-25|15|187|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-26|15|187|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-27|15|187|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-28|15|190|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-29|15|206|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-30|15|206|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-31|15|208|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-32|15|208|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-33|15|208|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-34|15|208|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-35|15|208|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-36|15|211|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-37|15|213|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-38|15|213|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-39|15|213|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-40|15|213|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-41|15|218|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-42|15|227|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-43|15|233|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-44|15|233|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-45|15|233|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-46|15|236|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-47|15|240|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-48|15|240|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-49|15|240|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-50|15|240|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-51|15|240|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-52|15|240|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-53|15|240|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-54|15|243|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-55|15|254|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-56|15|254|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-57|15|254|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-58|15|262|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-59|15|262|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-60|15|262|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-61|15|262|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-62|15|262|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-63|15|262|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-64|15|269|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-65|15|269|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-66|15|269|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-67|15|269|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-68|15|275|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-69|15|275|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-70|15|275|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-71|15|275|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-72|15|275|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-73|15|275|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-74|15|275|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-75|15|275|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-76|15|275|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-77|15|275|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-78|15|285|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TMFS/ jaw, with lysis of bone.muscle,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-79|15|403|Neoplasia benign|Bloodvessels among cardiovascular system|TCVO/ conn tiss of outer wall of colon & attached loosely to panc.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-80|15|416|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-81|15|420|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-82|15|421|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ nasal sinus. Metastases maxilla, dermis, nerve fibers..|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-83|15|428|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-84|15|439|Other deterministic changes|Whole body|MCDU/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-85|15|444|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-86|15|450|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-87|15|485|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-88|15|492|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-89|15|493|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWR: TRAC TO MEDIASTINAL.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-90|15|494|Neoplasia malignant|Bloodvessels among cardiovascular system|TNVS/ frontal lobe of brain.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-91|15|509|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-92|15|519|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-93|15|520|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-94|15|523|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-95|15|526|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-96|15|544|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-97|15|550|Inflammation and/or fibrotic diseases|Integumentary system|MSDA/  acute Metastases  tkac invas. of visceral peritoneum of opposite kidney & spleen.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-98|15|558|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-99|15|562|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-100|15|568|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  TLWR Metastases pt.ln, heart, visceral/parietal peritoneum, pleura,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-101|15|572|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-102|15|578|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-103|15|578|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-104|15|580|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-105|15|582|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-106|15|583|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-107|15|586|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  trac to mediastinal.,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-108|15|601|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-109|15|602|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-110|15|604|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-111|15|612|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-112|15|613|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWM: TMLS OF INTERCOSTAL MUSCLE TO LUNG.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-113|15|617|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-114|15|636|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWK: TKAC TO LUNG.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-115|15|645|Other deterministic changes|Whole body|MCDU/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-116|15|654|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-117|15|659|Other deterministic changes|Whole body|MCDU/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-118|15|674|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-119|15|675|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-120|15|676|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-121|15|677|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-122|15|680|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-123|15|680|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-124|15|681|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac to pt ln. Metastases  Muscle trac to costal muscle. Metastases  trac to visc. pleura, thorax, & mediastinum.,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-125|15|682|Neoplasia unclassified|Other local manifestations and miscellaneus|THWR: TRAC TO LIVER.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-126|15|682|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-127|15|683|Inflammation and/or fibrotic diseases|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|MHIA/  acute,MPATH: 212 - inflammation|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-128|15|687|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-129|15|688|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  trac to pleura all along thoracic parietal pleura. Metastases  Lymphoret.System trac to pt ln.,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-130|15|690|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-131|15|691|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC IN PT LN.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-132|15|697|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-133|15|698|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-134|15|699|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-135|15|701|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-136|15|703|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC METAST PT LN & CN.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-137|15|704|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-138|15|704|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-139|15|709|Other deterministic changes|Whole body|MCDU/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-140|15|709|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-141|15|711|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-142|15|712|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWR: TRAC TO MUSCLES OF THE RIB CAGE.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-143|15|713|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-144|15|714|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-145|15|715|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-146|15|719|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-147|15|719|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-148|15|721|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-149|15|723|Other deterministic changes|Whole body|MCDU/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-150|15|723|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ musc surrounding pelvis. Muscle|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-151|15|724|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-152|15|724|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-153|15|725|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-154|15|725|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-155|15|725|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT LN.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-156|15|726|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-157|15|729|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-158|15|731|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-159|15|731|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-160|15|731|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWR: TRAC TO MEDIASTINAL.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-161|15|734|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/   Metastases Lung Metastases  tkac invades visc perit.Head/neck missing Eye(s) missing,MPATH: 549 - carcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-162|15|734|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWR: TRAC PLEURAL SPREAD.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-163|15|736|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-164|15|738|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWR: TRAC TO MUSCLES OF THE RIB CAGE.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-165|15|738|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWR: TRAC TO STERNAL MUSCLE.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-166|15|740|Neoplasia benign|Bone among musculo-skeletal system diseases|TBOO/ spine.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-167|15|743|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-168|15|743|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-169|15|743|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-170|15|746|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-171|15|747|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-172|15|749|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-173|15|750|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/ attached to peritoneal surface of diaphragm.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-174|15|753|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-175|15|753|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-176|15|755|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-177|15|758|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac metast pt ln & cn. Metastases  trac to visc perit of lung, esop, trac, & ht base. Metastases  Muscle trac to costal muscles.,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-178|15|758|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-179|15|759|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS OF RT FORELIMB AND RIBS INFILTR OF MUSC.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-180|15|760|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-181|15|764|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac to pt ln.,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-182|15|764|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  trac pleural spread.,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-183|15|765|Other deterministic changes|Whole body|MCDU/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-184|15|770|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-185|15|771|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-186|15|771|Neoplasia malignant|Bloodvessels among cardiovascular system|TSVS/ preputial skin.Skin|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-187|15|773|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-188|15|774|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-189|15|775|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-190|15|776|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ tail. Metastases Lung,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-191|15|776|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  Metastases heart, liver, parietal pleura, kidney, sternal, axiallary, thoracic muscles,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-192|15|778|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO CN. L.N..|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-193|15|778|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-194|15|780|Neoplasia malignant|Bloodvessels among cardiovascular system|TYVS/  Heart|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-195|15|781|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-196|15|783|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLSS/  undifferentiated lymphoma,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-197|15|785|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-198|15|785|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-199|15|785|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-200|15|787|Other deterministic changes|Whole body|MCDU/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-201|15|788|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT LN.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-202|15|792|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT. L.N.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-203|15|793|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-204|15|793|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-205|15|794|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-206|15|794|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-207|15|798|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWK: TKAC TO LUNG.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-208|15|803|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-209|15|806|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ visceral peritoneum (fat & muscle).|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-210|15|806|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-211|15|807|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-212|15|807|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-213|15|808|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-214|15|808|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-215|15|813|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-216|15|815|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|MPNA/  Pancreatitis|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-217|15|816|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-218|15|817|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-219|15|817|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-220|15|820|Other deterministic changes|Whole body|MCDU/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-221|15|820|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-222|15|820|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-223|15|822|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-224|15|824|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-225|15|827|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-226|15|827|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-227|15|828|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-228|15|828|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKVS/  ,MPATH: 551 - sarcoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-229|15|829|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-230|15|830|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-231|15|831|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-232|15|831|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-233|15|832|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWB: TBOS OF NASAL SINUS TO MAXILLA.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-234|15|834|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-235|15|835|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-236|15|835|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-237|15|836|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-238|15|838|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-239|15|841|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-240|15|842|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-241|15|842|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-242|15|844|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-243|15|845|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-244|15|846|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-245|15|847|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-246|15|849|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac to pt. l.n. and in l.n. Metastases Heart,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-247|15|850|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-248|15|850|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ subcut groin region & invasion of epididymus.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-249|15|850|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-250|15|851|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-251|15|852|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-252|15|855|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWK: TKAC TO LUNG.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-253|15|856|Neoplasia malignant|Other local manifestations and miscellaneus|TMLS/ skeletal muscle of lumbar spine. Metastases  tmls of skel musc of lumb spine to peritoneum of kidney.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-254|15|857|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-255|15|858|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-256|15|858|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-257|15|858|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKVS/  ,MPATH: 551 - sarcoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-258|15|862|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-259|15|862|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/   Metastases  Muscle trac to muscles of the rib cage.,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-260|15|863|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases Lung,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-261|15|863|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac to cn. l.n..,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-262|15|864|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-263|15|866|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-264|15|866|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC METAST PT LN & CN.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-265|15|866|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-266|15|866|Other deterministic changes|Whole body|MCDU/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-267|15|866|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-268|15|867|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-269|15|867|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-270|15|870|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-271|15|872|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-272|15|872|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-273|15|876|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-274|15|876|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  Eye(s) missing Head/neck missing,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-275|15|876|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-276|15|876|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-277|15|877|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-278|15|878|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-279|15|878|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-280|15|880|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-281|15|880|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-282|15|882|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-283|15|884|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-284|15|885|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-285|15|886|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-286|15|886|Neoplasia malignant|Other local manifestations and miscellaneus|TCSS/ TCSS/ TCSS/ TCSS/ ct surrounding epididymus; spindle cell.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-287|15|888|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-288|15|890|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-289|15|890|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWK: TKAC INVAS. OF VISCERAL PERITONEUM OF OPPOSITE KIDNEY & SPLEEN.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-290|15|891|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-291|15|894|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-292|15|894|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-293|15|897|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-294|15|898|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-295|15|899|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-296|15|900|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-297|15|901|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-298|15|901|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-299|15|903|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-300|15|904|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWK: TKAC TO LUNG.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-301|15|906|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-302|15|906|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-303|15|907|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/   Metastases Heart,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-304|15|907|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-305|15|908|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-306|15|908|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-307|15|909|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-308|15|910|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-309|15|911|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-310|15|911|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-311|15|911|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-312|15|912|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-313|15|914|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-314|15|918|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-315|15|919|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT. L.N.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-316|15|919|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-317|15|920|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-318|15|920|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-319|15|921|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-320|15|922|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-321|15|923|Neoplasia malignant|Endocrine system|TGAC/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-322|15|924|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-323|15|925|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-324|15|925|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-325|15|925|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-326|15|926|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-327|15|927|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-328|15|928|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-329|15|928|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-330|15|929|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-331|15|929|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-332|15|929|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-333|15|932|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-334|15|932|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-335|15|933|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-336|15|936|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-337|15|936|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ conn tiss adjac to testis.Eye(s) missing Head/neck missing|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-338|15|936|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-339|15|936|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-340|15|938|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-341|15|939|Neoplasia malignant|Bloodvessels among cardiovascular system|TTVS/  Testis|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-342|15|940|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-343|15|940|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-344|15|941|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-345|15|941|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-346|15|943|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-347|15|943|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-348|15|944|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-349|15|944|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-350|15|946|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-351|15|947|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-352|15|947|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWM: TMLS OF SKEL MUSC OF LUMB SPINE TO PERITONEUM OF KIDNEY.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-353|15|948|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-354|15|948|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ connective tiss adjacent to anus.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-355|15|950|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-356|15|951|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-357|15|955|Neoplasia malignant|Bloodvessels among cardiovascular system|TXVS/ cowper's gl.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-358|15|955|Neoplasia malignant|Other local manifestations and miscellaneus|TMLS/ intercostal muscle. Metastases Lung tmls of intercostal muscle to lung.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-359|15|956|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPAC/  Carcinoma,MPATH: 218 - neoplasm|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-360|15|956|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle trac to sternal muscle.,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-361|15|957|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-362|15|958|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-363|15|959|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-364|15|960|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-365|15|961|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-366|15|961|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-367|15|963|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-368|15|963|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-369|15|964|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle trac to sternal muscle.,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-370|15|964|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-371|15|964|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-372|15|964|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-373|15|969|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-374|15|969|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/   Metastases Lung,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-375|15|969|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-376|15|970|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-377|15|971|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-378|15|971|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-379|15|972|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-380|15|973|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-381|15|973|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-382|15|974|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-383|15|974|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-384|15|975|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac to pt. l.n.,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-385|15|975|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-386|15|975|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-387|15|976|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC METAST PT LN & CN.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-388|15|976|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-389|15|976|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-390|15|976|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-391|15|977|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-392|15|978|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-393|15|979|Neoplasia malignant|Other local manifestations and miscellaneus|TMLS/ rib cage.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-394|15|980|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-395|15|981|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-396|15|981|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-397|15|982|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac to pt. l.n.,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-398|15|983|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-399|15|984|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-400|15|985|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-401|15|985|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-402|15|985|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-403|15|985|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-404|15|987|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases HeartHead/neck missing Eye(s) missing,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-405|15|987|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-406|15|987|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-407|15|989|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-408|15|989|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-409|15|990|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-410|15|991|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-411|15|992|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-412|15|995|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-413|15|995|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  Head/neck missing Eye(s) missing,MPATH: 242 - hemangiosarcoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-414|15|995|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-415|15|996|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-416|15|996|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-417|15|996|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-418|15|997|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-419|15|997|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-420|15|997|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-421|15|999|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-422|15|1002|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWR: TRAC TO MUSCLES OF THE RIB CAGE.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-423|15|1002|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-424|15|1002|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-425|15|1003|Other deterministic changes|Whole body|MCDU/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-426|15|1004|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-427|15|1004|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-428|15|1005|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-429|15|1005|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-430|15|1009|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-431|15|1009|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-432|15|1009|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-433|15|1009|Other deterministic changes|Whole body|MCDU/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-434|15|1016|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-435|15|1016|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-436|15|1017|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-437|15|1017|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-438|15|1019|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-439|15|1020|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-440|15|1023|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWK: TKAC TO LUNG.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-441|15|1023|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-442|15|1023|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-443|15|1023|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-444|15|1025|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  Metastases lung|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-445|15|1025|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-446|15|1026|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-447|15|1026|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-448|15|1026|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-449|15|1027|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-450|15|1028|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-451|15|1029|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-452|15|1030|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-453|15|1030|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-454|15|1031|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-455|15|1031|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-456|15|1032|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-457|15|1033|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-458|15|1033|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWG: TGAC TO LUNG.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-459|15|1033|Other deterministic changes|Whole body|MCDU/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-460|15|1033|Other deterministic changes|Whole body|MCDU/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-461|15|1034|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-462|15|1034|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-463|15|1034|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-464|15|1034|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-465|15|1034|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-466|15|1034|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-467|15|1035|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|MRMP/  Murine,MPATH: 212 - inflammation|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-468|15|1036|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWS: PRIMARY NOT TAKEN, SQUAMOUS CELL CARCINOMA METASTASES TO LUNG.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-469|15|1037|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-470|15|1041|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-471|15|1041|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-472|15|1044|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-473|15|1044|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-474|15|1045|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-475|15|1046|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-476|15|1047|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-477|15|1048|Other deterministic changes|Whole body|MCDU/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-478|15|1051|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-479|15|1051|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ right forelimb & ribs-- underarm. Metastases  Muscle tcfs of rt forelimb and ribs infiltr of musc. Metastases  Skin tcfs of rt forelimb and ribs infiltr of skin.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-480|15|1051|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-481|15|1053|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-482|15|1054|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/   Metastases  Muscle trac to muscles of the rib cage.,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-483|15|1054|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT LN.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-484|15|1054|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWS: PRIMARY NOT TAKEN, SQUAMOUS CELL CARCINOMA METASTASES TO LUNG.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-485|15|1055|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-486|15|1056|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-487|15|1056|Neoplasia benign|Lower digestive tract,MA: 0000323 - gastrointestinal system|TIPL/  Plaque pylorique region,MPATH: 491 - polyp|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-488|15|1058|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-489|15|1058|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT LN.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-490|15|1059|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-491|15|1059|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-492|15|1062|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-493|15|1062|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-494|15|1062|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-495|15|1064|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-496|15|1065|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-497|15|1065|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-498|15|1066|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-499|15|1067|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-500|15|1068|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-501|15|1069|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-502|15|1069|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  trac invas of visc perit between lobes of lung.,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-503|15|1069|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-504|15|1072|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-505|15|1074|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-506|15|1076|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-507|15|1076|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-508|15|1077|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-509|15|1077|Neoplasia malignant|Bloodvessels among cardiovascular system|TXVS/ cowper's gl.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-510|15|1077|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-511|15|1079|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  Eye(s) missing,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-512|15|1079|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-513|15|1079|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-514|15|1080|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-515|15|1081|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-516|15|1081|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-517|15|1081|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ left hind leg.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-518|15|1082|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-519|15|1082|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/   Metastases  tkac spread on visc perit of panc & spleen. Metastases Lung,MPATH: 549 - carcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-520|15|1082|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-521|15|1083|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-522|15|1083|Neoplasia unclassified|Lower digestive tract,MA: 0000328 - intestine|TIAC/ pylorus.,MPATH: 218 - neoplasm|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-523|15|1084|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-524|15|1086|Neoplasia malignant|Endocrine system|TGAC/   Metastases Lung|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-525|15|1086|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-526|15|1086|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-527|15|1089|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-528|15|1090|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-529|15|1090|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/   Metastases Lung Metastases  tkac metast to mesenteries at base of liver & kidn (contralateral).,MPATH: 549 - carcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-530|15|1090|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-531|15|1093|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWH: THAC TO LUNG.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-532|15|1093|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TXAC/ prostate gl.,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-533|15|1095|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-534|15|1095|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-535|15|1097|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases Lung,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-536|15|1098|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-537|15|1099|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-538|15|1100|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-539|15|1102|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-540|15|1105|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/   Metastases  Lymphoret.System trac to pt lymph node.,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-541|15|1107|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-542|15|1107|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-543|15|1107|Neoplasia malignant|Bloodvessels among cardiovascular system|TTVS/  Testis|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-544|15|1108|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ c.t. adj to ureter.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-545|15|1108|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-546|15|1109|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-547|15|1110|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases Heart Metastases  Lymphoret.System trac to cn & pt ln. Metastases  trac to wall of esop & perit of lung & esop.,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-548|15|1111|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-549|15|1111|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-550|15|1113|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT LN.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-551|15|1114|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-552|15|1114|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-553|15|1115|Other deterministic changes|Whole body|MCDU/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-554|15|1116|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-555|15|1116|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-556|15|1117|Neoplasia malignant|Bloodvessels among cardiovascular system|TYVS/  Heart|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-557|15|1118|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-558|15|1119|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-559|15|1121|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-560|15|1122|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-561|15|1122|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-562|15|1122|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-563|15|1122|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-564|15|1124|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-565|15|1125|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-566|15|1125|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-567|15|1126|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-568|15|1126|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWR: TRAC TO MUSCLES OF THE RIB CAGE.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-569|15|1126|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac in pt ln.,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-570|15|1127|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-571|15|1127|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-572|15|1128|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-573|15|1128|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-574|15|1130|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-575|15|1130|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-576|15|1131|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-577|15|1132|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-578|15|1137|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-579|15|1138|Other deterministic changes|Whole body|MCDU/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-580|15|1138|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-581|15|1139|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-582|15|1139|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-583|15|1140|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-584|15|1142|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-585|15|1142|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-586|15|1145|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWK: TKAC INVAS. OF VISCERAL PERITONEUM OF OPPOSITE KIDNEY & SPLEEN.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-587|15|1145|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-588|15|1146|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-589|15|1146|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-590|15|1147|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-591|15|1147|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ attached to r testis.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-592|15|1148|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-593|15|1149|Neoplasia unclassified|Integumentary system,MA: 0000151 - skin|TSEC/ skin in preputial gl area.,MPATH: 218 - neoplasm|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-594|15|1149|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-595|15|1152|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-596|15|1152|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-597|15|1156|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-598|15|1156|Other deterministic changes|Whole body|MCDU/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-599|15|1157|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-600|15|1158|Other deterministic changes|Whole body|MCDU/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-601|15|1159|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-602|15|1162|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-603|15|1162|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-604|15|1163|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-605|15|1163|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT LN.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-606|15|1165|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-607|15|1166|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-608|15|1177|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-609|15|1177|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-610|15|1178|Neoplasia malignant|Lower digestive tract,MA: 0000328 - intestine|TIFS/ colon.,MPATH: 551 - sarcoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-611|15|1181|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-612|15|1181|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-613|15|1182|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-614|15|1182|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-615|15|1183|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-616|15|1184|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-617|15|1186|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-618|15|1188|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO CN. L.N..|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-619|15|1199|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-620|15|1199|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-621|15|1200|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-622|15|1202|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-623|15|1205|Inflammation and/or fibrotic diseases|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|MHCN/  Coagulative focal hepatitis,MPATH: 212 - inflammation|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-624|15|1206|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-625|15|1206|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-626|15|1207|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ ct surrounding kidn, in mediastinum, at base of heart, & in brown fat.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-627|15|1208|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-628|15|1209|Other deterministic changes|Whole body|MCDU/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-629|15|1212|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-630|15|1212|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-631|15|1215|Neoplasia malignant|Bloodvessels among cardiovascular system|TYVS/  Heart|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-632|15|1219|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-633|15|1219|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung| Murine,MPATH: 212 - inflammation|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-634|15|1221|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-635|15|1223|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-636|15|1223|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-637|15|1226|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-638|15|1226|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-639|15|1228|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-640|15|1229|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-641|15|1232|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-642|15|1234|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-643|15|1236|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-644|15|1256|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-645|15|1258|Other deterministic changes|Whole body|MCDU/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-646|15|1259|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-647|15|1262|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-648|15|1265|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-649|15|1268|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ femur- (osteoclastoma) giant cell tumor. Metastases  Muscle tbos of femur to thigh musc.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-650|15|1269|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-651|15|1272|Neoplasia malignant|Endocrine system|TGAC/   Metastases Lung|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-652|15|1272|Neoplasia systemic|Haematolymphatic system|TLML/   Metastases  Muscle tgac to musc & skin of head.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-653|15|1274|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT. L.N. AND IN L.N.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-654|15|1279|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-655|15|1282|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-656|15|1284|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-657|15|1291|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-658|15|1296|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-659|15|1296|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-660|15|1303|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-661|15|1309|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-662|15|1310|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-663|15|1312|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-664|15|1324|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-665|15|1327|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-666|15|1331|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-667|15|1335|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ pelvis.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-668|15|1339|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-669|15|1344|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWM: TMLS OF INTERCOSTAL MUSCLE TO LUNG.|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-670|15|1345|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-671|15|1346|n/a|n/a|n/a|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-672|15|1347|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-673|15|1353|Neoplasia malignant|Bloodvessels among cardiovascular system|TYVS/  Heart|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-674|15|1397|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ thigh musc. Muscle|
1003-22-15|n/a,K6|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|675 (675 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|593 records survival 846 ± 8 lifespan study|1003-22-15-675|15|1418|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-1|16|255|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-2|16|321|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-3|16|325|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWB: TBOS OF FEMUR TO THIGH MUSC.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-4|16|383|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-5|16|386|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWG: TGAC INVADES MUSC & SKIN.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-6|16|402|Neoplasia malignant|Bloodvessels among cardiovascular system|TBVS/ spine. Metastases  Muscle tbvs of spine to adnexal musc.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-7|16|441|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ right axillary region. Invasion rt axilla surrounding muscle and overlying skin|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-8|16|451|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-9|16|451|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-10|16|460|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-11|16|478|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-12|16|483|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-13|16|495|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-14|16|501|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-15|16|505|Neoplasia malignant|Endocrine system|TGAC/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-16|16|509|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-17|16|512|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-18|16|517|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUVS/   Metastases  tuvs extends into adnexal tiss.,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-19|16|521|Neoplasia malignant|Endocrine system|TGAC/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-20|16|521|Neoplasia unclassified|Other local manifestations and miscellaneus|TNWP: TPAC INVADES CEREBRUM BASE.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-21|16|522|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-22|16|526|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-23|16|527|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-24|16|529|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ lumbar vertebrae. Metastases Lung|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-25|16|530|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-26|16|533|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-27|16|544|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-28|16|562|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-29|16|563|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-30|16|565|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  invas. Parietal pleura, rib cage attached to heart metastases pt. Ln and heart,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-31|16|568|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWM: TMLS OF ABDOMEN TO RN LN.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-32|16|568|Other deterministic changes|Whole body|MCDU/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-33|16|572|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-34|16|575|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-35|16|577|Other deterministic changes|Whole body|MCDU/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-36|16|578|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TMAB/  Predominantly ductal,MPATH: 218 - neoplasm|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-37|16|589|Other deterministic changes|Whole body|MCDU/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-38|16|591|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-39|16|596|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-40|16|598|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/   Metastases Lung,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-41|16|603|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-42|16|606|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWB: TBVS OF SPINE INVASION OF MUSC.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-43|16|614|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-44|16|618|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-45|16|623|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWB: TBVS OF SPINE INVASION OF MUSC.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-46|16|624|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-47|16|626|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-48|16|626|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-49|16|631|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-50|16|637|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-51|16|637|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-52|16|639|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWM: TMAB TO LUNG|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-53|16|640|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-54|16|640|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-55|16|640|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-56|16|640|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-57|16|640|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-58|16|641|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-59|16|646|Neoplasia malignant|Bloodvessels among cardiovascular system|TIVS/ stomach wall. Metastases  tivs of stomach wall invades musc.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-60|16|647|Neoplasia benign|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUVO/  ,MPATH: 236 - angiofibroma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-61|16|649|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|MCRD/  ,MPATH: 1 - cell and tissue damage|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-62|16|652|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-63|16|653|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-64|16|654|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-65|16|654|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TULS/ vagina. Metastases  tuls to perivaginal skeletal musc.,MPATH: 551 - sarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-66|16|654|Other deterministic changes|Whole body|MCDU/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-67|16|658|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-68|16|659|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-69|16|661|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-70|16|663|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ right upper arm. Muscle|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-71|16|666|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-72|16|668|Other deterministic changes|Whole body|MCDU/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-73|16|669|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-74|16|670|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TXEC/ salivary gl. epithelium. Metastases lung multiple metastases,MPATH: 446 - squamous cell carcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-75|16|671|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/   Metastases  tmab invades eye, orbit, & lacrymal hard glands.,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-76|16|675|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-77|16|676|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-78|16|677|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-79|16|677|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ base of spine- sacral.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-80|16|677|Neoplasia malignant|Other local manifestations and miscellaneus|TMLS/ retroperitoneum.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-81|16|683|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-82|16|684|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-83|16|691|Neoplasia malignant|Endocrine system|TGAC/  metastases to pancreas, ovary, pt. ln., lung, heart,  3RD. & and lateral brain ventricles and muscle of skull and rib cage|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-84|16|693|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-85|16|694|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-86|16|696|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-87|16|697|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ rt. hind leg & hip. Metastases to liver, lung, visc pleura(lung) & vaisc peritoneum (kid.spleen) and skin of leg,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-88|16|698|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|TMRS/ region of upper incisors & upper lip.,MPATH: 428 - rhabdomyosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-89|16|701|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-90|16|704|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-91|16|709|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-92|16|715|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-93|16|716|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-94|16|717|Neoplasia malignant|Endocrine system|TGAC/  invades muscle and skin, Metastases lung|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-95|16|718|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-96|16|719|Neoplasia malignant|Bloodvessels among cardiovascular system|TSVS/ skin of nose & lips.Skin|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-97|16|719|Neoplasia malignant|Endocrine system|TGAC/  Metastases to lung, muscle and skin adjac. To orbita|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-98|16|719|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-99|16|722|Neoplasia unclassified|Other local manifestations and miscellaneus|THWC: TCFS OF SKULL TO LIVER.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-100|16|723|Other deterministic changes|Whole body|MCDU/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-101|16|723|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-102|16|724|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-103|16|727|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-104|16|728|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  Eye(s) missing Head/neck missing,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-105|16|729|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-106|16|733|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-107|16|733|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-108|16|735|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-109|16|736|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-110|16|736|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-111|16|736|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-112|16|737|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TMAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-113|16|738|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-114|16|739|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ abdominal soft tiss.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-115|16|740|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-116|16|740|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-117|16|740|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-118|16|741|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-119|16|741|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-120|16|746|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-121|16|752|Other deterministic changes|Whole body|MCDU/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-122|16|754|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-123|16|755|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-124|16|755|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-125|16|755|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-126|16|757|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-127|16|757|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|MMTA/ vagina prolapsed.Metritis|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-128|16|758|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWC: TCFS INFILTR. CNLN.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-129|16|760|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-130|16|761|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-131|16|761|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUVS/   Metastases Kidney Metastases  tuvs infilt into visc & par peritoneum.,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-132|16|762|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-133|16|764|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TXAC/ salivary gl. Metastases lung,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-134|16|764|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-135|16|765|Inflammation and/or fibrotic diseases|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|MHIC/  chronic hepatitis,MPATH: 212 - inflammation|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-136|16|765|Other deterministic changes|Whole body|MCDU/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-137|16|766|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-138|16|768|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-139|16|769|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-140|16|769|Other deterministic changes|Whole body|MCDU/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-141|16|770|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLSS/  undifferentiated lymphoma,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-142|16|771|Neoplasia malignant|Bloodvessels among cardiovascular system|TXVS/ next to uter; no ovar identified in or about mass. Extension to muscle|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-143|16|772|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-144|16|773|Neoplasia malignant|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-145|16|773|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-146|16|779|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-147|16|783|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-148|16|784|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-149|16|785|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  trac invades pleura of heart base & lung.,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-150|16|787|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-151|16|790|Other deterministic changes|Whole body|MCDU/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-152|16|793|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-153|16|795|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-154|16|795|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-155|16|796|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-156|16|796|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-157|16|796|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-158|16|797|Neoplasia malignant|Lower digestive tract,MA: 0000328 - intestine|TIFS/ anal wall.,MPATH: 551 - sarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-159|16|798|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-160|16|799|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-161|16|799|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-162|16|799|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-163|16|800|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-164|16|803|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-165|16|805|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-166|16|806|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-167|16|806|Neoplasia unclassified|Other local manifestations and miscellaneus|TKWX: TXEC OF SALIVARY GLAND TO KIDNEY.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-168|16|806|Neoplasia unclassified|Other local manifestations and miscellaneus|THWC: TCFS OF LEFT SHOULDER TO LIVER.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-169|16|807|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-170|16|807|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-171|16|808|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-172|16|809|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-173|16|813|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-174|16|813|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ cervical vertebrae. Metastases to lung|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-175|16|815|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-176|16|815|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ paravertebral soft tiss.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-177|16|816|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-178|16|817|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-179|16|820|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-180|16|820|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-181|16|821|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-182|16|823|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS IN ABD. CAVITY INVADES SKELETAL MUSC.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-183|16|824|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TMAB/  Predominantly ductal Metastases  Muscle tmab invas of musc.,MPATH: 218 - neoplasm|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-184|16|825|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-185|16|825|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-186|16|825|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-187|16|827|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INVAS. OF MUSCLE OF RIB CAGE.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-188|16|827|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-189|16|827|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-190|16|827|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-191|16|828|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWB: TBOS OF SACRAL SPINE INVAS OF MUSC OF LOWER BACK.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-192|16|828|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-193|16|828|Neoplasia malignant|Other local manifestations and miscellaneus|TMLS/ musc of the femur.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-194|16|829|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-195|16|830|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-196|16|831|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-197|16|831|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-198|16|832|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-199|16|833|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWC: TCFS INFILTR. CNLN.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-200|16|833|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-201|16|834|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-202|16|835|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-203|16|836|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-204|16|837|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOVO/  ,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-205|16|837|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ vertebrae-thoracic.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-206|16|838|Neoplasia malignant|Other local manifestations and miscellaneus|TXUS/ TXUS/ TXUS/ TXUS/ mammary gl.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-207|16|842|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-208|16|842|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-209|16|843|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ lumbar vertebrae. Invades skeletal muscle Metastases lung|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-210|16|844|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-211|16|845|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-212|16|846|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-213|16|848|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-214|16|849|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-215|16|850|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  Metastases to visceral Perit.of liver, pancreas with hemmorh. And invasion of pancreas,MPATH: 549 - carcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-216|16|852|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-217|16|852|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-218|16|853|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TULS/   Metastases Lung,MPATH: 551 - sarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-219|16|857|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-220|16|858|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|MNIA/ base of cerebrum involving thalamus & hypothalamus.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-221|16|858|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-222|16|858|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-223|16|859|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-224|16|859|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-225|16|861|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-226|16|862|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-227|16|865|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-228|16|865|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-229|16|865|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-230|16|867|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-231|16|869|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-232|16|870|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-233|16|872|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-234|16|872|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-235|16|872|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-236|16|873|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-237|16|874|Other deterministic changes|Whole body|MCDU/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-238|16|876|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-239|16|876|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-240|16|876|Neoplasia benign|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUAO/  Including papillary type,MPATH: 270 - adenoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-241|16|876|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-242|16|878|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWB: TBOS INVAS OF SPINAL MUSC.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-243|16|879|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-244|16|880|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-245|16|883|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-246|16|883|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-247|16|883|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-248|16|884|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-249|16|886|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-250|16|886|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-251|16|886|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-252|16|886|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-253|16|887|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-254|16|887|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-255|16|887|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-256|16|888|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-257|16|888|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-258|16|891|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-259|16|891|Neoplasia malignant|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-260|16|891|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-261|16|891|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ lumbar spinal region. Invasion of muscle bone and bm,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-262|16|891|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-263|16|892|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-264|16|892|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/ associated with hemorr.,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-265|16|894|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-266|16|894|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWB: TBOS INVADES SKELETAL MUSC.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-267|16|894|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-268|16|895|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|MPNA/  Pancreatitis|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-269|16|895|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TOAO/  Adenoma,MPATH: 418 - liposarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-270|16|896|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-271|16|896|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-272|16|896|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-273|16|898|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-274|16|898|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/   Metastases Lung,MPATH: 549 - carcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-275|16|900|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOVO/  ,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-276|16|901|Other deterministic changes|Whole body|MCDU/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-277|16|901|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-278|16|901|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-279|16|901|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ r inguinal region & thigh.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-280|16|904|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-281|16|904|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-282|16|904|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-283|16|904|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-284|16|905|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS INVADING SKELETAL MUSC.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-285|16|905|Neoplasia malignant|Endocrine system|TGAC/   Metastases Lung|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-286|16|906|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-287|16|906|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-288|16|908|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-289|16|908|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-290|16|909|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-291|16|911|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-292|16|911|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-293|16|911|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-294|16|912|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ in abd cavity invading skeletal muscle and visceral peritoneum of kidney),MPATH: 408 - soft tissue fibrosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-295|16|912|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-296|16|913|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-297|16|913|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-298|16|913|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-299|16|914|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-300|16|914|Other deterministic changes|Whole body|MCDU/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-301|16|915|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-302|16|915|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-303|16|916|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-304|16|916|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-305|16|916|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-306|16|917|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-307|16|918|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ lower abdominal cavity-- obstructing colon, invasion of colon wall, perit.and Pancreas . skin and muscle metastases lung,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-308|16|918|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/ with spread to contralateral kidn. Metastases lung,MPATH: 549 - carcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-309|16|918|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-310|16|922|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWG: TGAC INVADES MUSC & SKIN.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-311|16|922|Neoplasia malignant|Endocrine system|TGAC/   Metastases Lung Metastases  Muscle tgac invades musc & skin of skull. Metastases  Lymphoret.System tgac to pt ln. Metastases  tgac metast on parietal pleura of rib cage.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-312|16|922|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-313|16|922|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-314|16|925|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-315|16|927|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-316|16|927|Other deterministic changes|Whole body|MCDU/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-317|16|928|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-318|16|929|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-319|16|929|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-320|16|929|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-321|16|930|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-322|16|931|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-323|16|932|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|MMTA/  Metritis|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-324|16|932|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-325|16|932|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-326|16|933|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-327|16|933|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-328|16|933|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-329|16|933|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-330|16|934|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-331|16|935|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-332|16|935|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-333|16|936|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWB: TBVS OF SPINE TO ADNEXAL MUSC.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-334|16|939|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-335|16|939|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-336|16|939|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-337|16|939|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ sacral spine & pelvic region. Metastases  tbos of sacral spine infiltrates nerve.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-338|16|939|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWB: TBVS OF SPINE TO ADNEXAL MUSC.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-339|16|940|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-340|16|942|Other deterministic changes|Whole body|MCDU/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-341|16|942|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-342|16|943|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-343|16|943|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-344|16|945|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-345|16|945|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-346|16|946|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-347|16|946|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOVO/  ,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-348|16|947|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-349|16|947|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-350|16|947|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ lt axilla infiltrates skel musc. Metastases  Muscle tcfs of lt axilla invades diap & musc of forelimb. Metastases  Lymphoret.System tcfs of lt axilla invades pt ln. Metastases Lung,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-351|16|950|Neoplasia malignant|Other local manifestations and miscellaneus|TCSS/ TCSS/ TCSS/ TCSS/ lower abd cavity & musc invas & growth on perit of kidn & spleen.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-352|16|952|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-353|16|952|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-354|16|953|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-355|16|953|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-356|16|953|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-357|16|953|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases  Muscle tnns of nerve of abd. wall to skeletal musc adjacent to uterus & ovary; diaphragmatic musc.,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-358|16|954|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-359|16|954|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWG: TGAC TO MUSCLE & SKIN ADJAC. TO ORBIT.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-360|16|955|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/   Metastases Lung|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-361|16|957|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOVO/  ,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-362|16|957|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-363|16|957|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TXAC/ nasal sinuses.,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-364|16|959|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-365|16|960|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-366|16|960|Neoplasia benign|Mammary gland,MA: 0000145 - mammary gland|TMAT/  Metastases lung also invading muscle,MPATH: 255 - adenoacanthoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-367|16|961|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-368|16|961|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-369|16|963|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-370|16|963|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-371|16|963|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-372|16|964|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-373|16|965|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-374|16|966|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-375|16|967|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-376|16|967|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|TSFS/ nose. Metastases  Muscle tsfs of nose invades skel musc of head.,MPATH: 219 - adnexal and skin appendage tumor|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-377|16|967|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ dorsal thoracic-lumbar region. Invading skeletal muscle,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-378|16|967|Neoplasia systemic|Haematolymphatic system|TLML/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-379|16|968|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-380|16|969|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-381|16|969|Neoplasia unclassified|Other local manifestations and miscellaneus|TKWX: TXEC OF SALIVARY GLAND TO KIDNEY.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-382|16|970|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-383|16|971|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-384|16|971|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|MCRD/  ,MPATH: 1 - cell and tissue damage|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-385|16|973|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-386|16|974|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-387|16|974|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-388|16|974|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-389|16|975|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-390|16|977|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-391|16|978|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-392|16|979|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOVO/  ,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-393|16|980|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-394|16|981|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-395|16|981|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ adjacent to r kidn.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-396|16|981|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-397|16|982|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ r axial & inguinal regions. Invasion of skelet. Muscle and skin Metastases lung,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-398|16|982|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-399|16|983|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-400|16|987|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-401|16|988|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOVO/  ,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-402|16|988|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-403|16|989|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-404|16|990|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-405|16|990|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-406|16|990|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-407|16|990|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-408|16|991|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-409|16|991|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-410|16|991|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT LN.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-411|16|997|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-412|16|997|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-413|16|997|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-414|16|997|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-415|16|997|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ lumbar spine. Metastases  Muscle tbos invas of spinal musc.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-416|16|999|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-417|16|999|Neoplasia unclassified|Central nervous system among nervous system|TNAS/ hippocampus-cerebrum.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-418|16|1002|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-419|16|1002|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-420|16|1003|Neoplasia malignant|Bloodvessels among cardiovascular system|TBVS/ spine-sacral. Metastases Lung Metastases  Muscle tbvs of spine invasion of musc.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-421|16|1004|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  Head/neck missing Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-422|16|1005|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-423|16|1005|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-424|16|1005|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-425|16|1005|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-426|16|1006|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-427|16|1007|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-428|16|1008|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-429|16|1008|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-430|16|1009|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-431|16|1011|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-432|16|1011|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-433|16|1012|Neoplasia systemic|Haematolymphatic system|TLML/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-434|16|1013|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-435|16|1014|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-436|16|1015|Neoplasia unclassified|Other local manifestations and miscellaneus|TNWB: TBOS OF SACRAL SPINE INFILTRATES NERVE.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-437|16|1016|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-438|16|1017|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-439|16|1017|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-440|16|1018|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-441|16|1019|Other deterministic changes|Whole body|MCDU/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-442|16|1019|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TXAC/ ureter of r kidn with invas of musc wall of ureter.,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-443|16|1020|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-444|16|1023|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ skull with lysis of bone & invasion of bone marrow. Metastases  Muscle tcfs of skull invades skeletal musc. Metastases  Skin tcfs of skull invades skin of skull & ear. Metastases Liver Metastases Lung,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-445|16|1023|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-446|16|1023|Neoplasia malignant|Other local manifestations and miscellaneus|TMLS/ abdominal region. Metastases reg.ln, to lung and rib cage muscles|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-447|16|1025|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ lumbar spine. Metastases  Muscle tbos invades skeletal musc.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-448|16|1026|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-449|16|1026|Other deterministic changes|Whole body|MCDU/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-450|16|1027|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-451|16|1028|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-452|16|1029|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-453|16|1029|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-454|16|1030|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-455|16|1030|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-456|16|1030|Neoplasia malignant|Adrenal gland  among endocrine systems|TAPS/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-457|16|1030|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-458|16|1030|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/ tevs invades visc perit over kidn at hilus.,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-459|16|1031|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ thigh musc. Invasion of thigh muscle and bone|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-460|16|1032|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/   Metastases  Lymphoret.System trac metastasis to pt ln.,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-461|16|1032|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-462|16|1037|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-463|16|1037|Neoplasia malignant|Bloodvessels among cardiovascular system|TXVS/ perit adjacent to ovar & uter.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-464|16|1040|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-465|16|1040|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPAA/  Acidophilic adenoma,MPATH: 218 - neoplasm|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-466|16|1041|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-467|16|1042|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-468|16|1043|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-469|16|1043|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-470|16|1044|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/   invades tail skeletal muscle,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-471|16|1044|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|MRMP/  Murine,MPATH: 212 - inflammation|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-472|16|1044|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-473|16|1044|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-474|16|1045|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-475|16|1046|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-476|16|1046|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-477|16|1047|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-478|16|1047|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle trac to scirrhous form. Metastases  Lymphoret.System trac to pt ln.Eye(s) missing,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-479|16|1048|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-480|16|1050|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWK: TKAC TO LUNG.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-481|16|1052|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-482|16|1052|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-483|16|1053|Other deterministic changes|Whole body|MCDU/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-484|16|1055|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-485|16|1058|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-486|16|1060|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-487|16|1065|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWH: THVS TO LUNG.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-488|16|1065|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-489|16|1069|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  Metastases liver, pt ln. and visceral pleura,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-490|16|1071|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-491|16|1072|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-492|16|1073|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-493|16|1076|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-494|16|1079|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/   Metastases Lung,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-495|16|1080|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-496|16|1082|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-497|16|1082|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-498|16|1084|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-499|16|1084|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-500|16|1086|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-501|16|1086|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-502|16|1087|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-503|16|1088|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ sacral spine. Invasion muscle of lower back|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-504|16|1088|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-505|16|1088|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-506|16|1091|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-507|16|1094|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPAC/  Carcinoma Metastases  tpac invades cerebrum base.,MPATH: 218 - neoplasm|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-508|16|1094|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-509|16|1095|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ left shoulder Metastases lung and liver,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-510|16|1096|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|TMRS/ abdominal region. , invading peritoneum, pancreas, uterine wall as well as  intestinal wall.,MPATH: 428 - rhabdomyosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-511|16|1097|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-512|16|1097|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ rib (costal) musc & hemorr on visc pleura. Muscle|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-513|16|1099|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-514|16|1100|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-515|16|1100|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-516|16|1101|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-517|16|1104|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-518|16|1104|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-519|16|1107|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC METASTASIS TO PT LN.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-520|16|1108|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-521|16|1110|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-522|16|1111|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-523|16|1111|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ subcut. under rt. ear. Metastases  Lymphoret.System tcfs infiltr. cnln. Metastases  tcfs infiltr. salivary gland.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-524|16|1111|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-525|16|1114|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-526|16|1115|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|MCRD/ bilateral.,MPATH: 1 - cell and tissue damage|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-527|16|1115|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-528|16|1116|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-529|16|1116|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TULS/  metastases to visc perit. (caps. of kid. & spl),MPATH: 551 - sarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-530|16|1118|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-531|16|1121|Changes due to an abnormal circulation|Bloodvessels among cardiovascular system|MTHR/  auricular|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-532|16|1121|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-533|16|1121|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-534|16|1122|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-535|16|1123|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-536|16|1125|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-537|16|1129|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-538|16|1130|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-539|16|1132|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-540|16|1135|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-541|16|1135|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|MRMP/  Murine,MPATH: 212 - inflammation|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-542|16|1139|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-543|16|1144|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-544|16|1144|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-545|16|1146|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ femur. Metastases to lung and thigh muscle|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-546|16|1149|Neoplasia malignant|Endocrine system|TGAC/   Metastases  Lymphoret.System tgac to cn ln. Metastases Lung|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-547|16|1151|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-548|16|1151|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOVO/  ,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-549|16|1152|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-550|16|1152|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-551|16|1155|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-552|16|1156|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-553|16|1157|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-554|16|1164|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-555|16|1167|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TXEC/ salivary gland with secondaries to skin, mes. fat, uterus &visc. pleura of esoph. & visc. perit. of kid. Metastases  Kidney txec of salivary gland to kidney. Metastases  Lung txec of salivary gland to lung.,MPATH: 446 - squamous cell carcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-556|16|1169|n/a|n/a|n/a|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-557|16|1172|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-558|16|1175|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-559|16|1176|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-560|16|1176|Other deterministic changes|Whole body|MCDU/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-561|16|1177|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-562|16|1178|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-563|16|1178|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-564|16|1180|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-565|16|1189|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-566|16|1190|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/ Metastases to Pt. Ln. , kidney, mediastinum and visc. Perit. And skeletal muscle,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-567|16|1190|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ sternal muscle. Muscle|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-568|16|1195|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-569|16|1196|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-570|16|1204|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-571|16|1204|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-572|16|1205|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-573|16|1212|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-574|16|1213|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-575|16|1216|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-576|16|1219|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-577|16|1219|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-578|16|1220|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|MRMP/  Murine,MPATH: 212 - inflammation|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-579|16|1220|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-580|16|1228|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TMAB/  Predominantly ductal Metastases Lung tmab to lung,MPATH: 218 - neoplasm|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-581|16|1231|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-582|16|1235|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-583|16|1241|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-584|16|1244|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-585|16|1247|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-586|16|1248|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ skull including mandibular bone & bone marrow.|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-587|16|1255|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-588|16|1257|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/   Metastases Lung,MPATH: 242 - hemangiosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-589|16|1264|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-590|16|1268|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-591|16|1272|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-592|16|1276|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-593|16|1319|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-594|16|1327|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|MCRD/  ,MPATH: 1 - cell and tissue damage|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-595|16|1329|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-596|16|1334|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-597|16|1346|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|TNNS/ rt. dorsal hip region. Metastases  Muscle tnns of rt hip region infiltr. skel. musc.,MPATH: 437 - neurofibrosarcoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-598|16|1349|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-599|16|1366|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-16|n/a,K1|1| 100|neutrons fission|0.2|grays|External exposure| code K1 24 fractions 45 m 1/w|600 (600 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|593 records survival 800 ± 8 lifespan study|1003-22-16-600|16|1399|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-1|17|122|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-2|17|127|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-3|17|127|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-4|17|131|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-5|17|131|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-6|17|131|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-7|17|131|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-8|17|155|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-9|17|155|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-10|17|157|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-11|17|159|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-12|17|162|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-13|17|162|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-14|17|162|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-15|17|162|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-16|17|166|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-17|17|166|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-18|17|166|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-19|17|171|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-20|17|176|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-21|17|176|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-22|17|180|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-23|17|183|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-24|17|183|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-25|17|194|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-26|17|194|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-27|17|194|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-28|17|206|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-29|17|206|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-30|17|206|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-31|17|206|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-32|17|208|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-33|17|208|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-34|17|208|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-35|17|208|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-36|17|208|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-37|17|211|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-38|17|211|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-39|17|220|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-40|17|220|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-41|17|220|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-42|17|233|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-43|17|233|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-44|17|233|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-45|17|233|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-46|17|233|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-47|17|236|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-48|17|236|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-49|17|240|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-50|17|240|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-51|17|240|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-52|17|247|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-53|17|247|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-54|17|247|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-55|17|262|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-56|17|262|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-57|17|262|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-58|17|262|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-59|17|262|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-60|17|262|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-61|17|262|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-62|17|262|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-63|17|262|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-64|17|262|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-65|17|268|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-66|17|268|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-67|17|268|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-68|17|268|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-69|17|268|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-70|17|268|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-71|17|268|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-72|17|268|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-73|17|268|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-74|17|268|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-75|17|268|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-76|17|298|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-77|17|308|Inflammation and/or fibrotic diseases|Cardiovascular system,MA: 0000164 - myocardium|MMCC/ MMCC/ MMCC/ MMCC/  chronic,MPATH: 212 - inflammation|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-78|17|397|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ pelvic region with lysis of bone and invas. of adipose tissue. Muscle|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-79|17|403|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ subcutis surr. testis & cowper's gl., infiltr. caps. of testis & adipose tiss.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-80|17|415|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-81|17|446|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-82|17|457|Neoplasia malignant|Bloodvessels among cardiovascular system|TTVS/  Testis|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-83|17|479|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-84|17|491|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-85|17|494|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWG: TGAC INVAS. OF SKEL. MUSCLE & SKIN.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-86|17|499|Other deterministic changes|Whole body|MCDU/  |
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-87|17|515|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-88|17|519|Neoplasia unclassified|Other local manifestations and miscellaneus|TNWP: TPAC TO BRAIN.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-89|17|527|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-90|17|529|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-91|17|536|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|MRMP/  Murine,MPATH: 212 - inflammation|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-92|17|538|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-93|17|542|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-94|17|542|Other deterministic changes|Whole body|MCDU/  |
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-95|17|551|Inflammation and/or fibrotic diseases|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|MHCN/  Coagulative focal hepatitis,MPATH: 212 - inflammation|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-96|17|582|Other deterministic changes|Whole body|MCDU/  |
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-97|17|589|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-98|17|589|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-99|17|596|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-100|17|597|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ thigh. Muscle|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-101|17|606|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-102|17|615|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ inguinal region.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-103|17|619|Neoplasia malignant|Bloodvessels among cardiovascular system|TXVS/ visc. perit.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-104|17|627|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-105|17|633|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-106|17|637|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-107|17|638|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWG: TGAC TO CERVICAL L.N.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-108|17|639|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-109|17|640|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-110|17|641|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-111|17|641|Other deterministic changes|Whole body|MCDU/  |
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-112|17|643|Other deterministic changes|Whole body|MCDU/  |
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-113|17|645|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-114|17|648|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS OF TAIL BASE INVAS. OF SKEL. MUSCLE.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-115|17|648|Neoplasia malignant|Other local manifestations and miscellaneus|TXUS/ TXUS/ TXUS/ TXUS/ saliv. gl. of myo epitheliomatous cells.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-116|17|654|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-117|17|654|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-118|17|658|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-119|17|658|Other deterministic changes|Whole body|MCDU/  |
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-120|17|661|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-121|17|664|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-122|17|664|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWG: TGAC TO CERVICAL L.N.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-123|17|666|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-124|17|668|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-125|17|672|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-126|17|674|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|TNMS/ with invas. of nasal sinus.,MPATH: 551 - sarcoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-127|17|680|Neoplasia malignant|Bloodvessels among cardiovascular system|TXVS/ preputial tiss. Metastases  txvs of preputial tiss. to muscle of pelvic reg. and adnexal adipose tissue.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-128|17|681|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-129|17|686|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-130|17|688|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-131|17|690|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-132|17|690|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-133|17|690|Neoplasia malignant|Bloodvessels among cardiovascular system|TTVS/  Testis|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-134|17|691|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-135|17|692|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-136|17|694|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-137|17|696|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-138|17|696|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-139|17|703|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-140|17|703|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-141|17|711|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-142|17|714|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-143|17|716|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-144|17|718|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-145|17|722|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-146|17|723|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-147|17|724|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-148|17|725|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-149|17|729|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWG: TGAC TO PT. L.N., BR. L.N.'S.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-150|17|731|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-151|17|731|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS OF PERINEUM TO ADNEXA.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-152|17|733|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-153|17|733|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-154|17|734|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/   Metastases Lung,MPATH: 549 - carcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-155|17|736|Other deterministic changes|Whole body|MCDU/   Metastases  Lymphoret.System tgac to pt. l.n., br. l.n.'s.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-156|17|736|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-157|17|736|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWK: TKAC TO LUNG.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-158|17|738|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-159|17|739|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWG: TGAC TO PT. L.N., BR. L.N.'S.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-160|17|743|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-161|17|744|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-162|17|746|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-163|17|750|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-164|17|750|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/   Metastases  Lung txus of saliv. gl. to lung.,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-165|17|751|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-166|17|754|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-167|17|756|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWI: TIFS OF COLON TO MN. L.N.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-168|17|756|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-169|17|756|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPAC/  Carcinoma,MPATH: 218 - neoplasm|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-170|17|760|Inflammation and/or fibrotic diseases|Heart among cardiovascular system,MA: 0000076 - heart endocardium|MECC/  Chronic valvular endocarditisEye(s) missing,MPATH: 214 - chronic inflammation|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-171|17|760|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-172|17|765|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-173|17|766|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-174|17|769|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-175|17|771|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-176|17|771|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle trac to sternal muscle. Metastases  Lymphoret.System trac to pt. l.n. Metastases  trac to pleura, visc(heart base).,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-177|17|771|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-178|17|771|Other deterministic changes|Whole body|MCDU/  |
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-179|17|772|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-180|17|775|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-181|17|777|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-182|17|778|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-183|17|780|Neoplasia unclassified|Other local manifestations and miscellaneus|TNWX: TNNS (MALIG. SCHWANNOMA) INV. OF BRAIN.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-184|17|781|Neoplasia unclassified|Other local manifestations and miscellaneus|TNWP: TPAC TO BRAIN.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-185|17|785|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-186|17|786|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-187|17|790|Neoplasia malignant|Endocrine system|TGAC/   Metastases  Lymphoret.System tgac to cervical l.n. Metastases Lung|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-188|17|791|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-189|17|793|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-190|17|795|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-191|17|797|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-192|17|799|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-193|17|800|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-194|17|802|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-195|17|802|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TXAC/ sal. gl. with invas. of skin.,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-196|17|805|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-197|17|806|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ thigh. Muscle|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-198|17|806|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPAO/  Adenoma,MPATH: 218 - neoplasm|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-199|17|806|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-200|17|807|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|TNMS/  ,MPATH: 551 - sarcoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-201|17|809|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-202|17|810|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-203|17|813|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-204|17|813|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-205|17|815|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-206|17|818|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TXEC/ ear canal. Metastases  Lymphoret.System txec of ear canal metas. to cn. Metastases  Lung txec of ear canal metas. to lung.,MPATH: 446 - squamous cell carcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-207|17|823|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT. L.N.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-208|17|828|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ perineum. Metastases  Muscle tcfs of perineum to adnexa.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-209|17|828|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System tifs of colon to mn. l.n. Metastases  tifs of colon to visc. perit. of kidney.,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-210|17|829|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-211|17|829|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-212|17|831|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases Lung,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-213|17|832|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-214|17|833|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS TO MUSCLE OF PELVIS & VERTEBRAE.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-215|17|834|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS TO MUSCLE OF PELVIS & VERTEBRAE.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-216|17|837|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle trac to muscles of lumbar region.,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-217|17|838|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-218|17|838|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-219|17|841|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-220|17|842|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-221|17|842|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-222|17|842|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWG: TGAC TO LUNG.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-223|17|844|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-224|17|845|Other deterministic changes|Whole body|MCDU/  |
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-225|17|848|Other deterministic changes|Whole body|MCDU/  |
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-226|17|848|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-227|17|853|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-228|17|854|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-229|17|855|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-230|17|855|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPAC/  Carcinoma Metastases  tpac to brain.,MPATH: 218 - neoplasm|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-231|17|856|Other deterministic changes|Whole body|MCDU/  |
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-232|17|857|Other deterministic changes|Whole body|MCDU/  |
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-233|17|857|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-234|17|858|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-235|17|860|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-236|17|860|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-237|17|862|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-238|17|862|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWI: TIFS OF COLON TO MN. L.N.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-239|17|864|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-240|17|864|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-241|17|865|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-242|17|865|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-243|17|870|Other deterministic changes|Whole body|MCDU/  |
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-244|17|872|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-245|17|875|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-246|17|876|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWR: TRAC TO VISC. & PARIET. PLEURA.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-247|17|876|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWG: TGAC TO PT. L.N., BR. L.N.'S.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-248|17|877|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-249|17|878|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-250|17|878|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWK: TKAC TO LUNG.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-251|17|879|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|TNNS/ malig. schwannoma. Metastases  tnns (malig. schwannoma) inv. of brain.,MPATH: 437 - neurofibrosarcoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-252|17|881|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases  tgac to rib cage pleura & at hilus of lung.,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-253|17|883|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-254|17|884|Neoplasia malignant|Endocrine system|TGAC/   Metastases  Lymphoret.System tgac to cn. l.n. Metastases  Muscle tgac to muscles of face.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-255|17|892|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPAC/  Carcinoma Metastases  tpac to base of brain,MPATH: 218 - neoplasm|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-256|17|892|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-257|17|894|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-258|17|894|Neoplasia malignant|Endocrine system|TGAC/ with skin invas.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-259|17|896|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWR: TRAC TO MUSCLES OF LUMBAR REGION.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-260|17|896|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-261|17|898|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-262|17|899|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-263|17|900|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ lumbar, pelvic region. Metastases  Skin tcfs to dermis of lumbar & pelvic reg.. Metastases  Muscle tcfs to muscle of pelvis & vertebrae.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-264|17|901|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-265|17|902|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-266|17|905|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-267|17|905|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-268|17|907|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-269|17|911|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-270|17|912|Other deterministic changes|Whole body|MCDU/  |
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-271|17|912|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-272|17|915|Other deterministic changes|Whole body|MCDU/  |
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-273|17|915|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-274|17|917|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-275|17|918|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-276|17|918|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-277|17|919|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  Head/neck missing Eye(s) missing,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-278|17|925|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWX: TXUS OF SALIV. GL. TO LUNG.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-279|17|928|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases Heart,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-280|17|929|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-281|17|930|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-282|17|931|Neoplasia malignant|Endocrine system|TGAC/  |
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-283|17|931|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  Head/neck missing Eye(s) missing|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-284|17|932|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS OF PERINEUM TO ADNEXA.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-285|17|932|Neoplasia unclassified|Other local manifestations and miscellaneus|TYWR: TRAC TO HEART.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-286|17|933|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-287|17|934|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-288|17|935|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-289|17|937|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/   Metastases Lung,MPATH: 549 - carcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-290|17|937|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-291|17|938|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-292|17|938|Other deterministic changes|Whole body|MCDU/  |
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-293|17|939|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWX: TXEC OF EAR CANAL METAS. TO CN.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-294|17|939|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-295|17|939|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-296|17|939|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  Eye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-297|17|939|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-298|17|943|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-299|17|945|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-300|17|946|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-301|17|948|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-302|17|949|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-303|17|950|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-304|17|950|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-305|17|951|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-306|17|954|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-307|17|956|Other deterministic changes|Whole body|MCDU/  |
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-308|17|959|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TMFS/ femur & tibia.muscle,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-309|17|961|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-310|17|962|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-311|17|963|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWG: TGAC INVAS. OF SKEL. MUSCLE & SKIN.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-312|17|964|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-313|17|967|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-314|17|967|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS TO MUSCLE OF PELVIS & VERTEBRAE.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-315|17|968|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-316|17|968|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-317|17|969|Neoplasia malignant|Endocrine system|TGAC/   Metastases  Lymphoret.System tgac to cn. l.n.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-318|17|970|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-319|17|971|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-320|17|971|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-321|17|974|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-322|17|974|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-323|17|974|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-324|17|976|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWR: TRAC TO MUSCLES OF LUMBAR REGION.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-325|17|977|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ scapular region. Metastases  Skin tcfs of scapular region invad. skin and skel. muscle.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-326|17|978|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-327|17|978|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-328|17|978|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-329|17|980|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-330|17|982|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-331|17|983|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-332|17|984|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-333|17|985|Other deterministic changes|Whole body|MCDU/  |
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-334|17|985|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-335|17|985|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-336|17|989|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-337|17|990|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-338|17|990|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-339|17|992|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-340|17|994|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWG: TGAC INVAS. OF SKEL. MUSCLE & SKIN.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-341|17|995|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-342|17|999|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-343|17|999|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases Liver,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-344|17|999|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-345|17|1000|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-346|17|1002|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-347|17|1002|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWK: TKAC TO LUNG.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-348|17|1002|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/   Metastases Lung,MPATH: 549 - carcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-349|17|1002|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-350|17|1003|Neoplasia malignant|Endocrine system|TGAC/   Metastases Lung Metastases  tgac to mediastinum (between rt. & lt. lobes of lung.) Metastases  Muscle tgac to intercostal muscle of rib cage.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-351|17|1008|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/   Metastases Lung|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-352|17|1008|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-353|17|1009|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-354|17|1016|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-355|17|1017|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-356|17|1017|Neoplasia unclassified|Nervous system and special sense organs|TANS/  Adrenal|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-357|17|1018|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-358|17|1018|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-359|17|1018|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWK: TKAC TO LUNG.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-360|17|1019|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-361|17|1020|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-362|17|1021|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-363|17|1022|Neoplasia malignant|Endocrine system|TGAC/  |
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-364|17|1023|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-365|17|1024|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-366|17|1024|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-367|17|1025|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-368|17|1026|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-369|17|1026|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-370|17|1028|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-371|17|1030|Other deterministic changes|Whole body|MCDU/  |
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-372|17|1030|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-373|17|1031|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-374|17|1031|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-375|17|1032|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-376|17|1034|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-377|17|1037|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-378|17|1038|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-379|17|1041|Other deterministic changes|Whole body|MCDU/  |
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-380|17|1045|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-381|17|1045|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-382|17|1046|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-383|17|1047|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-384|17|1049|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/   Metastases Lung,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-385|17|1050|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-386|17|1050|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-387|17|1051|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-388|17|1051|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-389|17|1053|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-390|17|1055|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-391|17|1058|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  Eye(s) missing Head/neck missing,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-392|17|1060|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-393|17|1060|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-394|17|1061|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-395|17|1062|Neoplasia unclassified|Other local manifestations and miscellaneus|TNWX: TNNS (MALIG. SCHWANNOMA) INV. OF BRAIN.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-396|17|1062|Other deterministic changes|Whole body|MCDU/  |
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-397|17|1066|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-398|17|1068|Other deterministic changes|Whole body|MCDU/  |
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-399|17|1069|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-400|17|1069|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-401|17|1072|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-402|17|1073|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-403|17|1077|Neoplasia malignant|Bloodvessels among cardiovascular system|TSVS/ anal & adj. s.c. of skin.Skin|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-404|17|1079|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-405|17|1080|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  trac to visc. & pariet. pleura.,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-406|17|1081|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-407|17|1081|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-408|17|1082|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/ hard. gl.,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-409|17|1086|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-410|17|1086|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  Head/neck missing Eye(s) missing,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-411|17|1087|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-412|17|1088|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-413|17|1090|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-414|17|1093|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/   Metastases  tkac to visc. perit.,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-415|17|1093|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-416|17|1103|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-417|17|1107|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-418|17|1107|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-419|17|1108|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-420|17|1109|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-421|17|1111|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-422|17|1116|Neoplasia unclassified|Other local manifestations and miscellaneus|TYWR: TRAC TO HEART.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-423|17|1123|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-424|17|1125|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-425|17|1125|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWK: TKAC TO LUNG.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-426|17|1125|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/ metas. to spleen.,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-427|17|1128|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-428|17|1135|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-429|17|1137|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-430|17|1139|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ rt. hip. Muscle|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-431|17|1151|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-432|17|1153|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-433|17|1153|Neoplasia systemic|Haematolymphatic system|TLML/  |
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-434|17|1158|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-435|17|1163|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-436|17|1163|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-437|17|1164|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-438|17|1164|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-439|17|1172|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-440|17|1175|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-441|17|1179|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-442|17|1189|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-443|17|1191|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-444|17|1192|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-445|17|1193|Neoplasia systemic|Haematolymphatic system|TLML/  Head/neck missing Eye(s) missing|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-446|17|1195|Inflammation and/or fibrotic diseases|Kidney among urinary system diseases,MA: 0000368 - kidney|MINA/  acute,MPATH: 212 - inflammation|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-447|17|1199|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKCA/  cystic adenoma,MPATH: 418 - liposarcoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-448|17|1201|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-449|17|1202|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-450|17|1211|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-451|17|1212|Neoplasia malignant|Endocrine system|TGAC/   Metastases  Muscle tgac invas. of skel. muscle & skin.|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-452|17|1219|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-453|17|1220|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-454|17|1223|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ base of tail. Metastases  Muscle tcfs of tail base invas. of skel. muscle.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-455|17|1227|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-456|17|1234|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-457|17|1239|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|TACC/ metas. visc. perit. & pancr. Metastases  Lymphoret.System tacc in rn. l.n.,MPATH: 549 - carcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-458|17|1245|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-459|17|1248|Other deterministic changes|Whole body|MCDU/  |
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-460|17|1249|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-461|17|1255|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-462|17|1265|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-463|17|1269|Other deterministic changes|Whole body|MCDU/  |
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-464|17|1270|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-465|17|1270|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-466|17|1272|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-467|17|1291|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|MRMP/  Murine,MPATH: 212 - inflammation|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-468|17|1298|Other deterministic changes|Whole body|MCDU/  |
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-469|17|1298|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-470|17|1299|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-471|17|1331|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-472|17|1355|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-473|17|1360|n/a|n/a|n/a|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-474|17|1408|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|TACC/  ,MPATH: 549 - carcinoma|
1003-22-17|n/a,K1|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|475 (475 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|400 records survival 799 ± 10 lifespan study|1003-22-17-475|17|1447|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-1|18|325|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-2|18|348|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-3|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-4|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-5|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-6|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-7|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-8|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-9|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-10|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-11|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-12|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-13|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-14|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-15|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-16|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-17|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-18|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-19|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-20|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-21|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-22|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-23|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-24|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-25|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-26|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-27|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-28|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-29|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-30|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-31|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-32|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-33|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-34|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-35|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-36|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-37|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-38|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-39|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-40|18|430|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-41|18|472|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-42|18|472|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-43|18|472|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-44|18|472|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-45|18|472|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-46|18|476|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-47|18|479|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-48|18|479|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-49|18|479|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-50|18|479|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-51|18|479|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-52|18|479|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-53|18|479|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-54|18|479|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-55|18|479|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-56|18|479|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-57|18|486|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-58|18|486|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-59|18|486|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-60|18|486|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-61|18|486|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-62|18|486|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-63|18|486|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-64|18|486|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-65|18|486|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-66|18|486|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-67|18|486|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-68|18|486|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-69|18|486|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-70|18|486|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-71|18|486|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-72|18|486|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-73|18|486|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-74|18|486|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-75|18|486|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-76|18|486|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-77|18|486|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-78|18|486|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-79|18|486|n/a|n/a|n/a|
1003-22-18|n/a,K2|1| 100|neutrons fission|0.4|grays|External exposure| code K2 24 fractions 45 m 1/w|80 (80 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-18-80|18|486|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-1|19|106|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-2|19|106|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-3|19|106|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-4|19|106|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-5|19|110|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-6|19|113|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-7|19|120|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-8|19|128|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-9|19|128|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-10|19|128|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-11|19|128|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-12|19|128|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT. L.N.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-13|19|128|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-14|19|131|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-15|19|134|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-16|19|134|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-17|19|134|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-18|19|138|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-19|19|138|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-20|19|141|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-21|19|141|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-22|19|141|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-23|19|141|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-24|19|145|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-25|19|145|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-26|19|148|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-27|19|148|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-28|19|155|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-29|19|155|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-30|19|155|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-31|19|155|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-32|19|155|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-33|19|155|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-34|19|155|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-35|19|155|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-36|19|159|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-37|19|159|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-38|19|164|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-39|19|164|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-40|19|183|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-41|19|183|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-42|19|194|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-43|19|194|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-44|19|197|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-45|19|197|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-46|19|204|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-47|19|205|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-48|19|205|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-49|19|205|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-50|19|205|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-51|19|208|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-52|19|208|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-53|19|208|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-54|19|208|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-55|19|208|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-56|19|211|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-57|19|213|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-58|19|213|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-59|19|213|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-60|19|232|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-61|19|233|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-62|19|233|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-63|19|239|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-64|19|240|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-65|19|240|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-66|19|240|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-67|19|240|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-68|19|240|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-69|19|261|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-70|19|261|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-71|19|261|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-72|19|262|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-73|19|262|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-74|19|262|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-75|19|262|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-76|19|262|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-77|19|262|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-78|19|262|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-79|19|262|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-80|19|262|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-81|19|269|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-82|19|288|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-83|19|387|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-84|19|407|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-85|19|431|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ left side thorax.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-86|19|453|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWS: TSEC OF PREPUTIAL AREA TO SM. INTEST.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-87|19|461|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKVS/  ,MPATH: 551 - sarcoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-88|19|469|Neoplasia malignant|Other local manifestations and miscellaneus|TXUS/ TXUS/ TXUS/ TXUS/ left foreleg. Metastases  Lung txus of left foreleg to lung.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-89|19|491|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-90|19|493|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-91|19|502|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  trac to through pleura to mediast.,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-92|19|515|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-93|19|520|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT. L.N.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-94|19|521|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-95|19|529|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  trac to mediastinum, rib cage & pleural tissues.,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-96|19|531|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ head. Metastases Lung Metastases Harderian gland Metastases  tcfs of head invas. of retro-orbital tissues.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-97|19|533|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWS: TSEC OF PREPUTIAL AREA TO SM. INTEST.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-98|19|533|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-99|19|568|Neoplasia malignant|Bloodvessels among cardiovascular system|TTVS/  Testis Metastases Lung|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-100|19|569|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT. L.N.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-101|19|578|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-102|19|579|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-103|19|583|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ thigh with invasion of dermis. Muscle|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-104|19|593|Other deterministic changes|Whole body|MCDU/  |
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-105|19|595|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-106|19|604|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  trac to pleura between lobes.,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-107|19|604|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-108|19|607|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac to pt. l.n..,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-109|19|611|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-110|19|611|Other deterministic changes|Whole body|MCDU/  |
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-111|19|614|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-112|19|619|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWB: TBOS OF THORACIC VERT. TO THOR. MUSCLE.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-113|19|624|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWR: TRAC TO STERNAL MUSCLE.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-114|19|627|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ along lumbar spine. Metastases  Muscle tcvs along lumbar spine to skel. muscle.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-115|19|641|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac to pt. l.n. Metastases  trac to visc. pleura & mediastinum.,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-116|19|653|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-117|19|671|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS OF LEFT SIDE OF THORAX INFILTR. SKEL. MUSCLE.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-118|19|688|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-119|19|698|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ thor. spinal c.t. with invas. of bone. Metastases  Muscle tcvs to thor. muscle.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-120|19|702|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-121|19|703|Neoplasia malignant|Bloodvessels among cardiovascular system|TSVS/ derm. around lt. eye.Skin|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-122|19|705|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-123|19|706|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-124|19|714|Neoplasia malignant|Bloodvessels among cardiovascular system|TLVS/ inguinal l.n.. Lymphoret.tissue|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-125|19|718|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ jaw.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-126|19|727|Other deterministic changes|Whole body|MCDU/  |
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-127|19|728|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-128|19|735|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-129|19|735|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT. L.N.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-130|19|743|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-131|19|744|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-132|19|745|Other deterministic changes|Whole body|MCDU/  |
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-133|19|746|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ thigh. Metastases  Muscle tcfs of left side of thorax infiltr. skel. muscle. Metastases  Muscle tcvs of thigh to thigh muscle.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-134|19|757|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ thigh with invas. of bone of femur. Metastases  Muscle tcvs of thigh invades femur, knee joint, & head of tibia.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-135|19|762|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-136|19|764|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWG: TGAC INVAS. OF MUSCLE & SKIN OF SKULL.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-137|19|766|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWS: TSEC OF PREPUTIAL AREA TO SM. INTEST.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-138|19|774|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-139|19|776|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac to pt. l.n. Metastases  trac to parietal pleura over sternum.,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-140|19|782|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-141|19|783|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ lumbar spine. Muscle|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-142|19|786|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS OF LEFT SIDE OF THORAX INFILTR. SKEL. MUSCLE.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-143|19|787|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-144|19|790|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-145|19|798|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  Head/neck missing Eye(s) missing,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-146|19|802|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-147|19|805|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-148|19|806|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-149|19|806|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWG: TGAC INVAS. OF MUSCLE & SKIN OF SKULL.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-150|19|808|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-151|19|810|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-152|19|811|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-153|19|813|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-154|19|813|Other deterministic changes|Whole body|MCDU/  |
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-155|19|813|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-156|19|816|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-157|19|821|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  trac. abdominal wall & in mediast. Metastases Kidney,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-158|19|841|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-159|19|845|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-160|19|846|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-161|19|848|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TXAC/ prostate gl.,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-162|19|855|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-163|19|856|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-164|19|861|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-165|19|862|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-166|19|863|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-167|19|863|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-168|19|864|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-169|19|865|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-170|19|870|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-171|19|880|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-172|19|880|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-173|19|880|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-174|19|883|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-175|19|884|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-176|19|886|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-177|19|887|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|TSBC/ thigh. Metastases  Muscle tsbc of thigh to thigh muscle.,MPATH: 446 - squamous cell carcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-178|19|891|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS OF THIGH INVADES FEMUR, KNEE JOINT, & HEAD OF TIBIA.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-179|19|891|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWS: TSBC OF THIGH TO THIGH MUSCLE.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-180|19|891|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-181|19|899|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-182|19|900|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-183|19|901|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle trac to rib muscle. Metastases  Lymphoret.System trac to pt. l.n. Metastases Heart,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-184|19|902|Neoplasia unclassified|Other local manifestations and miscellaneus|THWR: TRAC TO LIVER.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-185|19|906|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-186|19|909|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-187|19|911|Other deterministic changes|Whole body|MCDU/  |
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-188|19|912|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-189|19|912|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-190|19|914|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-191|19|915|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-192|19|918|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-193|19|919|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-194|19|925|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-195|19|928|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-196|19|933|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-197|19|939|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-198|19|941|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWR: TRAC TO STERNAL MUSCLE.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-199|19|941|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|MRMP/  Murine,MPATH: 212 - inflammation|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-200|19|942|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-201|19|944|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-202|19|945|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-203|19|947|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-204|19|950|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-205|19|953|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT. L.N.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-206|19|954|Other deterministic changes|Whole body|MCDU/  |
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-207|19|954|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/   Metastases Heart|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-208|19|960|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases Liver,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-209|19|961|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-210|19|962|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-211|19|962|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-212|19|964|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-213|19|967|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS OF LEFT SIDE OF THORAX INFILTR. SKEL. MUSCLE.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-214|19|968|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-215|19|971|Neoplasia systemic|Haematolymphatic system|TLML/  |
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-216|19|972|Neoplasia malignant|Bloodvessels among cardiovascular system|TXVS/ prepuce.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-217|19|977|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-218|19|983|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-219|19|985|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  trac to visc. pleura at ht. base.,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-220|19|987|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-221|19|996|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-222|19|999|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle trac to sternal muscle.,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-223|19|1003|Neoplasia malignant|Endocrine system|TGAC/   Metastases  tgac to olfactory lobe. Metastases  Muscle tgac invas. of muscle & skin of skull.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-224|19|1006|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-225|19|1009|Other deterministic changes|Whole body|MCDU/  |
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-226|19|1009|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWB: TBOS OF THORACIC VERT. TO THOR. MUSCLE.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-227|19|1015|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-228|19|1020|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-229|19|1020|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  trac to visc. pleura of ht. base.,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-230|19|1025|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-231|19|1026|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-232|19|1026|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-233|19|1030|Neoplasia malignant|Endocrine system|TGAC/   Metastases Lung|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-234|19|1037|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-235|19|1041|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-236|19|1042|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO L.N. AT SIDE OF TRACHEA, NEAR LUNG.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-237|19|1043|Other deterministic changes|Whole body|MCDU/  |
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-238|19|1048|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-239|19|1051|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-240|19|1067|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-241|19|1070|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases  Lymphoret.System trac to l.n. at side of trachea, near lung.,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-242|19|1072|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/ metas. to opposite kidney.,MPATH: 549 - carcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-243|19|1079|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-244|19|1081|Neoplasia malignant|Other local manifestations and miscellaneus|TXUS/ TXUS/ TXUS/ TXUS/ around penis - tissue unident.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-245|19|1086|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-246|19|1088|Neoplasia unclassified|Integumentary system,MA: 0000151 - skin|TSEC/ preputial area. Metastases  Lymphoret.System tsec of preputial area to sm. intest. Metastases Lung Metastases  Muscle tsec of preputial area to diaphragm.,MPATH: 218 - neoplasm|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-247|19|1092|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-248|19|1094|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-249|19|1096|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWR: TRAC TO STERNAL MUSCLE.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-250|19|1096|Inflammation and/or fibrotic diseases|Cardiovascular system,MA: 0000164 - myocardium|MMCC/ MMCC/ MMCC/ MMCC/  chronic,MPATH: 212 - inflammation|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-251|19|1100|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT. L.N.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-252|19|1100|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-253|19|1106|Other deterministic changes|Whole body|MCDU/  |
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-254|19|1115|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/   Metastases Lung|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-255|19|1116|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-256|19|1121|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS OF THIGH INVADES FEMUR, KNEE JOINT, & HEAD OF TIBIA.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-257|19|1121|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-258|19|1135|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWR: TRAC TO VISC. PLEURA AT HT. BASE.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-259|19|1145|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-260|19|1157|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/ type undetermined - dried out tissues.,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-261|19|1159|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-262|19|1168|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ thor. vert. Metastases  Muscle tbos of thoracic vert. to thor. muscle.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-263|19|1171|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-264|19|1172|Neoplasia systemic|Haematolymphatic system|TLML/  |
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-265|19|1177|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-266|19|1181|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-267|19|1192|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-268|19|1193|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-269|19|1193|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS OF LEFT SIDE OF THORAX INFILTR. SKEL. MUSCLE.|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-270|19|1199|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle trac to muscle of rib cage. Metastases Liver Metastases  trac to kidney capsules.,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-271|19|1205|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-272|19|1233|n/a|n/a|n/a|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-273|19|1234|Other deterministic changes|Whole body|MCDU/  |
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-274|19|1257|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-19|n/a,K2|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|275 (275 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|194 records survival 762 ± 15 lifespan study|1003-22-19-275|19|1298|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases  Muscle trac to costal muscles of rib cage.,MPATH: 513 - Lymphoid neoplasms|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-1|20|430|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-2|20|430|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-3|20|430|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-4|20|430|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-5|20|430|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-6|20|430|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-7|20|430|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-8|20|430|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-9|20|430|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-10|20|430|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-11|20|430|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-12|20|430|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-13|20|430|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-14|20|430|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-15|20|430|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-16|20|430|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-17|20|430|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-18|20|430|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-19|20|430|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-20|20|430|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-21|20|479|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-22|20|479|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-23|20|479|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-24|20|479|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-25|20|479|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-26|20|479|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-27|20|479|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-28|20|479|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-29|20|479|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-30|20|479|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-31|20|486|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-32|20|486|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-33|20|486|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-34|20|486|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-35|20|486|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-36|20|486|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-37|20|486|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-38|20|486|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-39|20|486|n/a|n/a|n/a|
1003-22-20|n/a,K3|1| 100|neutrons fission|0.6|grays|External exposure| code K3 24 fractions 45 m 1/w|40 (40 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-20-40|20|486|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-1|21|110|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-2|21|113|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-3|21|117|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-4|21|117|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-5|21|120|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-6|21|120|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-7|21|120|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-8|21|120|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-9|21|120|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-10|21|124|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-11|21|127|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-12|21|127|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-13|21|141|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-14|21|141|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-15|21|141|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-16|21|141|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-17|21|148|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-18|21|148|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-19|21|152|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-20|21|155|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-21|21|155|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-22|21|155|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-23|21|155|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-24|21|159|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-25|21|159|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-26|21|162|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-27|21|166|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-28|21|169|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-29|21|169|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-30|21|169|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-31|21|169|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-32|21|171|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-33|21|171|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-34|21|183|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-35|21|194|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-36|21|194|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-37|21|197|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-38|21|204|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-39|21|205|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-40|21|205|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-41|21|205|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-42|21|208|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-43|21|208|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-44|21|208|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-45|21|208|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-46|21|208|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-47|21|211|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-48|21|211|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-49|21|220|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-50|21|220|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-51|21|220|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-52|21|226|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-53|21|233|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-54|21|233|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-55|21|239|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-56|21|239|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-57|21|247|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-58|21|247|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-59|21|247|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-60|21|247|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-61|21|247|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-62|21|254|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-63|21|254|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-64|21|254|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-65|21|254|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-66|21|262|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-67|21|262|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-68|21|262|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-69|21|262|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-70|21|262|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-71|21|262|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-72|21|262|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-73|21|263|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWG: TGAC TO MUSCLE & DERMIS AROUND EYE.|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-74|21|269|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-75|21|269|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-76|21|269|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-77|21|285|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS OF SPINE TO MUSCLE ALONG SPINE & VERT. BONE.|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-78|21|292|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-79|21|352|Hyperplastic changes|Cardiovascular system|MPAN/  Polyarteritis nodosa|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-80|21|375|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-81|21|386|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWG: TGAC TO ADNEXAL MUSCLE.|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-82|21|389|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|TNMS/  ,MPATH: 551 - sarcoma|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-83|21|390|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-84|21|394|Neoplasia malignant|Bloodvessels among cardiovascular system|TTVS/  Testis|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-85|21|400|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-86|21|400|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-87|21|406|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-88|21|498|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-89|21|501|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-90|21|503|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-91|21|509|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWG: TGAC INV. MUSCLE & SKIN AROUND EYE.|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-92|21|512|Other deterministic changes|Whole body|MCDU/   Metastases  tcvs of lumbar region to aortic serosa.|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-93|21|517|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ spine.|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-94|21|527|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-95|21|538|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-96|21|541|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-97|21|558|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-98|21|561|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWG: TGAC TO MUSCLE OF SKULL.|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-99|21|565|Neoplasia malignant|Endocrine system|TGAC/   Metastases Lung|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-100|21|567|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-101|21|570|Neoplasia unclassified|Lower digestive tract,MA: 0000328 - intestine|TIAC/ stomach.,MPATH: 218 - neoplasm|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-102|21|571|Other deterministic changes|Whole body|MCDU/  |
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-103|21|584|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ spine (pelvic).|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-104|21|599|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRVS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-105|21|604|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-106|21|609|Inflammation and/or fibrotic diseases|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|MHIC/  chronic hepatitis,MPATH: 212 - inflammation|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-107|21|621|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-108|21|627|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-109|21|627|Neoplasia malignant|Endocrine system|TGAC/   Metastases Lung|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-110|21|638|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-111|21|643|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-112|21|654|Neoplasia malignant|Adrenal gland  among endocrine systems|TAPS/  |
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-113|21|654|Neoplasia unclassified|Nervous system and special sense organs|TANS/  Adrenal|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-114|21|655|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-115|21|659|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ abdomen, dorsal. Metastases Lung|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-116|21|663|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|TDTC/  Transitional cell,MPATH: 549 - carcinoma|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-117|21|664|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-118|21|672|Other deterministic changes|Whole body|MCDU/  |
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-119|21|676|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ pressing against rt. kidney. Muscle|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-120|21|677|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-121|21|677|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac to l. n. in hilus of lung.,MPATH: 268 - adenocarcinoma|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-122|21|681|Other deterministic changes|Whole body|MCDU/  |
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-123|21|683|Neoplasia unclassified|Other local manifestations and miscellaneus|TNWG: TGAC TO FRONTAL LOBES CEREBRUM.|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-124|21|683|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPAC/  Carcinoma,MPATH: 218 - neoplasm|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-125|21|689|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-126|21|691|Neoplasia unclassified|Other local manifestations and miscellaneus|THWA: TACC TO LIVER.|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-127|21|694|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney| ,MPATH: 1 - cell and tissue damage|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-128|21|702|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-129|21|715|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-130|21|716|Neoplasia malignant|Endocrine system|TGAC/   Metastases Lung|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-131|21|719|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-132|21|719|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-133|21|731|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-134|21|736|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle tgac to muscle of skull.,MPATH: 268 - adenocarcinoma|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-135|21|738|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/   Metastases Liver,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-136|21|743|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-137|21|744|Neoplasia malignant|Bloodvessels among cardiovascular system|TVVS/  Seminal vesicle|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-138|21|750|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-139|21|753|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases  Muscle tcvs of spine to muscle along spine & vert. bone.,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-140|21|756|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle tgac inv. muscle & skin around eye.,MPATH: 268 - adenocarcinoma|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-141|21|761|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-142|21|765|Neoplasia unclassified|Nervous system and special sense organs|TANS/  Adrenal Metastases  Muscle tcvs to skel. muscle of pelvis. Metastases Lung Metastases  Muscle tans invas. spinal musc. Metastases  Muscle tgac to muscle about eye. Metastases Kidney|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-143|21|769|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|MPNA/  Pancreatitis Metastases  Lymphoret.System tans to renal l.n.|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-144|21|769|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-145|21|770|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWB: TBOS OF FEMUS TO LUNG.|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-146|21|775|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases Liver,MPATH: 268 - adenocarcinoma|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-147|21|778|Other deterministic changes|Whole body|MCDU/  |
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-148|21|779|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-149|21|781|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-150|21|787|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWG: TGAC INVAS. OF MUSCLE & SKIN.|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-151|21|787|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-152|21|788|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-153|21|790|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-154|21|794|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWG: TGAC TO MUSCLE OF SKULL.|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-155|21|795|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-156|21|802|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-157|21|807|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-158|21|809|Other deterministic changes|Whole body|MCDU/  |
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-159|21|810|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-160|21|813|Neoplasia unclassified|Nervous system and special sense organs|TNNO/ nerve sheath of rt. optic n.|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-161|21|817|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-162|21|819|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-163|21|821|Neoplasia malignant|Endocrine system|TGAC/  |
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-164|21|823|Inflammation and/or fibrotic diseases|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|MHIC/  chronic hepatitis,MPATH: 212 - inflammation|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-165|21|829|Neoplasia malignant|Endocrine system|TGAC/   Metastases  Muscle tgac to adnexal muscle. Metastases Lung|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-166|21|834|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle trac to rib cage muscle.,MPATH: 268 - adenocarcinoma|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-167|21|835|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO L. N. IN HILUS OF LUNG.|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-168|21|836|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-169|21|841|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-170|21|843|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-171|21|848|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWG: TGAC INVAS. OF MUSCLE & SKIN.|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-172|21|849|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ adj. to rt. gonad.|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-173|21|852|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-174|21|854|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-175|21|854|Neoplasia malignant|Endocrine system|TGAC/  |
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-176|21|855|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWH: THAC TO LUNG.|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-177|21|855|Other deterministic changes|Whole body|MCDU/  |
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-178|21|856|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-179|21|864|Other deterministic changes|Whole body|MCDU/  |
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-180|21|869|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-181|21|884|n/a|n/a|n/a|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-182|21|892|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases  tgac to frontal lobes cerebrum.,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-183|21|895|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ femur. Metastases Lung|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-184|21|901|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ forearm. Muscle|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-185|21|904|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-186|21|904|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ spine. Muscle|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-187|21|909|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/   Metastases Lung,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-188|21|913|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  Eye(s) missing Head/neck missing,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-189|21|915|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-190|21|920|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-191|21|925|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|TACC/   Metastases  Muscle trac to rib muscle. Metastases Lung Metastases Liver Metastases Heart,MPATH: 549 - carcinoma|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-192|21|936|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO BRONCHIAL & PT LN.|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-193|21|936|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-194|21|940|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ axillary region.|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-195|21|946|Other deterministic changes|Whole body|MCDU/  |
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-196|21|949|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac to bronchial & pt ln. Metastases  Muscle trac to intercostal muscle. Metastases  trac invas. of pleur at ht. base.Eye(s) missing Head/neck missing,MPATH: 268 - adenocarcinoma|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-197|21|950|Other deterministic changes|Whole body|MCDU/  |
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-198|21|957|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-199|21|966|Other deterministic changes|Whole body|MCDU/  |
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-200|21|975|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO BRONCHIAL & PT LN.|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-201|21|978|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-202|21|990|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-203|21|992|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-204|21|995|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-205|21|999|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPAC/  Carcinoma,MPATH: 218 - neoplasm|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-206|21|1000|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-207|21|1000|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-208|21|1003|Neoplasia malignant|Endocrine system|TGAC/   Metastases  Muscle tgac to muscle & dermis around eye. Metastases Lung|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-209|21|1004|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-210|21|1014|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-211|21|1016|Neoplasia malignant|Endocrine system|TGAC/  |
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-212|21|1032|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-213|21|1041|Other deterministic changes|Whole body|MCDU/  |
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-214|21|1041|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle tsfs to back muscle.,MPATH: 268 - adenocarcinoma|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-215|21|1041|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/   Metastases Lung|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-216|21|1061|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-217|21|1066|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-218|21|1067|Neoplasia malignant|Endocrine system|TGAC/   Metastases  Muscle tgac invas. of muscle & skin.|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-219|21|1072|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-220|21|1086|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-221|21|1100|Neoplasia unclassified|Integumentary system,MA: 0000151 - skin|TSEC/ abdomen. Metastases  tsec to visc. peritoneum. Metastases  Muscle tsec of abdomen to muscles of abdominal wall.,MPATH: 218 - neoplasm|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-222|21|1114|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-223|21|1150|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-224|21|1153|Other deterministic changes|Whole body|MCDU/  |
1003-22-21|n/a,K3|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|225 (225 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 666 ± 16 lifespan study|1003-22-21-225|21|1221|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-1|22|430|n/a|n/a|n/a|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-2|22|430|n/a|n/a|n/a|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-3|22|430|n/a|n/a|n/a|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-4|22|430|n/a|n/a|n/a|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-5|22|430|n/a|n/a|n/a|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-6|22|430|n/a|n/a|n/a|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-7|22|430|n/a|n/a|n/a|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-8|22|430|n/a|n/a|n/a|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-9|22|430|n/a|n/a|n/a|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-10|22|430|n/a|n/a|n/a|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-11|22|430|n/a|n/a|n/a|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-12|22|430|n/a|n/a|n/a|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-13|22|430|n/a|n/a|n/a|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-14|22|430|n/a|n/a|n/a|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-15|22|430|n/a|n/a|n/a|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-16|22|479|n/a|n/a|n/a|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-17|22|479|n/a|n/a|n/a|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-18|22|479|n/a|n/a|n/a|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-19|22|479|n/a|n/a|n/a|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-20|22|479|n/a|n/a|n/a|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-21|22|479|n/a|n/a|n/a|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-22|22|479|n/a|n/a|n/a|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-23|22|479|n/a|n/a|n/a|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-24|22|479|n/a|n/a|n/a|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-25|22|479|n/a|n/a|n/a|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-26|22|479|n/a|n/a|n/a|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-27|22|479|n/a|n/a|n/a|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-28|22|479|n/a|n/a|n/a|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-29|22|479|n/a|n/a|n/a|
1003-22-22|n/a,K4|1| 100|neutrons fission|1.2|grays|External exposure| code K4 24 fractions 45 m 1/w|30 (30 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|0 records females reassigned|1003-22-22-30|22|479|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-1|23|99|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-2|23|99|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-3|23|99|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-4|23|99|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-5|23|106|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-6|23|106|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-7|23|106|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-8|23|106|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-9|23|110|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-10|23|110|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-11|23|113|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-12|23|120|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-13|23|124|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-14|23|124|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-15|23|134|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-16|23|134|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-17|23|134|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-18|23|134|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-19|23|135|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-20|23|135|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-21|23|135|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-22|23|135|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-23|23|135|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-24|23|141|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-25|23|141|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-26|23|145|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-27|23|145|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-28|23|155|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-29|23|155|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-30|23|155|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-31|23|163|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-32|23|171|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-33|23|171|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-34|23|183|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-35|23|190|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-36|23|199|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-37|23|206|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-38|23|220|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-39|23|220|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-40|23|220|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-41|23|240|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWC: TCFS C.T. AGAINST VERT. MUSCLE TO LUNG.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-42|23|304|Neoplasia unclassified|Other local manifestations and miscellaneus|TKWC: TCFS OF MESENTERY TO KIDNEY.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-43|23|316|Other deterministic changes|Whole body|MCDU/  |
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-44|23|369|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-45|23|383|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-46|23|396|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ pelvis with lysis of bone. Muscle|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-47|23|438|Neoplasia unclassified|Other local manifestations and miscellaneus|TKWR: TRAC TO KIDNEY.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-48|23|438|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle trac to muscle of thorax, diaphragm, sternal muscles & rib cage. Metastases  Lymphoret.System trac to pt. l.n.,MPATH: 268 - adenocarcinoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-49|23|439|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-50|23|444|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-51|23|454|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-52|23|457|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-53|23|464|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ c.t. against vert. muscle. Metastases Lung,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-54|23|471|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-55|23|487|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-56|23|488|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-57|23|491|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWG: TGAC TO LUNG.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-58|23|496|Neoplasia malignant|Bloodvessels among cardiovascular system|TTVS/  Testis|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-59|23|496|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWR: TRAC TO PT. L.N..|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-60|23|519|Neoplasia unclassified|Other local manifestations and miscellaneus|TKWR: TRAC TO KIDNEY.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-61|23|527|Other deterministic changes|Whole body|MCDU/  |
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-62|23|540|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWK: TKAC TO LUNG.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-63|23|540|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-64|23|541|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-65|23|546|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-66|23|548|Neoplasia malignant|Other local manifestations and miscellaneus|TXFS/ TXFS/ TXFS/ TXFS/ pancreas - metas. to mesenteric tissue & visc. perit..|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-67|23|552|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-68|23|554|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWG: TGAC TO SKEL. MUSCLE OF SKULL.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-69|23|556|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ intercostal conn. tissue.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-70|23|561|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-71|23|568|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-72|23|568|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWG: TGAC TO LUNG.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-73|23|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases Lung Metastases  Lymphoret.System trac to parathymic & popliteal. Metastases  Muscle trac to base of skull.,MPATH: 268 - adenocarcinoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-74|23|572|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKVS/  ,MPATH: 551 - sarcoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-75|23|579|Neoplasia malignant|Endocrine system|TGAC/   Metastases  tgac to cerebrum. Metastases  tgac to parietal pleura of rib cage. Metastases Lung Metastases  Muscle tgac to intercostal muscle.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-76|23|584|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-77|23|596|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-78|23|596|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-79|23|599|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/   Metastases  trac to visc. pleura at heart base.,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-80|23|599|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-81|23|600|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-82|23|617|Neoplasia unclassified|Other local manifestations and miscellaneus|THWG: TGAC TO LIVER.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-83|23|617|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWR: TRAC TO RIB CAGE MUSCLE.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-84|23|627|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-85|23|635|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-86|23|645|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWG: TGAC TO LUNG.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-87|23|646|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-88|23|647|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac to pt. l.n. Metastases  Muscle trac to intercostal, vertebral, sternal, femoral muscles.,MPATH: 268 - adenocarcinoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-89|23|653|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-90|23|659|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-91|23|661|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle trac to rib cage muscle.,MPATH: 268 - adenocarcinoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-92|23|666|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  Eye(s) missing,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-93|23|667|Neoplasia malignant|Endocrine system|TGAC/   Metastases Lung Metastases  Muscle tgac to muscle about eye. Metastases  Lymphoret.System tgac to cn. l.n.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-94|23|673|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-95|23|679|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-96|23|687|Neoplasia malignant|Upper digestive tract,MA: 0000341 - oral region|TBUS/ mandible.,MPATH: 551 - sarcoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-97|23|689|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/   Metastases Lung|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-98|23|690|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-99|23|700|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ muscle of left forelimb with lysis of bone & invasion of dermis. Muscle|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-100|23|701|Neoplasia malignant|Endocrine system|TGAC/   Metastases  Muscle tgac to skel. muscle of skull.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-101|23|703|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-102|23|708|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-103|23|709|Other deterministic changes|Whole body|MCDU/  |
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-104|23|712|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases Heart Metastases  Lymphoret.System trac to pt. l.n..,MPATH: 268 - adenocarcinoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-105|23|718|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-106|23|719|Neoplasia malignant|Upper digestive tract,MA: 0000341 - oral region|TBUS/ odontogenic tumor upper left.,MPATH: 551 - sarcoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-107|23|722|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|MRMP/  Murine,MPATH: 212 - inflammation|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-108|23|724|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCVS OF LUMBAR REG. TO ADJ. SKELETAL MUSCLE.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-109|23|737|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-110|23|739|Other deterministic changes|Whole body|MCDU/  |
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-111|23|746|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|TACC/  ,MPATH: 549 - carcinoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-112|23|749|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ rib. Metastases  Muscle tbos of rib to diaphragm & sternal muscle.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-113|23|750|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ tag note says 'anal tumor'. Metastases  tcfs to visc. peritoneum near pancreas. Metastases  Skin tcfs to pelvic area. Metastases  Muscle tcfs to pelvic muscle & bone.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-114|23|750|Neoplasia unclassified|Other local manifestations and miscellaneus|THWK: TKAC TO LIVER.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-115|23|751|Neoplasia unclassified|Other local manifestations and miscellaneus|TKWC: TCFS OF MESENTERY TO KIDNEY.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-116|23|761|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS TO PELVIC MUSCLE & BONE.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-117|23|763|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWC: TCFS C.T. AGAINST VERT. MUSCLE TO LUNG.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-118|23|764|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-119|23|766|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases Lung,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-120|23|767|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-121|23|768|Neoplasia malignant|Endocrine system|TGAC/   Metastases Lung|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-122|23|769|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases Lung,MPATH: 268 - adenocarcinoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-123|23|771|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWK: TKAC TO LUNG.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-124|23|773|Neoplasia unclassified|Other local manifestations and miscellaneus|TKWC: TCFS OF MESENTERY TO KIDNEY.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-125|23|778|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-126|23|778|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases Liver,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-127|23|781|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ mesentery. Metastases  Kidney tcfs of mesentery to kidney. Metastases  Muscle tcfs of mesentery to diaphragm.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-128|23|785|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-129|23|795|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-130|23|795|Other deterministic changes|Whole body|MCDU/  Eye(s) missing|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-131|23|798|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-132|23|800|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWC: TCFS TO PELVIC MUSCLE & BONE.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-133|23|802|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-134|23|806|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ anal region, infiltr. skin of perineum.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-135|23|810|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-136|23|811|Other deterministic changes|Whole body|MCDU/  |
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-137|23|816|Neoplasia malignant|Bloodvessels among cardiovascular system|TYVS/  Heart|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-138|23|817|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-139|23|827|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-140|23|828|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/   Metastases Lung,MPATH: 549 - carcinoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-141|23|829|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-142|23|831|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-143|23|838|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-144|23|848|Other deterministic changes|Whole body|MCDU/  |
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-145|23|849|Neoplasia malignant|Endocrine system|TGAC/   Metastases Lung Metastases  Muscle tgac to muscle of skull.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-146|23|850|Other deterministic changes|Whole body|MCDU/   Metastases  tcfs to pancreas & visc. peritoneum surrounding kidney & adrenal.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-147|23|858|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-148|23|862|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Lymphoret.System trac to parathymic l.n.,MPATH: 268 - adenocarcinoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-149|23|863|Other deterministic changes|Whole body|MCDU/  |
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-150|23|870|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-151|23|876|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWG: TGAC TO MUSCLE OF SKULL.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-152|23|876|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases Liver,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-153|23|876|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-154|23|876|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWK: TKAC TO LUNG.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-155|23|877|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-156|23|878|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-157|23|878|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-158|23|880|Neoplasia malignant|Lower digestive tract,MA: 0000328 - intestine|TIAO/ pylorus.,MPATH: 549 - carcinoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-159|23|882|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-160|23|898|Neoplasia unclassified|Integumentary system,MA: 0000151 - skin|TSEC/ skin of nose.,MPATH: 218 - neoplasm|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-161|23|900|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-162|23|900|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ ct. about adrenal & kidney.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-163|23|900|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWG: TGAC TO LUNG.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-164|23|901|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-165|23|906|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-166|23|908|Neoplasia malignant|Endocrine system|TGAC/   Metastases Lung|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-167|23|911|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-168|23|916|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-169|23|920|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/   Metastases Lung,MPATH: 549 - carcinoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-170|23|921|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-171|23|925|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBCS/ adj. to testis & epid. but not incorp. them.|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-172|23|949|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-173|23|950|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-174|23|968|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-175|23|971|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-176|23|981|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-177|23|985|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/   Metastases  Muscle tcvs of lumbar reg. to adj. skeletal muscle.,MPATH: 268 - adenocarcinoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-178|23|992|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-179|23|995|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-180|23|1006|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-181|23|1008|n/a|n/a|n/a|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-182|23|1016|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ 2 foci; forearm & about spine at level of kidneys with lysis of spine & humerus. Metastases  Muscle tcvs of forearm to muscle of forearm & spine. Metastases  tcvs of forearm or spine to bone with lysis. Metastases Liver|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-183|23|1020|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-184|23|1034|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-185|23|1039|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/   Metastases Kidney,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-186|23|1052|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-187|23|1068|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-188|23|1079|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-189|23|1136|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-23|n/a,K4|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|190 (190 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|150 records survival 631 ± 15 lifespan study|1003-22-23-190|23|1184|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-1|24|226|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWM: TMAB WITH EXTENSIVE INVASION OF MUSCLE, SKIN & FAT OF LEFT AXILLARY REG|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-2|24|285|n/a|n/a|n/a|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-3|24|298|n/a|n/a|n/a|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-4|24|308|n/a|n/a|n/a|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-5|24|310|Neoplasia malignant|Bloodvessels among cardiovascular system|TIVS/ ileum|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-6|24|361|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-7|24|395|n/a|n/a|n/a|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-8|24|421|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|TMAB/  Predominantly ductal, extens. Invasion of muscle, skin and fat of left axill. Regio,MPATH: 218 - neoplasm|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-9|24|422|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-10|24|431|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-11|24|444|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  metastases of pt ln. Eye adn head/neck missing,MPATH: 268 - adenocarcinoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-12|24|461|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ around sacral spine.|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-13|24|469|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-14|24|476|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  Metastases liver, heart, pt.ln,MPATH: 268 - adenocarcinoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-15|24|484|Neoplasia unclassified|Other local manifestations and miscellaneus|TXWI: TIVS OF GUT WALL INVASION OF PANCREAS.|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-16|24|502|Neoplasia malignant|Other local manifestations and miscellaneus|TMLS/ nape of neck with infiltr. of fat & muscle.|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-17|24|505|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-18|24|508|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-19|24|522|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-20|24|526|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-21|24|527|Neoplasia malignant|Endocrine system|TGAC/  Infiltration of skin and muscle orbit.|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-22|24|535|Inflammation and/or fibrotic diseases|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|MHCN/  Coagulative focal hepatitis,MPATH: 212 - inflammation|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-23|24|537|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-24|24|544|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-25|24|544|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-26|24|550|n/a|n/a|n/a|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-27|24|552|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-28|24|552|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-29|24|565|Other deterministic changes|Whole body|MCDU/  |
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-30|24|565|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-31|24|568|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|MPNI/  acute/chronic,MPATH: 212 - inflammation|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-32|24|576|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWB: TBOS INVAS. MUSCLE OF THORACIC SPINE.|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-33|24|576|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-34|24|578|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-35|24|578|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/  |
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-36|24|584|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWG: TGAC METASTASIS TO CN LN.|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-37|24|585|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-38|24|596|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWG: TGAC METASTASIS TO CN LN.|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-39|24|599|Neoplasia unclassified|Other local manifestations and miscellaneus|TLWG: TGAC METASTASIS TO CN LN.|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-40|24|603|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-41|24|603|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-42|24|608|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-43|24|610|n/a|n/a|n/a|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-44|24|621|Neoplasia malignant|Other local manifestations and miscellaneus|TXUS/ TXUS/ TXUS/ TXUS/ esthesioneuroepithelioma olf. bulb.|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-45|24|627|n/a|n/a|n/a|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-46|24|630|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-47|24|631|n/a|n/a|n/a|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-48|24|638|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ sub. cut. left inguinal region. Metastases liver, lung, visc peritoneum|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-49|24|645|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-50|24|647|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-51|24|648|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-52|24|649|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-53|24|650|n/a|n/a|n/a|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-54|24|660|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-55|24|663|n/a|n/a|n/a|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-56|24|668|Inflammation and/or fibrotic diseases|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|MHIA/  acute,MPATH: 212 - inflammation|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-57|24|670|Other deterministic changes|Whole body|MCDU/  |
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-58|24|674|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-59|24|676|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-60|24|677|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-61|24|677|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWM: TMAB WITH EXTENSIVE INVASION OF MUSCLE, SKIN & FAT OF LEFT AXILLARY REG|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-62|24|681|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-63|24|686|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-64|24|690|Neoplasia malignant|Endocrine system|TGAC/  Metastases lung, cn.ln, muscle and skin of orbit.|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-65|24|691|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-66|24|695|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-67|24|695|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-68|24|702|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  Metastases liver,MPATH: 268 - adenocarcinoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-69|24|707|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOVO/  ,MPATH: 242 - hemangiosarcoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-70|24|707|n/a|n/a|n/a|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-71|24|708|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|TPAO/  Adenoma,MPATH: 218 - neoplasm|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-72|24|715|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ spine. Metastases skelet. Muscle|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-73|24|720|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-74|24|730|Degenerative changes|Kidney among urinary system diseases,MA: 0000368 - kidney|MCRD/  ,MPATH: 1 - cell and tissue damage|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-75|24|731|n/a|n/a|n/a|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-76|24|736|Neoplasia unclassified|Central nervous system among nervous system|TXUS/ esthesioneuroepithelioma of olf. bulb. Metastases cerebral hemisphere|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-77|24|740|Neoplasia unclassified|Other local manifestations and miscellaneus|THWR: TRAC TO LIVER.|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-78|24|745|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-79|24|745|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-80|24|745|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TXAC/ nasal cavity lining epithelium.,MPATH: 268 - adenocarcinoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-81|24|750|Hyperplastic changes|Other local manifestations and miscellaneus,MA: 0000003 - organ system|MOCY/  Ovary or testis,MPATH: 62 - cyst|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-82|24|750|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-83|24|752|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ pelvic bone invades skel. muscle. And kidney|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-84|24|759|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-85|24|759|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ thoracic spine. Invasion of thor. Spinal cord and muscle of thor. Spine|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-86|24|763|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  Metastases pt ln and mediastin. Tissues,MPATH: 268 - adenocarcinoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-87|24|764|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-88|24|764|n/a|n/a|n/a|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-89|24|765|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-90|24|767|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-91|24|767|Neoplasia unclassified|Central nervous system among nervous system|TNXS/  |
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-92|24|768|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  Metastases liver, heart,MPATH: 268 - adenocarcinoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-93|24|768|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-94|24|768|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLL/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-95|24|773|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-96|24|773|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-97|24|778|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-98|24|780|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-99|24|781|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-100|24|783|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-101|24|786|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-102|24|786|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-103|24|792|Neoplasia malignant|Bloodvessels among cardiovascular system|TIVS/ wall of the gut. Invasion pancreas|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-104|24|794|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/  ,MPATH: 549 - carcinoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-105|24|795|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-106|24|795|Neoplasia malignant|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUUS/  ,MPATH: 255 - adenoacanthoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-107|24|796|Other deterministic changes|Lower respiratory system|MPNC/  Lung congestion|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-108|24|796|Neoplasia malignant|Other local manifestations and miscellaneus|TSSS/ skin of upper leg. Invades thigh muscle|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-109|24|799|Neoplasia unclassified|Other local manifestations and miscellaneus|TRWO: TOGC TO LUNG.|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-110|24|800|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-111|24|801|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ mesentery.|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-112|24|802|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-113|24|804|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ vertebra-lumbar. Invasion surrounding muscle and spinal cord|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-114|24|806|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-115|24|806|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-116|24|808|Neoplasia unclassified|Nervous system and special sense organs|TANS/ metast. to contralat. adr. & perit. seeding to serosa of uterus.Adrenal, metastases liver lung|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-117|24|813|n/a|n/a|n/a|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-118|24|815|Neoplasia malignant|Adrenal gland  among endocrine systems|TAPS/  |
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-119|24|815|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-120|24|820|Neoplasia unclassified|Lower digestive tract,MA: 0000328 - intestine|TIAC/ pylorus.,MPATH: 218 - neoplasm|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-121|24|822|Neoplasia malignant|Endocrine system|TGAC/  Metastases lung, parietal pleura thorax, pt ln, rib cage, skelet. Muscle cheek|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-122|24|827|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ sub. cut. over preputial gland. Metastases lung,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-123|24|829|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/  |
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-124|24|830|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-125|24|834|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|MRMP/  Murine,MPATH: 212 - inflammation|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-126|24|841|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-127|24|844|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  Head/neck missing,MPATH: 268 - adenocarcinoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-128|24|846|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-129|24|851|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-130|24|854|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-131|24|857|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|THVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-132|24|873|Neoplasia unclassified|Uterus among reproductive system diseases,MA: 0000389 - uterus|TUAC/  ,MPATH: 218 - neoplasm|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-133|24|873|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-134|24|877|Neoplasia malignant|Liver among hepato-pancreatic system diseases|THAC/  |
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-135|24|887|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-136|24|890|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-137|24|891|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-138|24|894|Neoplasia unclassified|Ovary among reproductive system diseases,MA: 0000384 - ovary|TOVO/  ,MPATH: 242 - hemangiosarcoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-139|24|901|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|TDTC/  Transitional cell,MPATH: 549 - carcinoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-140|24|908|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-141|24|925|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-142|24|931|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-143|24|939|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-144|24|948|Neoplasia malignant|Bloodvessels among cardiovascular system|TMVS/ vertebral muscle. Muscle|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-145|24|964|Neoplasia unclassified|Ovary among reproductive system diseases|TOGC/  Metastases lung|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-146|24|973|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-147|24|996|Neoplasia malignant|Bloodvessels among cardiovascular system|TNVS/ meninges of spinal cord.|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-148|24|1002|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-149|24|1027|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-24|n/a,K5|1| 100|neutrons fission|1.68|grays|External exposure| code K5 24 fractions 45 m 1/w|150 (150 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|150 records survival 596 ± 13 lifespan study|1003-22-24-150|24|1055|Neoplasia malignant|Bloodvessels among cardiovascular system|TYVS/  Heart|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-1|25|99|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-2|25|99|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-3|25|99|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-4|25|99|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-5|25|106|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-6|25|113|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-7|25|113|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-8|25|124|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-9|25|124|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-10|25|127|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-11|25|127|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-12|25|127|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-13|25|131|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-14|25|131|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-15|25|134|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-16|25|134|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-17|25|134|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-18|25|134|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-19|25|135|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-20|25|135|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-21|25|135|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-22|25|135|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-23|25|135|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-24|25|141|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-25|25|142|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-26|25|142|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-27|25|142|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-28|25|142|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-29|25|142|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-30|25|145|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-31|25|145|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-32|25|145|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-33|25|148|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-34|25|155|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-35|25|156|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-36|25|157|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-37|25|157|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-38|25|159|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-39|25|159|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-40|25|169|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-41|25|169|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-42|25|183|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-43|25|183|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-44|25|199|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-45|25|199|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-46|25|207|Other deterministic changes|Whole body|MCDU/  |
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-47|25|296|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-48|25|322|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ tail.|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-49|25|343|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-50|25|351|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-51|25|352|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-52|25|365|Neoplasia unclassified|Central nervous system among nervous system|TNAS/ left cerebrum & cerebellum.|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-53|25|390|Other deterministic changes|Whole body|MCDU/  |
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-54|25|400|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-55|25|410|Other deterministic changes|Whole body|MCDU/  |
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-56|25|418|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-57|25|421|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-58|25|424|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-59|25|428|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-60|25|430|Other deterministic changes|Whole body|MCDU/  |
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-61|25|435|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-62|25|441|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-63|25|444|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|TKAC/   Metastases Lung Metastases Liver Metastases Lung Metastases  tkac to thyroid.,MPATH: 549 - carcinoma|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-64|25|450|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-65|25|453|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-66|25|470|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-67|25|489|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-68|25|502|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-69|25|512|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-70|25|515|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ axil. region. Metastases Lung|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-71|25|519|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-72|25|525|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-73|25|526|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-74|25|528|Neoplasia unclassified|Other local manifestations and miscellaneus|TMWG: TGAC TO ORBITAL MUSCLE.|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-75|25|535|Other deterministic changes|Whole body|MCDU/  |
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-76|25|536|Other deterministic changes|Whole body|MCDU/  |
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-77|25|542|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-78|25|551|Neoplasia unclassified|Other local manifestations and miscellaneus|THWG: TGAC TO LIVER.|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-79|25|559|Other deterministic changes|Whole body|MCDU/  |
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-80|25|565|Neoplasia unclassified|Other local manifestations and miscellaneus|THWK: TKAC TO LIVER.|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-81|25|567|Other deterministic changes|Whole body|MCDU/  |
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-82|25|569|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-83|25|572|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-84|25|576|Neoplasia unclassified|Lower digestive tract,MA: 0000328 - intestine|TIAC/ small intestine.,MPATH: 218 - neoplasm|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-85|25|583|Other deterministic changes|Whole body|MCDU/  |
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-86|25|596|Degenerative changes|Haematolymphatic system,MA: 0000134 - bone marrow|MBMZ/  ,MPATH: 127 - atrophy|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-87|25|605|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-88|25|606|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-89|25|608|Other deterministic changes|Whole body|MCDU/  |
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-90|25|611|Degenerative changes|Haematolymphatic system,MA: 0000134 - bone marrow|MBMZ/  ,MPATH: 127 - atrophy|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-91|25|614|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|MRMP/  Murine,MPATH: 212 - inflammation|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-92|25|616|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-93|25|625|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TXAC/ nasal sinus. Metastases  txac of nasal sinus to frontal lobe of brain.,MPATH: 268 - adenocarcinoma|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-94|25|631|Other deterministic changes|Whole body|MCDU/  |
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-95|25|634|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-96|25|638|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-97|25|645|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-98|25|647|Neoplasia malignant|Bloodvessels among cardiovascular system|TCVS/ perineal.|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-99|25|655|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-100|25|659|Other deterministic changes|Whole body|MCDU/  |
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-101|25|671|Other deterministic changes|Whole body|MCDU/  |
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-102|25|671|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-103|25|672|Other deterministic changes|Whole body|MCDU/  |
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-104|25|673|Neoplasia malignant|Endocrine system|TGAC/   Metastases Lung Metastases Liver|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-105|25|676|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-106|25|676|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-107|25|677|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|TACC/  ,MPATH: 549 - carcinoma|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-108|25|708|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-109|25|715|Degenerative changes|Haematolymphatic system,MA: 0000134 - bone marrow|MBMZ/  ,MPATH: 127 - atrophy|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-110|25|715|Other deterministic changes|Whole body|MCDU/  |
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-111|25|722|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLXS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-112|25|728|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-113|25|730|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-114|25|741|Neoplasia malignant|Endocrine system|TGAC/   Metastases  Muscle tgac to orbital muscle. Metastases Lung|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-115|25|746|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-116|25|746|Other deterministic changes|Whole body|MCDU/  |
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-117|25|747|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-118|25|757|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-119|25|762|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-120|25|764|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-121|25|769|Other deterministic changes|Whole body|MCDU/  |
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-122|25|773|Neoplasia malignant|Bloodvessels among cardiovascular system|TYVS/  Heart|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-123|25|775|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-124|25|775|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|TCFS/ thigh. Metastases  Muscle tgac to orbital, facial muscle.,MPATH: 408 - soft tissue fibrosarcoma|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-125|25|785|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLUS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-126|25|792|Neoplasia malignant|Bone among musculo-skeletal system diseases|TBOS/ calvarium. Metastases Lung|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-127|25|797|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-128|25|800|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-129|25|804|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-130|25|804|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-131|25|812|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLHS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-132|25|836|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVS/  ,MPATH: 242 - hemangiosarcoma|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-133|25|845|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-134|25|864|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-135|25|865|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|TLLS/  ,MPATH: 513 - Lymphoid neoplasms|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-136|25|872|Other deterministic changes|Whole body|MCDU/  |
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-137|25|874|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-138|25|885|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|TRAC/  ,MPATH: 268 - adenocarcinoma|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-139|25|891|n/a|n/a|n/a|
1003-22-25|n/a,K5|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|140 (140 in ERA)|Mouse|Mouse, B6CF1|Male|Juvenile|95 records survival 511 ± 16 lifespan study|1003-22-25-140|25|899|Neoplasia benign|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|TEVO/  ,MPATH: 240 - hemangioma|
1003-22-26|n/a,K6|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|20 (20 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-26-1|26|312|n/a|n/a|n/a|
1003-22-26|n/a,K6|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|20 (20 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-26-2|26|393|n/a|n/a|n/a|
1003-22-26|n/a,K6|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|20 (20 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-26-3|26|430|n/a|n/a|n/a|
1003-22-26|n/a,K6|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|20 (20 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-26-4|26|430|n/a|n/a|n/a|
1003-22-26|n/a,K6|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|20 (20 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-26-5|26|430|n/a|n/a|n/a|
1003-22-26|n/a,K6|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|20 (20 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-26-6|26|430|n/a|n/a|n/a|
1003-22-26|n/a,K6|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|20 (20 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-26-7|26|430|n/a|n/a|n/a|
1003-22-26|n/a,K6|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|20 (20 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-26-8|26|430|n/a|n/a|n/a|
1003-22-26|n/a,K6|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|20 (20 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-26-9|26|430|n/a|n/a|n/a|
1003-22-26|n/a,K6|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|20 (20 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-26-10|26|430|n/a|n/a|n/a|
1003-22-26|n/a,K6|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|20 (20 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-26-11|26|430|n/a|n/a|n/a|
1003-22-26|n/a,K6|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|20 (20 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-26-12|26|472|n/a|n/a|n/a|
1003-22-26|n/a,K6|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|20 (20 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-26-13|26|472|n/a|n/a|n/a|
1003-22-26|n/a,K6|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|20 (20 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-26-14|26|472|n/a|n/a|n/a|
1003-22-26|n/a,K6|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|20 (20 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-26-15|26|472|n/a|n/a|n/a|
1003-22-26|n/a,K6|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|20 (20 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-26-16|26|473|n/a|n/a|n/a|
1003-22-26|n/a,K6|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|20 (20 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-26-17|26|486|n/a|n/a|n/a|
1003-22-26|n/a,K6|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|20 (20 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-26-18|26|486|n/a|n/a|n/a|
1003-22-26|n/a,K6|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|20 (20 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-26-19|26|486|n/a|n/a|n/a|
1003-22-26|n/a,K6|1| 100|neutrons fission|3.2|grays|External exposure| code K6 24 fractions 45 m 1/w|20 (20 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|3 records females reassigned|1003-22-26-20|26|486|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-1|27|102|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-2|27|206|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-3|27|269|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-4|27|269|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-5|27|269|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-6|27|269|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-7|27|269|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-8|27|277|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-9|27|277|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-10|27|277|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-11|27|277|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-12|27|277|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-13|27|277|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-14|27|277|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-15|27|277|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-16|27|277|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-17|27|277|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-18|27|278|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-19|27|278|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-20|27|278|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-21|27|278|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-22|27|278|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-23|27|284|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-24|27|284|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-25|27|284|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-26|27|284|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-27|27|284|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-28|27|284|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-29|27|284|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-30|27|284|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-31|27|284|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-32|27|284|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-33|27|374|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-34|27|440|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-35|27|477|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-36|27|481|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-37|27|481|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-38|27|481|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-39|27|481|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-40|27|481|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-41|27|481|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-42|27|481|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-43|27|481|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-44|27|481|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-45|27|481|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-46|27|528|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-47|27|537|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-48|27|540|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-49|27|561|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-50|27|562|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-51|27|571|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-52|27|573|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-53|27|586|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-54|27|597|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-55|27|606|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-56|27|611|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-57|27|615|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-58|27|625|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-59|27|625|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-60|27|628|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-61|27|636|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-62|27|646|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-63|27|649|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-64|27|655|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-65|27|662|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-66|27|669|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-67|27|669|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-68|27|669|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-69|27|669|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-70|27|669|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-71|27|674|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-72|27|676|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-73|27|676|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-74|27|676|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-75|27|676|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-76|27|676|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-77|27|676|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-78|27|676|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-79|27|676|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-80|27|676|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-81|27|683|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-82|27|683|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-83|27|683|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-84|27|683|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-85|27|683|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-86|27|683|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-87|27|683|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-88|27|683|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-89|27|683|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-90|27|683|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-91|27|691|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-92|27|698|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-93|27|698|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-94|27|698|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-95|27|698|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-96|27|698|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-97|27|705|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-98|27|705|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-99|27|705|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-100|27|705|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-101|27|715|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-102|27|718|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-103|27|722|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-104|27|726|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-105|27|729|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-106|27|730|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-107|27|730|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-108|27|730|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-109|27|731|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-110|27|731|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-111|27|733|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-112|27|736|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-113|27|739|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-114|27|740|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-115|27|741|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-116|27|744|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-117|27|746|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-118|27|746|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-119|27|746|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-120|27|749|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-121|27|749|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-122|27|752|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-123|27|753|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-124|27|757|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-125|27|764|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-126|27|765|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-127|27|767|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-128|27|768|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-129|27|773|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-130|27|779|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-131|27|780|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-132|27|780|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-133|27|782|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-134|27|783|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-135|27|783|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-136|27|789|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-137|27|794|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-138|27|798|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-139|27|808|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-140|27|809|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-141|27|810|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-142|27|813|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-143|27|815|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-144|27|815|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-145|27|816|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-146|27|817|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-147|27|817|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-148|27|818|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-149|27|819|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-150|27|820|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-151|27|820|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-152|27|823|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-153|27|824|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-154|27|829|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-155|27|830|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-156|27|830|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-157|27|831|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-158|27|832|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-159|27|834|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-160|27|838|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-161|27|838|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-162|27|841|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-163|27|842|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-164|27|843|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-165|27|845|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-166|27|848|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-167|27|850|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-168|27|851|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-169|27|851|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-170|27|852|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-171|27|852|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-172|27|859|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-173|27|861|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-174|27|866|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-175|27|870|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-176|27|872|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-177|27|877|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-178|27|880|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-179|27|883|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-180|27|887|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-181|27|889|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-182|27|891|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-183|27|897|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-184|27|897|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-185|27|900|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-186|27|900|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-187|27|900|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-188|27|901|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-189|27|904|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-190|27|907|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-191|27|910|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-192|27|911|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-193|27|911|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-194|27|914|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-195|27|914|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-196|27|915|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-197|27|916|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-198|27|919|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-199|27|920|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-200|27|921|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-201|27|922|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-202|27|922|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-203|27|924|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-204|27|925|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-205|27|926|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-206|27|929|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-207|27|931|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-208|27|932|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-209|27|932|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-210|27|932|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-211|27|935|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-212|27|937|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-213|27|937|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-214|27|937|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-215|27|938|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-216|27|939|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-217|27|940|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-218|27|942|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-219|27|942|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-220|27|944|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-221|27|944|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-222|27|945|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-223|27|946|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-224|27|946|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-225|27|947|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-226|27|948|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-227|27|948|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-228|27|950|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-229|27|953|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-230|27|954|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-231|27|959|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-232|27|959|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-233|27|959|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-234|27|961|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-235|27|962|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-236|27|964|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-237|27|967|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-238|27|967|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-239|27|967|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-240|27|967|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-241|27|968|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-242|27|970|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-243|27|970|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-244|27|974|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-245|27|975|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-246|27|976|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-247|27|977|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-248|27|978|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-249|27|981|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-250|27|981|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-251|27|982|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-252|27|983|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-253|27|983|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-254|27|984|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-255|27|987|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-256|27|988|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-257|27|989|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-258|27|989|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-259|27|992|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-260|27|995|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-261|27|996|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-262|27|999|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-263|27|1002|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-264|27|1002|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-265|27|1004|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-266|27|1006|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-267|27|1006|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-268|27|1007|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-269|27|1007|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-270|27|1008|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-271|27|1009|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-272|27|1011|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-273|27|1013|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-274|27|1016|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-275|27|1016|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-276|27|1017|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-277|27|1019|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-278|27|1022|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-279|27|1025|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-280|27|1025|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-281|27|1028|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-282|27|1032|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-283|27|1033|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-284|27|1033|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-285|27|1034|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-286|27|1036|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-287|27|1037|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-288|27|1044|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-289|27|1045|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-290|27|1045|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-291|27|1047|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-292|27|1048|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-293|27|1048|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-294|27|1049|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-295|27|1050|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-296|27|1052|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-297|27|1053|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-298|27|1054|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-299|27|1055|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-300|27|1057|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-301|27|1058|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-302|27|1058|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-303|27|1059|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-304|27|1060|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-305|27|1062|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-306|27|1062|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-307|27|1065|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-308|27|1073|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-309|27|1074|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-310|27|1074|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-311|27|1078|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-312|27|1079|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-313|27|1081|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-314|27|1082|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-315|27|1087|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-316|27|1088|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-317|27|1090|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-318|27|1097|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-319|27|1098|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-320|27|1103|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-321|27|1104|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-322|27|1108|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-323|27|1109|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-324|27|1114|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-325|27|1115|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-326|27|1115|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-327|27|1115|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-328|27|1117|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-329|27|1118|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-330|27|1121|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-331|27|1122|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-332|27|1125|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-333|27|1127|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-334|27|1127|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-335|27|1128|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-336|27|1129|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-337|27|1133|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-338|27|1135|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-339|27|1136|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-340|27|1137|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-341|27|1138|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-342|27|1140|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-343|27|1142|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-344|27|1145|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-345|27|1146|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-346|27|1147|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-347|27|1153|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-348|27|1158|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-349|27|1165|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-350|27|1166|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-351|27|1172|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-352|27|1176|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-353|27|1177|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-354|27|1180|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-355|27|1183|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-356|27|1185|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-357|27|1186|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-358|27|1187|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-359|27|1188|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-360|27|1191|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-361|27|1192|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-362|27|1194|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-363|27|1195|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-364|27|1196|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-365|27|1196|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-366|27|1200|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-367|27|1202|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-368|27|1202|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-369|27|1203|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-370|27|1204|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-371|27|1204|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-372|27|1205|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-373|27|1208|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-374|27|1208|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-375|27|1209|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-376|27|1212|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-377|27|1215|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-378|27|1219|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-379|27|1227|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-380|27|1247|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-381|27|1250|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-382|27|1250|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-383|27|1256|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-384|27|1266|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-385|27|1275|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-386|27|1288|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-387|27|1297|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-388|27|1303|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-389|27|1308|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-390|27|1310|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-391|27|1326|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-392|27|1326|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-393|27|1338|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-394|27|1340|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-395|27|1350|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-396|27|1355|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-397|27|1365|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-398|27|1367|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-399|27|1375|n/a|n/a|n/a|
1003-22-27|n/a,K6|1| 100|shamexposed|0|grays|External exposure| code W0 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|324 records survival 853 ± 11 lifespan study|1003-22-27-400|27|1466|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-1|28|123|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-2|28|271|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-3|28|271|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-4|28|271|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-5|28|271|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-6|28|271|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-7|28|278|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-8|28|278|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-9|28|278|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-10|28|278|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-11|28|278|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-12|28|278|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-13|28|278|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-14|28|278|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-15|28|278|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-16|28|278|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-17|28|278|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-18|28|278|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-19|28|278|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-20|28|278|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-21|28|278|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-22|28|278|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-23|28|278|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-24|28|278|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-25|28|278|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-26|28|278|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-27|28|289|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-28|28|289|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-29|28|289|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-30|28|289|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-31|28|289|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-32|28|296|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-33|28|296|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-34|28|296|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-35|28|296|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-36|28|296|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-37|28|296|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-38|28|296|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-39|28|296|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-40|28|296|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-41|28|296|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-42|28|296|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-43|28|296|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-44|28|296|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-45|28|296|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-46|28|296|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-47|28|333|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-48|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-49|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-50|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-51|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-52|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-53|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-54|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-55|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-56|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-57|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-58|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-59|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-60|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-61|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-62|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-63|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-64|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-65|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-66|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-67|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-68|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-69|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-70|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-71|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-72|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-73|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-74|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-75|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-76|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-77|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-78|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-79|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-80|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-81|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-82|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-83|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-84|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-85|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-86|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-87|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-88|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-89|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-90|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-91|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-92|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-93|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-94|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-95|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-96|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-97|28|347|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-98|28|361|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-99|28|407|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-100|28|413|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-101|28|439|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-102|28|451|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-103|28|453|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-104|28|464|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-105|28|470|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-106|28|471|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-107|28|474|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-108|28|481|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-109|28|481|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-110|28|481|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-111|28|481|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-112|28|481|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-113|28|481|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-114|28|481|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-115|28|481|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-116|28|481|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-117|28|481|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-118|28|486|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-119|28|486|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-120|28|486|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-121|28|486|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-122|28|486|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-123|28|486|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-124|28|486|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-125|28|486|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-126|28|486|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-127|28|486|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-128|28|493|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-129|28|500|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-130|28|507|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-131|28|511|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-132|28|516|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-133|28|516|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-134|28|516|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-135|28|516|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-136|28|516|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-137|28|528|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-138|28|529|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-139|28|538|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-140|28|541|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-141|28|556|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-142|28|560|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-143|28|565|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-144|28|566|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-145|28|581|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-146|28|582|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-147|28|586|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-148|28|589|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-149|28|592|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-150|28|593|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-151|28|596|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-152|28|601|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-153|28|606|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-154|28|606|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-155|28|606|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-156|28|606|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-157|28|608|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-158|28|610|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-159|28|611|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-160|28|613|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-161|28|617|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-162|28|618|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-163|28|624|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-164|28|625|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-165|28|625|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-166|28|626|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-167|28|628|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-168|28|637|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-169|28|638|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-170|28|640|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-171|28|647|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-172|28|647|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-173|28|647|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-174|28|654|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-175|28|654|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-176|28|654|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-177|28|654|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-178|28|654|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-179|28|654|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-180|28|654|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-181|28|654|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-182|28|655|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-183|28|659|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-184|28|659|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-185|28|659|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-186|28|666|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-187|28|668|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-188|28|669|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-189|28|673|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-190|28|674|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-191|28|675|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-192|28|676|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-193|28|676|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-194|28|676|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-195|28|676|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-196|28|676|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-197|28|680|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-198|28|683|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-199|28|683|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-200|28|684|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-201|28|687|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-202|28|687|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-203|28|690|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-204|28|691|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-205|28|692|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-206|28|694|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-207|28|694|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-208|28|694|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-209|28|694|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-210|28|701|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-211|28|701|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-212|28|701|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-213|28|702|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-214|28|703|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-215|28|704|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-216|28|705|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-217|28|705|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-218|28|706|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-219|28|708|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-220|28|709|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-221|28|713|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-222|28|713|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-223|28|713|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-224|28|716|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-225|28|719|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-226|28|719|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-227|28|722|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-228|28|723|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-229|28|724|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-230|28|726|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-231|28|726|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-232|28|728|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-233|28|729|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-234|28|729|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-235|28|731|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-236|28|732|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-237|28|733|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-238|28|734|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-239|28|736|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-240|28|738|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-241|28|738|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-242|28|738|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-243|28|738|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-244|28|740|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-245|28|741|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-246|28|742|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-247|28|743|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-248|28|745|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-249|28|745|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-250|28|748|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-251|28|751|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-252|28|751|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-253|28|752|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-254|28|752|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-255|28|753|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-256|28|757|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-257|28|757|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-258|28|759|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-259|28|761|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-260|28|764|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-261|28|765|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-262|28|766|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-263|28|768|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-264|28|771|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-265|28|772|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-266|28|772|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-267|28|774|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-268|28|775|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-269|28|775|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-270|28|775|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-271|28|776|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-272|28|776|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-273|28|778|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-274|28|778|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-275|28|781|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-276|28|782|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-277|28|782|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-278|28|784|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-279|28|787|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-280|28|789|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-281|28|792|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-282|28|793|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-283|28|794|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-284|28|795|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-285|28|796|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-286|28|796|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-287|28|796|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-288|28|797|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-289|28|800|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-290|28|800|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-291|28|800|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-292|28|801|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-293|28|803|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-294|28|805|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-295|28|805|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-296|28|806|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-297|28|808|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-298|28|813|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-299|28|814|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-300|28|815|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-301|28|819|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-302|28|819|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-303|28|820|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-304|28|823|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-305|28|824|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-306|28|824|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-307|28|825|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-308|28|826|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-309|28|826|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-310|28|827|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-311|28|827|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-312|28|828|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-313|28|828|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-314|28|829|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-315|28|829|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-316|28|831|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-317|28|833|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-318|28|833|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-319|28|833|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-320|28|835|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-321|28|836|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-322|28|838|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-323|28|839|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-324|28|842|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-325|28|842|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-326|28|847|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-327|28|848|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-328|28|849|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-329|28|851|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-330|28|857|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-331|28|859|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-332|28|859|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-333|28|859|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-334|28|861|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-335|28|862|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-336|28|862|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-337|28|863|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-338|28|863|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-339|28|866|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-340|28|868|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-341|28|870|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-342|28|870|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-343|28|873|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-344|28|873|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-345|28|876|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-346|28|877|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-347|28|878|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-348|28|880|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-349|28|881|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-350|28|882|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-351|28|883|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-352|28|883|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-353|28|883|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-354|28|886|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-355|28|888|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-356|28|888|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-357|28|890|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-358|28|897|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-359|28|899|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-360|28|903|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-361|28|904|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-362|28|904|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-363|28|905|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-364|28|906|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-365|28|907|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-366|28|910|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-367|28|910|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-368|28|912|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-369|28|912|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-370|28|915|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-371|28|915|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-372|28|916|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-373|28|918|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-374|28|921|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-375|28|922|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-376|28|922|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-377|28|929|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-378|28|929|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-379|28|932|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-380|28|932|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-381|28|932|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-382|28|932|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-383|28|932|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-384|28|934|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-385|28|935|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-386|28|937|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-387|28|939|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-388|28|941|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-389|28|941|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-390|28|946|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-391|28|948|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-392|28|949|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-393|28|962|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-394|28|963|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-395|28|964|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-396|28|964|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-397|28|968|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-398|28|970|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-399|28|970|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-400|28|971|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-401|28|972|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-402|28|973|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-403|28|976|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-404|28|984|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-405|28|987|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-406|28|988|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-407|28|988|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-408|28|989|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-409|28|989|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-410|28|992|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-411|28|997|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-412|28|997|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-413|28|998|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-414|28|998|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-415|28|1000|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-416|28|1014|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-417|28|1016|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-418|28|1017|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-419|28|1018|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-420|28|1023|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-421|28|1023|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-422|28|1026|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-423|28|1027|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-424|28|1027|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-425|28|1027|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-426|28|1031|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-427|28|1034|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-428|28|1036|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-429|28|1040|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-430|28|1051|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-431|28|1061|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-432|28|1064|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-433|28|1074|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-434|28|1076|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-435|28|1086|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-436|28|1097|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-437|28|1100|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-438|28|1102|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-439|28|1104|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-440|28|1108|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-441|28|1111|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-442|28|1134|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-443|28|1139|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-444|28|1141|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-445|28|1142|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-446|28|1145|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-447|28|1156|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-448|28|1187|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-449|28|1223|n/a|n/a|n/a|
1003-22-28|n/a,W1|1| 100|gamma-rays Co-60|8.07|grays|External exposure| code W1 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|307 records survival 703 ± 9 lifespan study|1003-22-28-450|28|1262|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-1|29|150|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-2|29|219|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-3|29|225|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-4|29|236|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-5|29|239|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-6|29|246|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-7|29|257|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-8|29|259|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-9|29|260|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-10|29|264|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-11|29|270|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-12|29|270|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-13|29|271|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-14|29|271|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-15|29|271|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-16|29|271|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-17|29|271|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-18|29|271|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-19|29|271|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-20|29|271|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-21|29|271|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-22|29|271|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-23|29|277|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-24|29|277|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-25|29|278|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-26|29|278|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-27|29|278|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-28|29|278|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-29|29|278|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-30|29|278|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-31|29|278|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-32|29|278|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-33|29|278|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-34|29|278|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-35|29|281|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-36|29|284|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-37|29|285|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-38|29|285|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-39|29|285|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-40|29|285|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-41|29|285|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-42|29|289|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-43|29|289|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-44|29|289|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-45|29|289|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-46|29|289|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-47|29|289|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-48|29|289|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-49|29|289|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-50|29|289|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-51|29|289|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-52|29|291|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-53|29|291|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-54|29|295|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-55|29|296|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-56|29|296|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-57|29|296|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-58|29|296|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-59|29|296|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-60|29|296|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-61|29|296|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-62|29|296|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-63|29|296|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-64|29|296|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-65|29|298|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-66|29|299|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-67|29|301|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-68|29|302|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-69|29|302|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-70|29|303|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-71|29|305|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-72|29|305|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-73|29|306|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-74|29|306|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-75|29|308|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-76|29|308|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-77|29|309|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-78|29|309|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-79|29|309|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-80|29|309|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-81|29|309|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-82|29|309|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-83|29|309|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-84|29|310|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-85|29|313|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-86|29|314|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-87|29|317|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-88|29|317|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-89|29|317|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-90|29|317|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-91|29|319|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-92|29|319|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-93|29|319|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-94|29|319|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-95|29|319|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-96|29|320|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-97|29|320|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-98|29|320|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-99|29|320|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-100|29|320|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-101|29|321|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-102|29|321|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-103|29|323|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-104|29|324|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-105|29|324|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-106|29|324|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-107|29|324|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-108|29|325|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-109|29|325|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-110|29|326|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-111|29|326|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-112|29|327|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-113|29|327|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-114|29|327|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-115|29|327|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-116|29|327|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-117|29|327|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-118|29|327|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-119|29|327|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-120|29|330|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-121|29|331|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-122|29|331|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-123|29|331|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-124|29|331|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-125|29|331|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-126|29|331|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-127|29|332|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-128|29|332|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-129|29|333|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-130|29|333|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-131|29|333|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-132|29|334|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-133|29|334|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-134|29|335|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-135|29|337|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-136|29|337|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-137|29|337|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-138|29|338|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-139|29|338|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-140|29|339|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-141|29|341|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-142|29|341|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-143|29|343|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-144|29|344|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-145|29|344|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-146|29|344|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-147|29|345|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-148|29|345|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-149|29|345|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-150|29|345|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-151|29|346|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-152|29|346|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-153|29|346|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-154|29|346|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-155|29|346|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-156|29|346|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-157|29|346|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-158|29|346|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-159|29|346|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-160|29|346|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-161|29|346|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-162|29|346|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-163|29|346|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-164|29|346|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-165|29|347|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-166|29|348|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-167|29|351|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-168|29|351|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-169|29|351|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-170|29|352|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-171|29|352|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-172|29|352|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-173|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-174|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-175|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-176|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-177|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-178|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-179|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-180|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-181|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-182|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-183|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-184|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-185|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-186|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-187|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-188|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-189|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-190|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-191|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-192|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-193|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-194|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-195|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-196|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-197|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-198|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-199|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-200|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-201|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-202|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-203|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-204|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-205|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-206|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-207|29|353|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-208|29|354|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-209|29|354|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-210|29|354|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-211|29|354|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-212|29|355|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-213|29|356|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-214|29|356|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-215|29|357|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-216|29|357|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-217|29|358|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-218|29|358|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-219|29|359|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-220|29|359|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-221|29|359|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-222|29|359|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-223|29|360|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-224|29|360|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-225|29|360|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-226|29|360|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-227|29|360|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-228|29|360|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-229|29|360|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-230|29|360|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-231|29|360|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-232|29|360|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-233|29|360|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-234|29|361|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-235|29|362|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-236|29|366|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-237|29|367|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-238|29|367|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-239|29|368|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-240|29|368|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-241|29|369|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-242|29|369|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-243|29|370|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-244|29|370|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-245|29|372|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-246|29|372|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-247|29|372|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-248|29|373|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-249|29|375|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-250|29|375|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-251|29|377|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-252|29|379|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-253|29|379|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-254|29|379|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-255|29|379|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-256|29|379|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-257|29|380|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-258|29|380|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-259|29|381|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-260|29|382|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-261|29|383|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-262|29|383|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-263|29|383|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-264|29|385|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-265|29|386|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-266|29|386|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-267|29|386|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-268|29|387|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-269|29|390|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-270|29|393|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-271|29|393|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-272|29|394|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-273|29|394|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-274|29|394|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-275|29|395|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-276|29|396|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-277|29|397|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-278|29|397|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-279|29|397|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-280|29|399|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-281|29|400|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-282|29|400|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-283|29|400|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-284|29|401|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-285|29|401|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-286|29|402|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-287|29|404|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-288|29|404|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-289|29|406|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-290|29|406|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-291|29|406|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-292|29|407|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-293|29|407|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-294|29|407|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-295|29|408|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-296|29|409|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-297|29|411|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-298|29|413|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-299|29|414|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-300|29|414|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-301|29|414|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-302|29|414|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-303|29|416|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-304|29|416|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-305|29|417|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-306|29|422|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-307|29|423|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-308|29|424|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-309|29|424|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-310|29|425|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-311|29|426|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-312|29|426|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-313|29|427|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-314|29|427|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-315|29|428|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-316|29|428|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-317|29|429|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-318|29|432|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-319|29|433|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-320|29|433|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-321|29|435|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-322|29|435|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-323|29|436|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-324|29|436|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-325|29|437|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-326|29|438|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-327|29|439|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-328|29|439|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-329|29|440|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-330|29|441|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-331|29|442|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-332|29|444|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-333|29|445|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-334|29|445|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-335|29|446|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-336|29|446|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-337|29|447|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-338|29|447|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-339|29|448|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-340|29|449|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-341|29|450|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-342|29|450|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-343|29|451|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-344|29|454|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-345|29|456|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-346|29|457|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-347|29|458|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-348|29|460|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-349|29|463|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-350|29|463|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-351|29|465|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-352|29|465|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-353|29|465|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-354|29|467|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-355|29|468|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-356|29|469|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-357|29|471|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-358|29|471|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-359|29|471|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-360|29|473|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-361|29|473|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-362|29|474|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-363|29|474|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-364|29|474|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-365|29|474|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-366|29|474|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-367|29|474|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-368|29|474|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-369|29|475|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-370|29|475|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-371|29|477|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-372|29|477|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-373|29|478|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-374|29|478|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-375|29|481|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-376|29|481|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-377|29|481|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-378|29|481|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-379|29|481|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-380|29|484|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-381|29|485|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-382|29|486|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-383|29|486|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-384|29|486|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-385|29|486|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-386|29|486|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-387|29|486|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-388|29|487|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-389|29|488|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-390|29|488|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-391|29|491|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-392|29|493|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-393|29|493|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-394|29|493|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-395|29|493|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-396|29|493|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-397|29|495|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-398|29|495|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-399|29|495|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-400|29|495|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-401|29|495|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-402|29|498|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-403|29|499|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-404|29|502|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-405|29|502|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-406|29|514|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-407|29|515|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-408|29|518|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-409|29|521|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-410|29|522|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-411|29|523|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-412|29|523|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-413|29|525|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-414|29|525|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-415|29|534|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-416|29|537|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-417|29|538|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-418|29|541|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-419|29|544|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-420|29|548|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-421|29|551|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-422|29|552|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-423|29|553|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-424|29|555|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-425|29|557|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-426|29|558|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-427|29|561|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-428|29|562|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-429|29|568|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-430|29|569|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-431|29|570|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-432|29|570|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-433|29|571|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-434|29|571|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-435|29|574|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-436|29|574|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-437|29|576|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-438|29|581|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-439|29|582|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-440|29|584|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-441|29|586|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-442|29|586|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-443|29|588|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-444|29|589|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-445|29|593|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-446|29|593|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-447|29|597|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-448|29|598|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-449|29|600|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-450|29|600|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-451|29|606|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-452|29|610|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-453|29|611|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-454|29|611|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-455|29|615|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-456|29|620|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-457|29|621|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-458|29|625|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-459|29|626|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-460|29|626|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-461|29|627|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-462|29|627|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-463|29|629|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-464|29|630|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-465|29|631|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-466|29|633|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-467|29|633|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-468|29|633|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-469|29|633|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-470|29|634|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-471|29|634|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-472|29|636|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-473|29|639|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-474|29|641|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-475|29|641|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-476|29|649|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-477|29|655|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-478|29|659|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-479|29|661|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-480|29|661|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-481|29|664|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-482|29|667|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-483|29|674|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-484|29|676|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-485|29|678|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-486|29|678|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-487|29|680|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-488|29|683|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-489|29|685|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-490|29|687|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-491|29|691|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-492|29|691|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-493|29|706|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-494|29|713|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-495|29|713|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-496|29|720|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-497|29|726|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-498|29|733|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-499|29|780|n/a|n/a|n/a|
1003-22-29|n/a,W2|1| 100|gamma-rays Co-60|26.9|grays|External exposure| code W2 24 fractions 45 m 1/w|500 (500 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|333 records survival 351 ± 7 lifespan study|1003-22-29-500|29|782|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-1|30|134|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-2|30|148|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-3|30|148|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-4|30|218|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-5|30|218|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-6|30|218|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-7|30|218|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-8|30|218|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-9|30|225|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-10|30|271|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-11|30|271|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-12|30|271|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-13|30|271|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-14|30|271|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-15|30|271|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-16|30|271|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-17|30|271|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-18|30|271|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-19|30|271|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-20|30|271|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-21|30|271|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-22|30|271|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-23|30|271|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-24|30|285|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-25|30|285|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-26|30|285|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-27|30|285|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-28|30|285|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-29|30|285|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-30|30|285|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-31|30|285|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-32|30|285|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-33|30|285|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-34|30|289|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-35|30|289|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-36|30|289|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-37|30|289|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-38|30|289|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-39|30|289|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-40|30|289|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-41|30|289|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-42|30|289|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-43|30|289|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-44|30|296|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-45|30|296|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-46|30|296|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-47|30|296|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-48|30|296|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-49|30|296|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-50|30|296|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-51|30|296|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-52|30|296|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-53|30|296|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-54|30|298|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-55|30|309|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-56|30|309|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-57|30|309|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-58|30|309|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-59|30|309|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-60|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-61|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-62|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-63|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-64|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-65|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-66|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-67|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-68|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-69|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-70|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-71|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-72|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-73|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-74|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-75|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-76|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-77|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-78|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-79|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-80|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-81|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-82|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-83|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-84|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-85|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-86|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-87|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-88|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-89|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-90|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-91|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-92|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-93|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-94|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-95|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-96|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-97|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-98|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-99|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-100|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-101|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-102|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-103|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-104|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-105|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-106|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-107|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-108|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-109|30|347|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-110|30|369|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-111|30|369|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-112|30|375|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-113|30|390|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-114|30|418|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-115|30|422|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-116|30|435|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-117|30|441|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-118|30|449|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-119|30|458|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-120|30|474|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-121|30|474|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-122|30|474|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-123|30|474|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-124|30|474|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-125|30|474|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-126|30|474|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-127|30|474|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-128|30|474|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-129|30|474|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-130|30|485|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-131|30|488|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-132|30|492|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-133|30|492|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-134|30|500|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-135|30|502|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-136|30|503|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-137|30|510|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-138|30|519|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-139|30|520|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-140|30|527|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-141|30|544|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-142|30|548|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-143|30|557|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-144|30|563|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-145|30|572|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-146|30|579|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-147|30|589|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-148|30|593|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-149|30|595|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-150|30|596|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-151|30|597|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-152|30|598|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-153|30|601|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-154|30|610|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-155|30|610|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-156|30|613|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-157|30|614|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-158|30|617|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-159|30|621|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-160|30|626|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-161|30|637|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-162|30|638|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-163|30|639|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-164|30|642|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-165|30|642|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-166|30|643|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-167|30|656|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-168|30|657|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-169|30|661|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-170|30|666|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-171|30|666|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-172|30|673|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-173|30|677|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-174|30|680|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-175|30|680|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-176|30|687|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-177|30|688|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-178|30|690|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-179|30|690|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-180|30|699|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-181|30|701|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-182|30|702|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-183|30|703|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-184|30|703|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-185|30|703|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-186|30|703|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-187|30|703|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-188|30|704|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-189|30|704|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-190|30|704|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-191|30|704|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-192|30|704|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-193|30|706|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-194|30|706|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-195|30|706|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-196|30|712|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-197|30|712|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-198|30|713|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-199|30|713|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-200|30|713|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-201|30|714|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-202|30|718|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-203|30|719|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-204|30|719|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-205|30|719|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-206|30|720|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-207|30|722|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-208|30|723|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-209|30|727|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-210|30|729|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-211|30|732|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-212|30|733|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-213|30|736|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-214|30|736|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-215|30|736|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-216|30|737|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-217|30|737|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-218|30|738|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-219|30|738|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-220|30|743|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-221|30|747|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-222|30|747|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-223|30|750|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-224|30|753|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-225|30|753|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-226|30|754|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-227|30|760|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-228|30|764|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-229|30|764|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-230|30|765|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-231|30|765|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-232|30|765|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-233|30|767|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-234|30|767|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-235|30|772|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-236|30|772|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-237|30|782|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-238|30|783|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-239|30|788|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-240|30|792|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-241|30|793|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-242|30|795|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-243|30|795|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-244|30|796|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-245|30|797|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-246|30|799|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-247|30|799|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-248|30|803|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-249|30|804|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-250|30|805|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-251|30|806|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-252|30|806|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-253|30|806|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-254|30|806|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-255|30|808|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-256|30|808|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-257|30|808|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-258|30|811|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-259|30|811|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-260|30|815|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-261|30|815|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-262|30|817|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-263|30|817|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-264|30|817|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-265|30|817|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-266|30|817|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-267|30|820|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-268|30|820|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-269|30|820|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-270|30|823|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-271|30|823|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-272|30|823|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-273|30|823|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-274|30|823|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-275|30|823|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-276|30|827|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-277|30|827|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-278|30|828|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-279|30|831|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-280|30|835|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-281|30|835|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-282|30|836|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-283|30|838|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-284|30|838|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-285|30|841|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-286|30|842|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-287|30|843|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-288|30|847|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-289|30|847|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-290|30|850|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-291|30|851|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-292|30|853|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-293|30|854|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-294|30|854|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-295|30|857|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-296|30|859|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-297|30|859|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-298|30|860|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-299|30|863|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-300|30|864|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-301|30|866|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-302|30|868|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-303|30|868|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-304|30|869|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-305|30|870|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-306|30|870|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-307|30|870|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-308|30|871|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-309|30|871|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-310|30|872|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-311|30|872|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-312|30|873|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-313|30|875|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-314|30|877|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-315|30|877|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-316|30|878|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-317|30|879|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-318|30|883|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-319|30|885|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-320|30|885|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-321|30|886|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-322|30|891|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-323|30|892|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-324|30|893|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-325|30|894|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-326|30|895|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-327|30|897|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-328|30|897|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-329|30|899|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-330|30|901|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-331|30|905|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-332|30|910|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-333|30|911|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-334|30|914|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-335|30|917|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-336|30|918|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-337|30|922|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-338|30|925|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-339|30|928|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-340|30|932|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-341|30|939|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-342|30|939|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-343|30|943|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-344|30|946|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-345|30|946|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-346|30|949|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-347|30|951|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-348|30|953|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-349|30|957|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-350|30|958|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-351|30|958|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-352|30|960|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-353|30|962|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-354|30|964|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-355|30|964|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-356|30|967|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-357|30|967|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-358|30|969|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-359|30|983|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-360|30|984|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-361|30|985|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-362|30|985|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-363|30|987|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-364|30|988|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-365|30|988|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-366|30|989|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-367|30|990|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-368|30|991|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-369|30|992|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-370|30|993|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-371|30|995|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-372|30|997|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-373|30|1000|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-374|30|1003|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-375|30|1003|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-376|30|1010|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-377|30|1013|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-378|30|1013|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-379|30|1016|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-380|30|1016|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-381|30|1019|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-382|30|1026|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-383|30|1034|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-384|30|1034|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-385|30|1040|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-386|30|1040|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-387|30|1042|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-388|30|1043|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-389|30|1050|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-390|30|1061|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-391|30|1065|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-392|30|1070|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-393|30|1070|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-394|30|1073|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-395|30|1073|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-396|30|1080|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-397|30|1109|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-398|30|1135|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-399|30|1155|n/a|n/a|n/a|
1003-22-30|n/a,W1|1| 100|neutrons fission|0.8|grays|External exposure| code W1 24 fractions 45 m 1/w|400 (400 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|263 records survival 695 ± 10 lifespan study|1003-22-30-400|30|1280|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-1|31|127|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-2|31|141|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-3|31|151|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-4|31|211|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-5|31|211|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-6|31|211|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-7|31|211|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-8|31|211|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-9|31|225|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-10|31|248|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-11|31|252|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-12|31|258|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-13|31|271|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-14|31|278|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-15|31|278|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-16|31|278|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-17|31|278|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-18|31|278|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-19|31|278|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-20|31|278|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-21|31|278|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-22|31|278|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-23|31|278|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-24|31|278|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-25|31|278|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-26|31|278|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-27|31|278|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-28|31|278|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-29|31|285|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-30|31|285|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-31|31|285|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-32|31|285|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-33|31|285|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-34|31|285|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-35|31|285|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-36|31|285|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-37|31|285|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-38|31|285|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-39|31|289|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-40|31|289|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-41|31|289|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-42|31|289|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-43|31|289|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-44|31|289|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-45|31|289|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-46|31|289|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-47|31|289|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-48|31|289|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-49|31|289|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-50|31|290|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-51|31|296|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-52|31|296|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-53|31|296|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-54|31|296|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-55|31|296|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-56|31|296|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-57|31|296|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-58|31|296|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-59|31|296|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-60|31|296|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-61|31|300|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-62|31|306|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-63|31|312|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-64|31|329|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-65|31|329|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-66|31|329|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-67|31|329|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-68|31|329|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-69|31|345|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-70|31|346|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-71|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-72|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-73|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-74|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-75|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-76|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-77|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-78|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-79|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-80|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-81|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-82|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-83|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-84|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-85|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-86|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-87|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-88|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-89|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-90|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-91|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-92|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-93|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-94|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-95|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-96|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-97|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-98|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-99|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-100|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-101|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-102|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-103|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-104|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-105|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-106|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-107|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-108|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-109|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-110|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-111|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-112|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-113|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-114|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-115|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-116|31|347|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-117|31|352|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-118|31|355|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-119|31|369|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-120|31|371|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-121|31|377|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-122|31|379|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-123|31|381|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-124|31|386|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-125|31|396|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-126|31|398|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-127|31|402|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-128|31|406|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-129|31|408|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-130|31|408|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-131|31|408|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-132|31|416|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-133|31|420|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-134|31|421|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-135|31|425|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-136|31|428|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-137|31|428|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-138|31|431|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-139|31|432|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-140|31|432|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-141|31|434|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-142|31|435|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-143|31|438|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-144|31|439|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-145|31|443|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-146|31|446|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-147|31|447|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-148|31|447|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-149|31|449|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-150|31|450|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-151|31|456|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-152|31|463|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-153|31|470|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-154|31|473|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-155|31|473|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-156|31|474|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-157|31|474|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-158|31|474|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-159|31|474|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-160|31|474|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-161|31|474|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-162|31|474|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-163|31|474|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-164|31|474|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-165|31|477|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-166|31|479|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-167|31|481|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-168|31|481|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-169|31|481|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-170|31|481|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-171|31|481|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-172|31|482|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-173|31|498|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-174|31|500|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-175|31|501|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-176|31|501|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-177|31|505|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-178|31|506|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-179|31|506|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-180|31|507|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-181|31|507|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-182|31|516|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-183|31|516|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-184|31|516|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-185|31|516|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-186|31|516|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-187|31|519|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-188|31|522|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-189|31|523|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-190|31|527|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-191|31|529|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-192|31|529|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-193|31|530|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-194|31|530|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-195|31|530|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-196|31|530|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-197|31|531|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-198|31|533|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-199|31|533|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-200|31|534|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-201|31|535|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-202|31|538|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-203|31|543|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-204|31|544|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-205|31|547|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-206|31|548|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-207|31|548|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-208|31|549|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-209|31|550|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-210|31|551|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-211|31|551|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-212|31|551|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-213|31|556|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-214|31|557|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-215|31|557|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-216|31|559|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-217|31|561|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-218|31|565|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-219|31|568|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-220|31|569|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-221|31|570|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-222|31|573|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-223|31|574|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-224|31|575|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-225|31|576|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-226|31|577|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-227|31|577|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-228|31|580|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-229|31|580|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-230|31|589|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-231|31|589|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-232|31|593|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-233|31|596|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-234|31|599|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-235|31|599|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-236|31|599|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-237|31|599|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-238|31|599|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-239|31|601|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-240|31|602|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-241|31|603|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-242|31|603|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-243|31|603|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-244|31|604|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-245|31|607|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-246|31|609|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-247|31|611|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-248|31|613|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-249|31|614|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-250|31|614|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-251|31|615|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-252|31|619|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-253|31|619|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-254|31|623|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-255|31|624|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-256|31|628|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-257|31|630|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-258|31|631|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-259|31|632|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-260|31|634|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-261|31|634|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-262|31|634|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-263|31|634|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-264|31|634|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-265|31|635|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-266|31|635|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-267|31|636|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-268|31|636|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-269|31|637|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-270|31|637|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-271|31|637|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-272|31|638|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-273|31|639|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-274|31|641|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-275|31|641|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-276|31|641|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-277|31|641|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-278|31|641|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-279|31|641|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-280|31|641|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-281|31|641|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-282|31|641|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-283|31|642|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-284|31|642|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-285|31|642|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-286|31|642|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-287|31|647|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-288|31|648|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-289|31|649|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-290|31|649|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-291|31|649|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-292|31|649|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-293|31|651|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-294|31|652|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-295|31|653|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-296|31|653|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-297|31|653|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-298|31|653|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-299|31|654|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-300|31|658|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-301|31|659|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-302|31|660|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-303|31|663|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-304|31|668|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-305|31|669|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-306|31|669|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-307|31|673|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-308|31|673|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-309|31|673|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-310|31|681|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-311|31|681|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-312|31|684|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-313|31|685|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-314|31|685|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-315|31|687|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-316|31|687|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-317|31|687|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-318|31|688|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-319|31|688|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-320|31|689|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-321|31|691|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-322|31|691|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-323|31|692|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-324|31|694|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-325|31|698|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-326|31|700|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-327|31|701|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-328|31|701|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-329|31|701|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-330|31|702|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-331|31|702|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-332|31|704|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-333|31|705|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-334|31|707|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-335|31|708|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-336|31|710|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-337|31|711|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-338|31|712|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-339|31|713|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-340|31|713|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-341|31|713|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-342|31|715|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-343|31|716|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-344|31|719|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-345|31|719|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-346|31|722|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-347|31|722|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-348|31|724|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-349|31|727|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-350|31|729|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-351|31|730|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-352|31|731|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-353|31|733|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-354|31|736|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-355|31|739|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-356|31|739|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-357|31|741|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-358|31|741|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-359|31|741|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-360|31|741|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-361|31|743|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-362|31|745|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-363|31|751|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-364|31|753|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-365|31|758|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-366|31|760|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-367|31|763|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-368|31|763|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-369|31|764|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-370|31|764|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-371|31|765|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-372|31|767|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-373|31|771|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-374|31|772|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-375|31|773|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-376|31|774|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-377|31|775|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-378|31|775|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-379|31|775|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-380|31|778|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-381|31|778|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-382|31|779|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-383|31|781|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-384|31|781|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-385|31|781|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-386|31|782|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-387|31|782|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-388|31|782|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-389|31|786|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-390|31|787|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-391|31|796|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-392|31|796|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-393|31|802|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-394|31|802|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-395|31|804|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-396|31|806|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-397|31|807|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-398|31|808|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-399|31|809|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-400|31|809|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-401|31|809|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-402|31|811|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-403|31|813|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-404|31|814|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-405|31|816|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-406|31|816|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-407|31|816|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-408|31|817|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-409|31|821|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-410|31|823|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-411|31|823|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-412|31|823|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-413|31|824|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-414|31|828|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-415|31|829|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-416|31|831|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-417|31|835|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-418|31|837|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-419|31|841|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-420|31|842|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-421|31|843|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-422|31|844|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-423|31|849|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-424|31|849|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-425|31|850|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-426|31|855|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-427|31|862|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-428|31|864|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-429|31|865|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-430|31|866|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-431|31|870|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-432|31|873|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-433|31|876|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-434|31|883|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-435|31|884|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-436|31|891|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-437|31|899|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-438|31|903|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-439|31|913|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-440|31|915|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-441|31|930|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-442|31|935|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-443|31|935|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-444|31|939|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-445|31|947|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-446|31|990|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-447|31|999|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-448|31|1022|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-449|31|1035|n/a|n/a|n/a|
1003-22-31|n/a,W2|1| 100|neutrons fission|2.4|grays|External exposure| code W2 24 fractions 45 m 1/w|450 (450 in ERA)|Mouse|Mouse, B6CF1|Female|Juvenile|292 records survival 554 ± 10 lifespan study|1003-22-31-450|31|1061|n/a|n/a|n/a|
		
